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ABSTRACT
THE STEREOSELECTIVE SYNTHESIS OF FUNCTIONALISED 
CYCLOBUTANOLS VIA THE SAMARIUM(II)-MEDIATED 
CYCLISATION OF UNSATURATED ALDEHYDES
Samarium(II) iodide continues to prove an incredibly versatile reagent in organic 
synthesis. y,5-Unsaturated aldehydes having a fully substituted centre in the a- position, 
have been prepared from substituted y-butyrolactones and undergo efficient 4-exo-trig 
cyclisation on treatment with samarium(II) iodide to give functionalised cyclobutanols. In 
all cases when the olefin has F-geometry, cyclisation occurs with complete 
diastereocontrol to give flwfr'-cyclobutanol products. The importance of olefin geometry 
on the stereochemical outcome in the cyclisation is discussed. The stereochemistry of the 
products has been confirmed by NOE and X-ray crystallographic studies. In the 
cyclisation of substrates having a third substituent on the double bond, a - to the ester, 
significant control is achieved at the third newly formed stereocentre lying outside the 
ring. The origin of the stereoselectivity at this third centre and its marked dependence on 
cosolvent are discussed. The application of this novel methodology in an approach to the 
core of pestalotiopsin A is also discussed. Pestalotiopsin A is a structurally unique 
caryophyllene-type sesquiterpene which has shown immunosuppressive activity and 
cytotoxicity in preliminary assays. Our approach is based upon our samarium(II)- 
mediated 4-^xo-trig cyclisation and a trans-lactonisation process triggered by the addition 
of alkylytterbium reagents to a cyclobutanone intermediate.
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Abbreviations
A Angstrom
Ac acetyl
AIBN 2,2’-azobis(2-methylpropionitrile)
Anal. combustion analysis
aq. aqueous
Ar aryl
Bn benzyl
Boc tert- butoxycarbonyl
Bz benzoyl
rc-BuLi «-butyllithium
s-BuLi 5-butyllithium
f-BuLi r-butyllithium
CAN cerric ammonium nitrate
CSA camphorsulfonic acid
Cl chemical ionisation
d days
D dextro rotary
A reflux
DBU l,8-diazabicyclo[5.4.0]undec-7-ene
DBM dibenzoylmethane
DCC N,N’-dicyclohexylcarbodiimide
de diastereoisomeric excess
DIBALH diwo-butylaluminium hydride
DMAP 4-dimethylaminopyridine
DMF A,A’-dimethylformamide
DMPU 1,3 -dimethyl- 3,4,5,6-tetrahy dro-2 (1H)-
pyrimidinone 
DMSO dimethyl sulfoxide
dr diastereoisomeric ratio
El electron impact
eq equivalents
er enantiomeric ratio
Et ethyl
FAB fast atom bombardment
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g gram
h hour
HMPA hexamethylphosphoramide
HOMO highest occupied molecular orbital
HRMS high resolution mass spectrometry
IR infrared
KHMDS potassium hexamethyldisilazide
L levo rotary
LDA lithium di/so-propylamide
LRMS low resolution mass spectrometry
LUMO lowest unoccupied molecular orbital
M molar
mCPBA raeta-chloroperbenzoic acid
Me methyl
mg milligram
MHz megaHertz
min minute
ml millilitre
mmol millimole
MOM methoxymethyl
mp melting point
Ms methanesulfonyl
MS molecular sieves
n normal
NBS A-bromosuccinimide
NMO 4-methylmorpholine A-oxide
NMR nuclear magnetic resonance
nOe nuclear Overhauser effect
PCC pyridinium chlorochromate
Ph phenyl
PMB 4-methoxybenzyl
PPTS pyridinium para-toluenesulfonate
Pr Propyl
pTSA para-toluene sulfonic acid
py pyridine
rt room temperature
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SOMO singularly occupied molecular orbital
SPS solid phase synthesis
t tertiary
TBDMS terf-butyldimethylsilyl
TBSCN terr-butyldimethylsilyl cyanide
TBDPS terf-butyldiphenylsilyl
Tf trifluoromethanesulfonate (triflate)
THF tetrahydrofuran
TIPS tri/so-propylsilyl
TMSC1 trimethylsilyl chloride
TPAP tetrapropylammonium perruthenate
Ts pflra-toluenesulfonyl
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Chapter 1: Samarium(II) iodide-mediated cyclisations in natural 
product synthesis 
1.1 Introduction
Since its introduction to the synthetic community by Kagan in 1977,1’ 2 samarium(II) 
iodide (Sml2) has established itself as a versatile single electron reducing agent. Part of 
the reagent’s popularity arises from its ability to mediate both radical and anionic 
processes and sequences involving both.311 It has been utilised in a wide range of 
synthetic transformations ranging from functional group interconversions to carbon- 
carbon bond forming reactions which include Barbier and Reformatsky reactions, pinacol 
and ketyl-olefin couplings. The reagent is often highly chemoselective and 
transformations instigated by Sml2 tend to proceed with high degrees of stereoselectivity. 
Adding to its appeal, the reactivity, chemoselectivity and stereoselectivity of Sml2 can be 
manipulated and fine-tuned by the addition of various salts and cosolvents to the reaction 
mixture.12 This later feature of the reagent, although still poorly understood, is currently 
an area of considerable potential. Amongst its various roles, the lanthanide reagent is 
arguably most often employed for the formation of carbocycles and heterocycles of 
varying ring size. In this review we will examine the use of Sml2 mediated cyclisation 
reactions in the synthesis of natural products.
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1.2. Carbon-carbon bond forming processes mediated by Sml2
In the following introductory section the main C-C bond forming Sml2 mediated 
processes are outlined and their mechanisms discussed. The aim of this section is to 
provide a brief introduction to the reagent and its reactions prior to a discussion of its use 
in natural product synthesis.
1.2.1. The Sml2 mediated Barbier reaction
The Sml2 mediated Barbier reaction has been well documented in the literature.2,8’10,13 Its 
advantage over the Mg, Li and Zn mediated Barbier reactions is that the Sml2 reaction is 
homogenous and highly chemoselective. Primary, secondary, allylic and benzylic halides 
as well as 1-iodoalkynes can be used in the transformation, although it has its limitations 
in that aryl, vinyl and tertiary halides do not normally give satisfactory results. As with 
many Sml2 reactions, HMPA increases the rate of the reaction.14 Such an accelerating 
effect has also been observed when adding Nil2 15 and ferric salts, such as FeCl3 2 and 
Fe(DBM)3,16 to the reaction mixture.
Ambiguity still surrounds the mechanism of many Sml2 mediated reactions. To enable 
the reader to appreciate the complexities of defining a mechanism for these reactions, a 
detailed discussion of the mechanism of the Sml2 mediated Barbier reaction has been 
included. Less detailed accounts of other important Sml2 mediated C-C bond forming 
reactions will then follow.
12
I.2 .I.I. Mechanism of the Sml2 mediated Barbier reaction
No definitive mechanism has been established for the intermolecular Sml2 Barbier 
reaction, with four possible mechanisms currently being postulated.17 Even more 
ambiguity surrounds the mechanism of the intramolecular Barbier reaction. Before 
discussing the intramolecular reaction it is important to look at the possible pathways for 
the intermolecular reaction.
The first mechanistic possibility involves the addition of a ketone dianion 1 to the halide 
in an SN2 type reaction (figure l .l ) .18
1
figure 1.1
Little evidence for this mechanism exists, although, in the attempted intramolecular 
Barbier reaction of 2 conducted by Molander (scheme 1.1), reduction of the ketone 
carbonyl in the presence of the iodide gives some support to this postulated mechanism.19
2
Sml2
wTHF, —78°C 
93% 
dr 2:1
3
scheme 1.1
The ketone dianion mechanism, however, has generally been dismissed following 
experiments by Kagan.18 A Sml2 mediated Barbier reaction carried out between optically
13
active (-) 2-bromooctane 4 and cyclohexanone 5 resulted in racemic product 6 (scheme 
1.2 ).
4 5 6
scheme 1.2
Due to the stereospecific nature of an SN2 mechanism, the isolation of a racemic product 
strongly indicates a different reaction pathway. The result also rules out a possible 
alternative ketyl radical SH2 attack on the halide since again, the reaction would be 
expected to proceed stereoselectively.17
The remaining three mechanisms all involve a radical intermediate accessed via the 
halide. The reaction carried out by Kagan shown in scheme 1.3 provides evidence for the 
Sml2 Barbier reaction progressing through a radical intermediate derived from the 
halide.18 In this experiment the use of a hexenyl radical-clock system shows a radical 
intermediate is involved since the initial radical formed from l-bromo-5-hexene 8 
irreversibly cyclises to form the methylcyclopentyl radical which then proceeds to give 
the Barbier addition products.20
7 8 9 10
scheme 1.3
The first of the three remaining mechanisms involves the addition of a radical to the 
carbonyl.9 There is precedent in the literature for such mechanisms in radical reactions 
involving Bu3SnH.21'23 However, there is little evidence to support the mechanism in Sml2
14
Barbier reactions, and Curran has recently dismissed the mechanism.17 Curran argues that 
radical addition to a ketone carbonyl is considerably slower than to an aldehyde yet the 
Barbier reaction of halides and ketones is more efficient than that of aldehydes. Curran 
also believes the rate of addition of radicals to carbonyls would be far slower than the 
lifetime expected for a radical under Sml2 reductive conditions, i.e. the radical would be 
prone to reduction to the corresponding anion. Independent experimental observations 
have also led Kagan to dismiss this mechanism.24 In a model system designed to shed 
light on the mechanism, n-dodecyl iodide was treated with Sml2 in the presence of 
cyclobutanone (scheme 1.4). If the reaction proceeded by radical attack on the carbonyl 
then the resultant, highly strained cyclobutylalkoxy radical 12 would be expected to 
undergo fast P-scission to give the acyclic ketone 13. However, cyclobutanol 14 was 
obtained from the reaction and none of the ketone 13, or any other fragmentation 
products, were observed clearly suggesting that the reaction does not proceed by this 
mechanism.
SmU
nC12H25l ► r  
11
RSml,
Ci2H2
DSm(lll)
C19H0
C „H ,
Sml2 Sml2 THF
s ' Sml2
C.0H0
13
OH
-C „H ,
90%
14
scheme 1.4
15
Further model studies using benzyl bromide as the radical precursor with the slow 
addition of Sml2 in an attempt to encourage the radical pathway, again showed the 
absence of fragmentation. In general then, it is possible to dismiss the addition of a 
radical to a ketone or aldehyde as the mechanism of the Sml2 mediated Barbier reaction.
The remaining two possible mechanisms are much stronger possibilities. The third 
mechanism involves the coupling of a ketyl radical anion and a radical derived from the 
halide (figure 1.2), while the fourth mechanism and the most widely accepted, involves 
the addition of an organosamarium, or carbanion, to the carbonyl.
R 1 X  +  S m lj — ►  r *  +  S m ljX
figure 1.2
Evidence supporting the ketyl radical anion-radical coupling mechanism has been 
gathered by Kagan (in addition to the previous reaction scheme 1.4, which could be 
explained by such a mechanism).18 When halide 11 was treated with Sml2 in the presence 
of ketone 15 (scheme 1.5) the product mixture was closely examined. Amongst the 
complex product mixture was a small quantity of pinacol coupling product 17 and various 
solvent adduct products. From the product mixture, it is clear that both alkyl and ketyl 
radicals are present in the reaction mixture. However the result is inconclusive since 
although it confirms the presence of both alkyl and ketyl radicals, it does not give direct
16
information about the mechanism of the Barbier reaction. The products detected could 
easily be the result of competitive side reactions.
P H OH
1  ■ o  u  -  1 ' T ~ C , H , 3
CH,
■/6n 13 " a -  - 6 ' i a  \ ^ Q
15 11 16
(75%) (8%) (3%) (1%)
+ I C12H25 H + ^12^26 + .F  +
^  H sC r c . h ”  25 H3C ^ C 6H,3
(1%) 17 (1%) 
(1%)
schem e 1.5
Further observations have been noted which appear to provide evidence for the 
mechanism, however, on closer examination this evidence is found to be largely 
circumstantial. For example, the observation that in the absence of alkyl halides, ketones 
and aldehydes can be reduced to alcohols or undergo pinacol coupling merely shows that 
ketyl radicals can be formed, but does not really give any mechanistic insight into the 
Barbier reaction with alkyl halides.17
Trapping experiments with D20  conducted by Kagan on alkyl halides reduced by Sml2, 
under essentially ‘Grignard’ conditions, did not result in deuterated alkyl products, 
instead giving the unlabelled reduction product.18 Furthermore, the reaction of alkyl 
halides with ketones in the presence of Sml2, again under Grignard conditions, gave no 
addition products. Such results can be interpreted as being indicative of the existence of 
an alkyl radical (which abstracts a hydrogen atom from the solvent). There is, however, 
substantial evidence against the ketyl radical anion-radical coupling mechanism.
17
In Curran’s argument against the mechanism he points out that aryl ketones are reduced 
more easily than dialkyl ketones yet, using “Kagan’s original Sml2 procedure”, the 
reduction of dialkyl ketones gives far better results. If aryl ketones form ketyl radical 
anions more efficiently than dialkyl ketones then, if this mechanism were correct, they 
should undergo more efficient Barbier reactions.17 This is not the case. Another 
discrepancy cited by Curran is the fact that when using tertiary halides in the reaction, the 
yield drops considerably and the reaction is inefficient. If the reaction proceeded by a 
ketyl radical anion-radical pathway such a poor result would be unexpected. Tertiary 
radicals are stable and easily formed and such low yields would appear to suggest the 
Barbier reaction does not proceed via such a radical.
The remaining mechanism to be discussed is the alkylsamarium addition to the carbonyl 
group (figure 1.3).
R ,— X + Sm^ — ► R, + SmlgX
R, + Smlj — ► R, — SmljX
figure 1.3
Curran has provided substantial evidence for this mechanism.17 D20  quenching studies on 
iodide 18 after treatment with Sml2 indicated the existence of an organosamarium 
(scheme 1.6). It was reasoned that the aryl radical was initially formed which then 
underwent 5-exo-tvig cyclisation to form a primary radical. Further reduction by Sml2
18
then gave the alkylsamarium and subsequent quenching with D20  resulted in efficient 
deuterium incorporation to give 19.
D
1. Sml2 
HMPA, THF -H
+
O 2. D -0 ' O '9 7 :3
80-90% 90% deuterium 
incorporation18 20
19
scheme 1.6
The result from this experiment would appear to contradict quenching studies carried out 
by Kagan, mentioned previously. Curran explains that Kagan’s conditions were harsh 
enough and the reaction time long enough to allow for the decomposition of 
alkylsamarium formed. Further evidence was also obtained in studies where, again 
following the Grignard procedure, the iodide 21 was added to a solution of Sml2 (scheme 
1.7).25 After loss of the blue/purple colour, 2-octanone was added. The formation of the 
tertiary alcohol 22 would suggest that attack on the carbonyl by an alkylsamarium had 
occurred. However, although these results certainly indicate the formation of an 
alkylsamarium, the studies were carried out under Grignard conditions, and not Barbier 
conditions (Grigard conditions involve the addition of the electrophile to a mixture of the 
halide and Sml2. Barbier conditions differ in that Sml2 is added to a mixture of the halide 
and electrophile).
THF, 25°C, 5 min 
80%
Sml2
HMPA
21 22
scheme 1.7
19
Having shown that alkylsamariums participate in Sml2 Grignard conditions, Curran 
designed studies that would shed some light on whether alkylsamariums also participate 
in Barbier reactions.25 He proposed that if the mechanism is the same under both Sml2 
Grignard and Barbier conditions, then the degree of stereoselectivity should be similar in 
the reaction of iodide 24 with 4-tert-butyl cyclohexanone 23 under both sets of 
conditions. The results showed similar stereoselectivity in the formation of 25 and adds 
weight to the intermediacy of alkylsamariums in the reaction (scheme 1.8).
Grignard conditions 91 : 9 88% 
Barbier conditions 97 : 3 86%
scheme 1.8
Even more ambiguity surrounds the mechanism of the intramolecular Barbier reaction 
with a lack of evidence supporting any of the above mechanisms for the cyclisation.26 
Studies by Molander have indicated that the intramolecular reaction probably does not 
proceed by a ketyl radical anion-radical coupling mechanism (scheme 1.9).27 In the 
cyclisation of ketone 26, no fragmentation from ring opening of a cyclopropyl carbinyl 
ketyl was observed in the formation of 27, which suggests that a ketyl radical anion was 
not formed in the reaction.
26
scheme 1.9
Sml2
Fe(DBM)3
THF, —78°C to 0°C, 2h 
75% 
dr 3:1
27
20
In an independent study by Curran, a similar observation was made (scheme 1.10).26 
Cyclopropyl ketone 28 undergoes smooth cyclisation to give 29 with no fragmentation 
observed.
THF, 23°C, 1h 
61% 
dr 2:1
Sml2
HMPA
28 29
scheme 1.10
Molander also conducted an experiment designed to show the existence of an 
alkylsamarium.27 p-Elimination of the methoxy group in 30 on treatment with Sml2 
clearly suggests the formation of an alkylsamarium (scheme 1.11). This report combined 
with a reported deuterium trapping study in the same paper certainly provides evidence 
for the alkylsamarium mechanism. Curran argues however, that caution is required when 
drawing conclusions from the experiment, as the presence of the a-heteroatom could 
quite conceivably change the reduction potential of the halide, thus resulting in a less than 
general result.26
Work by Curran has also provided inconclusive results.26 In an experiment designed to 
show the existence of an organosamarium, the cyclisation of iodide 32 was performed 
under a variety of Sml2 concentrations (scheme 1.12). In the event of the formation of an 
alkylsamarium the ratio of 33 formed to 34 and 35 should increase with increased Sml2 
concentration, as the existence of radicals becomes shorter lived with increased
Sml2
Fe(DBM)
30 31
scheme 1.11
21
concentration therefore less radical cyclisation products should be observed. However the 
opposite effect occurred. Other experiments were carried out by Curran in the study 
which provided equally puzzling results.
Sml.
HMPA 
THF, 23°C, Ih
Concentration 
Sml2 (M)
0.01
0.07
33
64%
20%
34
2 1 %
59%
35
11%
15%
36
4%
6%
scheme 1.12
In this section we have sought to illustrate the mechanistic ambiguity of the Sml2 Barbier 
reaction, an ambiguity which also surrounds many other important processes mediated by 
Sml2. Whatever the mechanism, the Sml2 mediated Barbier cyclisation has been used to 
great effect in many syntheses of natural products {vide infra).
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1.2.2. Reductive Radical Reactions
Simple Sml2 radical cyclisations have also been used in natural product synthesis. 
Radical generation in such cyclisations is normally achieved by the reduction of halides 
and sulfonates, etc. In the majority of radical cyclisations, the radical acceptor is either an 
olefin or an alkyne although examples involving hydrazones have also been reported.
Few simple intermolecular, reductive radical reactions mediated by Sml2 have been 
reported,28'30 however reductive radical cyclisations mediated by Sml2 have much 
precedent and provide an attractive alternative to Bu3SnH mediated reactions. The 
reac tion  itse lf  is a v ersa tile  p rocess w ith ha lides, N-((N’,N’- 
dialkylamino)alkenyl)benzotriazoles,31 and cyclopropyl ketones32 all being used as the 
radical precursors. The radicals formed have then been employed in cyclisations on to 
various functional groups including alkenes, alkynes and hydrazones.33,34 With the 
ability of Sml2 to further reduce carbon centred radicals to carbanions, it is important that 
the rate of cyclisation is faster than the rate of the second reduction. In order to aid 
cyclisation, reactions are often performed at low concentration of reagent. Work by 
Bennet has demonstrated the utility of Sml2 as an alternative to Bu3SnH,35 and Inanaga 
has reported cyclisations to form various heterocycles such as benzofurans, 
naphthofurans and indoles (scheme 1.13 and 1.14).36
H
MeCN, rt, 6h 
59%
Sml2
HMPA
H
37 38
scheme 1.13
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Sml2
HMPA
MeCN, rt, 6h
89%
scheme 1.14
The methodology can be extended to involve conjugate addition reactions, with a,P- 
unsaturated esters, amides, nitriles, lactones and lactams being used as the radical 
acceptor.37 Again, various heterocycles can be accessed using such reactions.31,38 A recent 
report by Guibe demonstrates that strained cyclopropane systems can also be prepared 
using this methodology (scheme 1.15).39
C 0 2Bn
41
scheme 1.15
Sml2
HMPA. >BuOH __ __
 :--------► C 0 2Bn
THF, rt, 5 min ^
42
1.2.2.1. Reductive Radical Cyclisations -  The Mechanism
In Bennett’s radical cyclisation of iodide 43 to give cyclopentane 46, it is proposed that 
the reaction proceeds by reduction of the halide to form the radical 44 (figure 1.4).35 
Cyclisation then occurs to form vinyl radical 45 which then abstracts a hydrogen atom 
from the solvent before a second Sml2 reduction can occur. Failure to obtain any 
deuterium incorporated products in D20  quenching studies adds support to this 
mechanism.
24
43 44 45 46
figure 1.4
It would appear probable that this is the usual mechanism for these types of reactions, 
however, whether hydrogen atom capture or proton capture terminates the sequence is 
probably dependent upon the type of radical formed after cyclisation and the specific 
reaction conditions. Indeed, in studies by Curran upon iodide 47, deuterium incorporation 
in the formation of 48 suggests proton capture is the final step (scheme 1.16),40 the 
second Sml2 reduction occurring before hydrogen atom capture can occur.
1. Sml2 
HMPA 
THF, 25°C
80%
47 48
scheme 1.16
I.2.2.2. Reductive Radical Conjugate Addition - The Mechanism
Three possible mechanisms exist for radical conjugate addition cyclisations.37 The first 
involves the Michael addition of a radical generated from the halide. The second involves 
the conjugate addition of an organosamarium. The last possibility entails the formation of 
a metal radical enolate species which attacks the halide in a SH2 manner. Studies by 
Molander support the radical Michael addition mechanism by discrediting the other two 
possibilities.37 The fact that the reactions proceed in the presence of a proton source 
would appear to rule out the later two mechanisms. In addition, the successful cyclisation
25
of iodide 49 proceeds with no p-elimination of the acetoxy group indicating that no 
organosamarium is formed in the cyclisation (scheme 1.17).
EtO
Sml2 
Nil2, <BuOH
THF, —78°C to rt 
77%
OAc
49
CO,Et
major
s yn /a n ti 2.5:1
scheme 1.17
Molander also suggests that the successful cyclisation of iodide 51 (scheme 1.18) 
indicates that the formation of a metal radical enolate (figure 1.5) is unlikely. Such a high 
yield of the cyclic product would not be expected due to competitive intramolecular 
proton transfer from the unprotected hydroxyl.
EtO, 1. Sml2
Nil2,'BuOH 
THF,—78°Cto rt
2‘ Ac20 , DMAP 
py, rt, 18h 
71%
scheme 1.18
— CO,Et
major
s yn /a n ti 1:1.4
OAc
52
figure 1.5
1.2.3. Reformatsky and aldol-type reactions
The Sml2 mediated Reformatsky reaction provides a useful alternative to the zinc 
mediated reaction with the main advantage that the reaction is homogenous. Again it is in 
the intramolecular sense that the Sml2 Reformatsky reaction has been used to greatest 
effect with cyclisations giving high yields and proceeding with high levels of
26
stereocontrol. For example, treatment of a-bromo ester 53 with Sml2 gives lactone 54 as 
a single diastereoisomer (scheme 1.19).41
The intermolecular reaction usually involves Barbier-type conditions where the a-halo 
ester, aldehyde or ketone and Sml2 are in the same pot. When Grignard conditions are 
used, side reactions are observed.42'44 Both chlorides and bromides have been used as 
substrates in these reactions. The intramolecular reaction has been used to access medium 
and large rings, carbocycles and lactones. The successful formation of such rings, 
Inanaga suggests, could be assisted by the large ionic radius of samarium, its flexible co­
ordination number and its high oxophilicity;45 the lanthanide centre effectively bringing 
the two reacting centres together through chelation.
53 54
scheme 1.19
27
I.2.3.I. Mechanism of Reformatsky and aldol-type reactions
It is generally believed that the intermolecular and intramolecular Reformatsky reactions 
progress through a samarium(III) enolate (figure 1.6).41,45
o
Smlj P  Sml2 OSml2
Rl^ Cf \* Rlvc r ^
Br
55 56 57
O
r2^ r3
SmL
R3R2 3 R,
59 58
figure 1.6
It would seem likely that a similar mechanism is occurring in the Sml2 aldol reaction, 
however, studies by Zhang would appear to indicate an alternative route for enolate 
formation (scheme 1.20).46 [Although it should be noted that the reaction was performed 
under Grignard type conditions]. Zhang found that optimal conditions for the 
transformation involved the use of equimolar amounts of a-halo ketone 60, aldehyde 61 
and Sml2. Strangely, when two equivalents of Sml2 were employed, only a 5% yield of 
the enone 62 was observed.
1  +
I Ph H THF, rt. 1h P f i ^ ^  Ph
Br 75%
60 61 62
scheme 1.20
Following the detection of I2 and/or IBr in the reaction mixture, Zhang has proposed two 
different mechanisms for enolate formation (figure 1.7).
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1.2.4. Ketyl-olefin coupling reactions
The Sml2 mediated ketyl-olefin reaction is a widely documented reaction with a wealth of 
precedent for both intermolecular and intramolecular reactions. The intramolecular 
reaction is particularly useful and allows a variety of cyclic alcohols of varying ring sizes 
to be assembled under mild conditions with normally high stereoselectivities being 
observed.19,47 The highly stereoselective nature of the reaction is demonstrated by the 
formation of bicyclic alcohol 69 from the cyclopentanone 68 (scheme 1.21).
Both aldehydes and ketones can be employed as the ketyl radical anion precursor and 
both activated and unactivated olefins and alkynes have been employed as radical 
acceptors in cyclisations.5 In the majority of cases, the olefin geometry has been found to
Sml2 
HMPA, 'BuOH
THF, rt, 20 mins 
80%
68
dr = >99:1 
69
scheme 1.21
have an effect upon the stereochemical outcome of the reaction. The reaction has also 
been used for the synthesis of a variety of heterocycles.5,48,49
I.2.4.I. Ketyl-olefin coupling mechanism
The most generally accepted mechanism for Sml2 mediated ketyl-olefin reactions is 
shown in figure 1.8. Reduction of the aldehyde or ketone carbonyl with Sml2 gives a 
samarium ketyl radical anion 71. The ketyl radical anion then attacks the double bond to 
form a new carbon-carbon bond 72. A second Sml2 reduction results in the formation of 
an enolate 73, which is protonated by the alcohol cosolvent or upon aqueous work up.
O OSml2A, A OSml,„(<)
j( l- L '^ v ' co*R2 0R!
70 71 72
|  Sml2
B1 B1
-OH ^  S^O Sm L ^  OSml m^l,
n « ) l  ff 2£L n« M  j f  SSL n( 0
OR2 ^ ^ O R 2 'O R 2
75 74  73
figure 1.8
Studies undertaken by Molander support this mechanism. Following the successful 
cyclisation of the keto-ester 76 by Sml2 in methanol, the reaction was repeated in the 
presence of deuterated methanol (scheme 1.22). More than 90% deuterium incorporation 
in the cyclopentanol product 77 indicating the existence of the anion.50 Additional 
evidence for this mechanism comes from the observation that at least two equivalents of 
Sml2 are required for the reaction to progress to completion.
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scheme 1.22
1.2.5. Pinacol couplings
Sml2 has been used to mediate the pinacol coupling reactions of both aldehydes and
It has been observed that the reactions of aromatic aldehydes or ketones progress faster 
than aliphatic aldehydes and ketones. The reaction is most often carried out in the 
absence of a proton source, and it has been reported that the presence of TMSC1 in the 
reaction mixture can accelerate the reaction.53 The coupling of an aldehyde or ketone with 
oximes,54,55 hydrazones,33,34 imines and nitriles50 has also been reported.
The Sml2 mediated intramolecular pinacol coupling normally progresses with significant 
stereoselectivity, as demonstrated previously in scheme 1.23. The coupling of two 
carbonyls tends to form predominately cis diols. Furthermore when the carbonyl has an 
alkoxy group in the a  position, the orientation of the hydroxyls is predominately ‘antV 
relative to that substituent. The cyclisation of dicarbonyl 80 illustrates this phenomena 
(scheme 1.24).52
ketones.13,51 An example of such a reaction is shown in scheme 1.23 where the 
dialdehyde 78 is transformed to the diol 79.52
Sml2
•BuOH
c i s : trans
81%
78 79
scheme 1.23
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'BuOH
THF, —78°C to 25°C, 3.5h 
81% TBDPS TBDPSO
96 :4
80 81 82
scheme 1.24
Interestingly, the coupling of an aldehyde or ketone with a hydrazone tends to yield 
products with trans stereochemistry across the newly formed bond. Such stereoselectivity 
was observed in the cyclisation of keto-hydrazone 83 to give the corresponding hydrazine 
84 (scheme 1.25).33
Ph2N \ .. Sml2 VMHNPh,k j  o m i 2A—Y  ~  CXtra n s : cis 
62% OH > 2 5 . 1
83 84
scheme 1.25
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1.2.5.1. Pinacol coupling -  the mechanism
There are three possible mechanisms for the Sml2 mediated pinacol coupling reaction.50.
56-58 fjrs^ involves the formation of a ketyl dianion after reduction of the dicarbonyl 
85 with 2 equivalents of Sml2 (equation 1). The dianion then attacks the other carbonyl. 
Molander has ruled out such a mechanism by claiming that under normal pinacol 
coupling conditions Sml2 is not a strong enough reducing agent to reduce a ketyl radical 
anion to a ketyl dianion. He also proposes that under the commonly used protic solvent 
conditions for the reaction, such as tert-BuOH and MeOH, a dianion intermediate would 
be rapidly protonated resulting in acyclic products.
The second possible mechanism involves the coupling of two ketyl radical anions 
(equation 2). Molander has also ruled out this mechanism by rationalising the normal cis 
stereochemistry of pinacol coupling products. If the reactions progressed via a di-Sm(III) 
complexed diketyl intermediate, trans diol products would be expected in the product 
mixture due to dipolar repulsion. However, this is not the case.
OSml. OSml.
.OSml,
OSml,
equation 1
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Instead Molander proposes the most likely mechanism to involve attack on a carbonyl 
group by a ketyl radical anion (figure 1.9). Reduction of one of the carbonyls by Sml2 
results in the formation of a ketyl radical anion. The Sm(III) centre then co-ordinates and 
possibly activates the second carbonyl before attack by the ketyl radical anion. A 
subsequent second reduction by Sml2 then occurs before protonation upon work up, or 
from the cosolvent, yields the diol 86. Co-ordination of the Sm(III) centre to the second 
carbonyl following the initial reduction, would explain the observed cis stereochemistry 
of the cyclisation products.
R.
85 1. Sml2
2. HaO+
R.
86
figure 1.9
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1.3 Sml2 mediated cyclisations in natural product synthesis
1.3.1 Four-membered rings
Despite the extensive literature surrounding Sml2 transformations, prior to our studies 
{vide infra) few examples of 4-membered ring formation using the reagent have been 
reported.59'61 More specifically, only a single example of the lanthanide reagent being 
used to mediate 4-membered ring formation in natural product synthesis had been 
reported in the literature prior to our work. The example in question involves the use of 
an intramolecular Barbier reaction.
Paeoniflorin 87 is an interesting monoterpene with a complex pinane structure extracted 
from the root of Paeonia albiflora Pallus.62 The plant has been used in traditional Chinese 
and Japanese medicine and since its isolation, Paeoniflorin has been found to show 
sedative, anticoagulant, anti-inflammatory and neuromuscular activities. In 1993, Corey 
reported the first total synthesis of Paeoniflorin.63 In Corey's approach to the natural 
product, paeoniflorigenin 89 was first prepared. Subsequent glycosylation then gave the 
natural product Paeoniflorin. The caged structure of 89 was prepared using a multistep 
reaction sequence, which featured a Sml2 mediated Barbier reaction (scheme 1.26). The 
Barbier reaction of chloride 88 proceeded smoothly in the absence of additives at —45°C 
to give cyclobutanol 89 in excellent yield. An aldol-type cyclisation could not be used to 
effect the transformation as the cyclobutanol products were found to be extremely base 
sensitive. In fact, when the authors attempted to protect the tertiary alcohol formed upon 
cyclisation with a silyl-protecting group, the mild base used in the transformation 
triggered a retro-aldol reaction and opening of the cyclobutanol ring. Protection of the 
hydroxyl was achieved however using TMSCN under non-basic conditions.
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Paeoniflorin 87
scheme 1.26
1.3.2 Five-Membered Rings
In stark contrast to Sml2 mediated 4-membered ring formation, many examples of the 
formation of 5-membered rings using the reagent have been reported. In the context of 
natural product synthesis, a wide variety of Sml2 mediated reaction types have been 
employed to form the 5-membered rings found in the targets.
The Eunicellins are polycyclic diterpenes isolated from soft corals and gorgonians 
octocorals. They are of particular interest due to their range of biological activity, which 
includes cytotoxicity, antiproliferative and anti-inflammatory properties. They possess an 
interesting a,a'-bridged nine-membered ring ether, a framework which Hoffmann has 
attempted to construct in model studies using a cerium(IV) ammonium nitrate (CAN) 
oxidative fragmentation process.64 In the preparation of the tricyclic substrate for CAN- 
mediated fragmentation, Hoffmann employs a Sml2 mediated Barbier reaction to form the 
tertiary cyclopentanol 91 necessary for the oxidative fragmentation step (scheme 1.27). 
The cyclisation of 90 proceeds very efficiently under mild conditions in the absence of 
additives to give 91 as a single diastereomer. The authors have yet to prepare eunicellin 
92 or any of the eunicellin based natural products using this methodology.
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scheme 1.27
The isomeric sesquiterpenes (±)-isocaryophyllene 93 and (±)-caryophyllene 94 isolated 
from clove oil contain 9-membered rings fused to cyclobutane rings (figure 1.10). In a 
similar strategy to the one discussed in the previous example, Suginome has utilised a 
Hg(II) oxide mediated oxidative fragmentation to access the nine membered ring in his 
approach to caryophyllene.65
Substrate 97, for oxidative fragmentation, was again prepared using a Sml2 mediated 
intramolecular Barbier reaction (scheme 1.28). The transformation was achieved under 
mild conditions in the absence of additives to give the tertiary alcohol 96 in good yield. In 
this particular transformation, the stereochemistry of the tertiary alcohol and the 
quaternary centre bearing the ethyl ester in 96 is unimportant as the stereochemistry at 
both centres is lost later in the synthesis.
(±)-isocarophyllene 93 (±)-carophyllene 94
figure 1.10
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Sml,
16h
69% HO
96
steps
98
HgQ, i2, py
PhH ,hv, 8h 
15%
scheme 1.28
In an earlier paper, Suginome again used a Sml2 mediated Barbier reaction to form the 
intermediate cyclopentanol 100 (scheme 1.29), followed by a similar Hg(II) oxide 13- 
scission of an alkoxy radical, in an approach to (±)-muscone 101.66 In this example of an 
intramolecular Barbier reaction, HMPA was employed as a cosolvent.
1. HgO, l2 
PhH, h\), 0°C 
59%
HO,„
Sml2
HMPA, THF 
90%
(±)-muscone 101100
scheme 1.29
99
Sml2 mediated Barbier reaction methodology has also been extended to additions to 
imide carbonyls, and applied in the synthesis of (+)-Lentiginosine 104. Indolizidine 
heterocycles have attracted much attention in recent years due to their broad range of 
potent biological activity. (+)-Lentiginosine is a dihydroxylated indolizidine alkaloid that 
has shown itself to be a selective inhibitor of amyloglucosidase. In a paper, which 
describes the synthesis of the natural product starting from L-malic acid, Ha and co­
workers use Sml2 in the key step to mediate the Barbier cyclisation of an A-(iodobutyl)-
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succinimide 102 (scheme 1.30).67 The cyclisation proceeded efficiently in the presence of 
a catalytic amount of Fe(DBM)3 and after subsequent dehydration, indolizidine 103 was 
obtained in good yield. The mechanism of the cyclisation is ambiguous with an earlier 
publication suggesting the possibility of a similar reaction progressing through a ketyl 
radical intermediate. Subsequent reduction of the olefin in 103, removal of the silyl 
protecting groups and reduction of the amide using LiAlH4, gave (+)-Lentiginosine. The 
paper also describes the application of this Sml2 reaction to the formation of pyrrolizidine 
and quinolizidine heterocycles, systems that are found extensively in biologically 
important molecules.
TBSl
TBSO'
102
1. Sml2 
Fe(DBM)3 
THF, 0°C, 2h
2. p-TsOH, celite, 4A MS 
CH2CI2, rt, 3h 
82%
1. CF3C 0 2H, EtgSiH 
CH2CI2, rt, 3h
2. HCI 
MeOH, rt, 3h
3 - LiAIH4 
THF, A, 4h 
(66% yield for 3 steps)
(+)-Lentiginosine 104
scheme 1.30
Simple Sml2 mediated radical cyclisations have also been used in natural product 
synthesis to generate five-membered rings. In Ohta’s racemic total synthesis of oxerine 
107, a monoterpene alkaloid isolated from the ariel parts of the tree Oxera morieri, a 
Sml2 mediated 5-exo-dig cyclisation was used to form the cyclopentane ring.68 The 
natural product is of interest since many monoterpene alkaloids have been found to 
display interesting biological activity. The primary radical was generated from bromide 
105, which attacked the triple bond to close the five-membered ring and form the 
exocyclic double bond of 106 (scheme 1.31). As would be expected, none of the 6-endo- 
dig cyclisation product was detected and furthermore, no products from the elimination of 
the O-benzyloxy group were observed - a common problem when the carbon radical has 
a heteroatom in the a  position. Ozonolysis, Grignard addition, and finally deprotection, 
furnished racemic oxerine.
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THF, —78°C, 30 min 
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Another example of a Sml2 mediated 5-exo-dig cyclisation appears in Kurozumi’s 
approach to Isocarbacyclin 110.69 Isocarbacyclin is of interest as, being a stable analogue 
of prostacyclin (PGI2), it has potential as a therapeutic agent for cardiovascular diseases. 
In 1990, Kurozumi et. al. described two similar strategies towards isocarbacyclin that 
both employ the reductive cyclisation of y-ethynyl aldehyde 108 to form the second 5- 
membered ring in the bicyclo[3.3.0] octane system present in the target molecule (scheme 
1.32). Several reagents for the transformation were examined, however Sml2 showed 
itself to be the reagent of choice giving the highest yield and rate of cyclisation. The 5- 
exo-dig aldehyde-alkyne coupling gave a 9:1 ratio of diastereomers, 109 being the major 
product. The intermolecular pinacol coupling product and the acyclic alcohol reduction 
product, probably arising from competitive reduction of the ketyl radical intermediate, 
were both formed as by-products in the reaction.
H 0 2i
Sml2
'BuOH 
THF, —70°C, 0.5h 
71%
T 4
OTBS
HOTBSO OH
isocarbacyclin 110109
scheme 1.32
TBSO OTBS
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(-)-a-Kainic acid 113 was first isolated in 1953 and is found in the algae Digenea simplex 
and Centrocerus clavulatum. The potent neuroexcitatory activity of the natural product
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aswell as the synthetic challenge of installing three contiguous stereocentres on the 
pyrrolidine ring has attracted the attention of many groups. In Cossy's approach to (-)-a- 
Kainic acid, which began from L-pyroglutamic acid, a Sml2 mediated intramolecular 
coupling of a ketone and an enamine was used as a key step.70 The ketyl radical anion 
derived from 111 attacked the olefin from the bottom face as shown in scheme 1.33, due 
to the stereochemistry at C3. The cyclisation, therefore, established the cis stereochemical 
relationship at C3 and C4 in the natural product.
Sml2 
HMPA, f-BuOH
scheme 1.33
COoH
CO,H
(-)-a-Kaimc acid 113
A 55% yield of the bicyclic pyrrolidine 112 was obtained from the cyclisation although, 
interestingly, significant amounts of the bis by-product 114 was also obtained (figure 
1.11). The formation of 114 is probably due to competitive dimerisation of the radical 
formed upon cyclisation. The stereochemistry of the newly generated tertiary alcohol is 
not discussed and is largely unimportant as the stereochemistry was lost during the 
formation of the propenyl group of the target.
.OTBS
TBSO
Boc
OH
114
figure 1.11
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(+)-Cyclomyltaylan-5-a-ol 117 is a tetracyclic sesquiterpenoid isolated from a Taiwanese 
thallus liverwort, Reboulia hemisphaerica. In Hagiwara's enantioselective total synthesis 
of the natural product, a Sml2 mediated reductive cyclisation was used to form a tricyclic 
intermediate.71 The reaction involved the coupling of an aldehyde with a cyclic enone in 
the presence of HMPA to give cyclopentanol 116 in moderate yield and with moderate 
diastereocontrol (scheme 1.34). The authors rationalised the observed stereochemistry by 
invoking a vinylogous pinacol coupling mechanism, the (3-stereoisomer predominating 
due to the steric repulsion of the two samarium alkoxides. They argue that if the reaction 
proceeded by conjugate addition of the ketyl radical to the enone then the a-stereoisomer 
would be favoured due to a 7-membered chelate intermediate. Furthermore, the additional 
observation that a poor yield was obtained when only 1 equivalent of Sml2 was used 
serves to support the vinylogous pinacol coupling theory. However, the alternative ketyl- 
olefin coupling mechanism should not be discarded. It is widely known that ketyl-olefin 
cyclisations to form 5-membered rings proceed with predominately anti stereochemistry 
across the new carbon-carbon bond, a scenario that is observed in this particular case. 
Two equivalents of Sml2 are also required in ketyl-olefin cyclisations. [Furthermore, if 
the reaction was proceeding via a ketyl-olefin coupling pathway and if chelation was 
possible thus favouring formation of the a-stereoisomer, carrying out the reaction in 
HMPA, which is a highly co-ordinating solvent for Sml2, could break down such 
chelation. Electronic factors would then result in predominately the (3-stereoisomer 
forming]. A further six steps were needed to convert 116 into the target compound.
BuOH. HMPA 
THF, —78°C, 10 min 
52%
scheme 1.34
HO N 
(+)-cyclomyltaylan-5a-ol 117
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In their approach to Grayanotoxin III 121, Matsuda and co-workers used Sml2 for the 
three key carbocycle forming steps.72 Two of these carbocycles are five membered rings. 
In the first Sml2 mediated step to form the CD rings of the natural product, the hemi-ketal 
118, which is in equilibrium with the hydroxy ketone 119, was treated with Sml2 in the 
presence of HMPA (scheme 1.35). Cyclisation of the ketyl-radical anion onto the 
unactivated olefin proceeded well to give 120 in high yield.
118 119
THF, —78°C to 0°C 
86%
HO
120
scheme 1.35
HO °
grayanotoxin III 121
In the second Sml2 mediated cyclisation in Matsuda’s approach, an allylic sulfide was 
used as a radical acceptor in a cyclisation to form the A ring of the natural product 
(scheme 1.36). The cyclisation of 122 resulted in elimination of the sulfide to generate a 
new double bond which was then epoxidised and reduced to form the tertiary alcohol 
found in the B ring of the target. The cyclisation proceeded to form exclusively the syn 
cyclopentanol 123 in good yield. Interestingly, in model studies, related cyclisation 
substrates without gem disubstitution on the aldehyde gave exclusively anti 
cyclopentanol products.73 No reason for the observed stereoselectivity is given by the 
authors. Also, noteworthy is the fact that the stereochemistry and yield of the cyclisation 
are independent of the initial olefin geometry. The third Sml2 mediated cyclisation in 
Matsuda’s approach will be discussed in a later section.
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The monoisoprenoid sesquiterpene (-)-upial 126 was isolated from the marine sponge 
Dysidea fragilis at Kaneohe Bay, Oahu, and provides an interesting target for synthetic 
chemists with its five stereocentres and unusual bicyclo[3.3.1]nonane framework. In his 
approach to the natural product, Yamada used an interesting 5-exo-ing cyclisation to 
generate tricyclic lactol 125 (scheme 1.37).74 The reaction, which progressed in the 
presence of HMPA, involved the use of 124 as a 2:1 mixture of double bond isomers and 
as 125 was obtained as a single diastereoisomer, it is clear the olefin geometry has no 
bearing on the stereochemical outcome of the reaction in this particular system. A single 
lactol isomer was obtained from the cyclisation, however stereochemistry at the lactol 
carbon is unimportant as oxidation at a later stage in the route resulted in the loss of 
stereochemistry at that centre.
o
124
CHO
THF, 25°C, 30 min 
76%
(-)-upial 126
OH
125
scheme 1.37
At first glance, the reaction appears to be analogous to Matsuda's second Sml2 cyclisation 
in his approach to Grayanotoxin III 121 (see scheme 1.36), i.e. ketyl-olefin addition 
followed by P-elimination, however, the mechanism here is quite different (figure 1.12).
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In model studies the authors showed the reaction proceeds by an allylic organosamarium 
127.75 By carrying out the cyclisation of simple substrate 128 in the presence of D20 , the 
formation of products 129 and 130 in which deuterium was incorporated in the allylic 
positions were observed (scheme 1.38).
HMPA, S20 Jf r ^ |  OCHO
 1 1 1  ?°H0 +THF, 25°C 1}
64% D
4 : 1
129 130
scheme 1.38
The Sml2 coupling of aldehydes and ketones with oximes has also been employed to 
access five-membered rings in approaches to natural products. Naito et. al. used an 
aldehyde-oxime coupling reaction to form the functionalised pyrrolidine ring in their 
approach to 4-pyrimidinyl and 4-purinylpyrrolidin-3-ol nucleoside analogues.74 Recently 
nucleoside analogues have attracted the attention of synthetic chemists as the range of 
their biological activities and potential as anti-cancer and anti-viral therapeutic agents has
128
become known. Naito has reported the synthesis of uridine 131, thymidine 132 and 
adenosine 133 analogues (figure 1.13).
131 132 133
uridine thymidine adenosine
analogue analogue analogue
figure 1.13
The aldehyde-oxime coupling of 134 proceeded efficiently in the presence of tert-BuOYL 
to afford the cyclic product in 70% yield with good stereoselectivity, giving a 9:1 mixture 
of diastereoisomers in favour of the anti product 135 (scheme 1.39). This is far superior 
to the analogous Bu3SnH mediated cyclisation that proceeded to give the product in 66% 
yield but as only a 3:1 ratio of diastereoisomers.
The origin of the stereoselectivity can be seen in the transition structures A and B (figure 
1.14). The syn transition structure B is disfavoured over the anti A due to electronic 
repulsion between the Sm-alkoxide and the developing partial negative charge of the 
nitrogen radical. Both the stereoselectivity and overall yield of the cyclisation were found 
to be dependent upon the reaction temperature, and furthermore the reaction was found 
not to proceed in the absence of tert-BuOH.
’BuOH
134 THF. 30 min 135
25°C; 33%, 3:2 
—78°C; 70%. 9:1
scheme 1.39
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transition structure A transition structure B
figure 1.14
Trehazolin 138 has been isolated from the culture broth of a Micromonospora strain. It is 
of particular interest as it has shown itself to be a potential insecticide due to its potent 
and specific inhibition of trehalase, an enzyme which plays an important role in the 
metabolism of insects and fungi. In Giese's synthesis of the natural product, a Sml2 
mediated ketone-oxime reductive coupling similar to the previous example was used to 
form the trehazolamine structure 137 as a single diastereoisomer (scheme 1.40).76
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'BuOH
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The substrate 136, which was derived from D-glucose, has three stereocentres already 
established. The authors found it necessary to protect the hydroxyls at C6 and C4 as a 
benzylidene acetal to obtain the desired stereochemistry from the cyclisation. When these 
hydroxyls were protected as benzyl ethers, the product formed on cyclisation had the 
wrong stereochemistry at C5. The authors propose that this is due to a normal preference 
(when P, and P2 = -CH2Ph) for the chair-like transition structure A over B (figure 1.15). 
The use of a cyclic acetal rules out conformation A and the cyclisation proceeds through 
conformation B resulting in the product having the correct stereochemistry at C5 in the 
product. The stereochemistry at Cl was inverted in a subsequent step.
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figure 1.15
Chiara has also used a ketone-oxime reductive cyclisation in an approach to trehazolin.77, 
78 The substrate 139 for the cyclisation was obtained from D-mannose in 9 steps and 
resulted in C2 possessing the wrong configuration for the natural product. This 
stereocentre, however, behaves as an element of stereocontrol in the cyclisation and was 
elegantly inverted later in the synthesis via an intramolecular SN2 cyclisation. An excess 
of Sml2 was used in the cyclisation of 139 and after the cyclisation a large excess of H20  
was added (scheme 1.41). This had the effect of converting the initially formed 
benzyloxyamine to the amine. In situ treatment with aqueous LiOH removed the acetate 
protecting group, giving trehazolamine 140 in almost quantitative yield. Amazingly, in 
contrast to Giese's exclusively syn relationship across the newly generated C-C bond, 
Chiara obtains exclusively the anti product. Scheme 1.41 also shows a transition structure
^ k ° sm|2
mV-'OBh
BnQ
H OAc
scheme 1.41
for the cyclisation which was proposed by the authors.
Bnl
AcO
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1.3.3 Six-membered rings
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Sml2 has been employed in a variety of ways to access 6-membered rings, with the most 
popular method involving 6-exo ketyl-olefin cyclisations. Nakata has used a Sml2 
mediated 6-exo-trig ketyl-olefin cyclisation to form the ABC trans-fused tricyclic furan 
ring system of the neurotoxin brevetoxin B 143 (scheme 1.42).79,80 The reductive 
cyclisation of 141 occurred very efficiently under mild conditions to form the 
tetrahydropyran C ring of 143 and followed the usual stereochemical course of such 
cyclisations to give anti stereochemistry across the newly formed C-C bond.
Me
Sml2, MeOH
THF, 0°C, 1h 
91%
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141
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brevetoxin B 143
scheme 1.42
Interestingly, similar anti stereochemistry was observed in the analogous cyclisation of 
144 which constructed the D ring system of maitotoxin, despite the fact that the ketyl 
radical was generated from the methyl ketone instead of the aldehyde (scheme 1.43).81
C 0 2Et Sml2, MeOH
scheme 1.43
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(-)-Anastrephin 146 and (-)-epianastrephin 147 are insect pheromones produced by the 
Caribbean fruit flies which are pests of citrus crops in Mexico (figure 1.16). In his 
approach to the natural products, Tadano used a Sml2 mediated 6-ex<9-trig ketyl-olefin 
cyclisation in conjunction with a glucose derived “chiral auxiliary” to generate the 6- 
membered ring stereoselectively.82
(-)-anastrephin 146 (-)-epianastrephin 147
figure 1.16
Following the cyclisation of aldehyde 148 on treatment with Sml2, in situ lactonisation 
occurred spontaneously to give the bicyclic lactone as a mixture of three stereoisomers, 
the major stereoisomer 149 having cis stereochemistry across the new carbon-carbon 
bond (scheme 1.44). As we have previously stated, Sml2 mediated ketyl-olefin couplings 
involving aldehydes, typically give products possessing anti stereochemistry. Hence, the 
stereochemical outcome of the cyclisation of 148 is unusual.
148
Sml2 
HMPA, /PrOH
THF, 0°C to rt, 1.5h
35%
149
scheme 1.44
The authors tentatively propose that the observed stereochemistry arises from a chair-like 
transition state for the cyclisation (figure 1.17). Interactions between the cyclic acetal and 
the ester group result in the olefin assuming an axial orientation and transition structure A 
is favoured. Furthermore, the samarium(III) alkoxide adopts an equatorial orientation due
50
to unfavourable 1,3-diaxial interactions when in an axial position. The role of HMPA in 
the cyclisation was of great importance. When the cyclisation was attempted in its 
absence, significant over-reduction of the ketyl-radical occurred to give the acyclic 
alcohol. The authors also report differing stereochemical outcomes from related 
cyclisations involving a Z-olefin substrate and a methyl ketone. The glucose derived 
fragment of the product was dismantled in a series of transformations en route to the final 
product.
OSml2
transition structure A
OSml2
O
figure 1.17
Matsuda utilised a Sml2 mediated 6-exo-trig ketyl-olefin cyclisation to form the cis- 
decalin skeleton of the diterpene vinigrol 152 in an 8 step approach from (+)- 
dihydrocarvone (scheme 1.45).83 The reaction proceeded with anti selectivity across the 
new C-C bond.
OH
vinigrol 152
THF, rt
85% OH
Me02i
150 151
scheme 1.45
Crucially, in this approach the (3-hydroxyl was protected as the acetate. When the 
substrate had a free (3-hydroxyl, chelation of the samarium(III) ketyl radical anion and the
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(3-hydroxyl led to transition structure A (figure 1.18), where the ketyl radical anion and 
olefin are held some distance apart. The use of acetate protection in 150 prevented such 
chelation and allowed the kety 1-radical and olefin to come into closer proximity, as seen 
in transition structure B, thus permitting cyclisation to the desired product 151.
ClO-desmethyl arteannuin B 155.84 The molecule is of importance as it can be used to 
prepare an anti-malarial analogue of artemisinin, and the route is general enough for the 
potential preparation of other active analogues of the natural product. The cyclisation of 
153 proceeded in excellent yield using similar conditions to those employed in Nakata's 
6-exo-tvig cyclisation (scheme 1.46). The authors reason that the observed stereochemical 
outcome can be explained by an eleven-membered ring chelate transition state (figure 
1.19). The target molecule is made in 6 steps from the cyclisation product 154.
OSml,H
transition structure A transition structure B
figure 1.18
Little also used a similar reaction as the key step in his approach to the synthesis of (-)-
H
C 0 2Me Sml2, MeOH
O
(-)-C10-desmethyl arteannuin B 
155
scheme 1.46
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figure 1.19
A Sml2 mediated 6-exo-dig ketyl-olefin cyclisation has been used to form the trans 
decalin skeleton of (±)-Erigerol 158 (scheme 1.47), a labdane type diterpene isolated 
from the plant Erigeron philadelphicus.85 The natural product has similarities in structure 
to the adenylate cyclase activator Forskoline. The cyclisation of 156 proceeded in the 
absence of HMPA to give 157 as a single diastereomer, in excellent yield.
OH OH
SiMe3Sml2, BuOH
THF, — 78°C, 1h 
90% OH
Erigerol 158
157156
scheme 1.47
Sml2 mediated pinacol coupling reactions have also been used to generate 6-membered 
rings. Such a reaction was used by Kajiwara as a key step in his preparation of the taxane 
ABC rings skeleton.86 Having previously established the AB ring system of substrate 161 
using a lactam-sulfoxide ring contraction (scheme 1.48), the authors then explored the 
use of Sml2 to set up the C ring. The cyclisation of aldehyde 161 was carried out in 
refluxing THF in the absence of any additives. The syn diol was obtained in 43% yield 
with the necessary trans stereochemistry at the BC ring junction.
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159
1. LDA
THF, —78°C to rt
2 - 5% Na-Hg, Na2H P04 
MeOH, Et20 , rt 
(80% for 2 steps)
steps
161
iMOM
CHO
161
Sml,
43%
iMOM
OH
OH
162
scheme 1.48
The angucycline antibiotics are a large group of secondary metabolites isolated from 
microbes. WP 3688-2 is such an antibiotic isolated from Streptomyces 
phaeochromogenes and has a cis 1,2-diol unit between the A and B rings. In Krohn’s 
synthesis of the aquayamycin, 8-deoxy WP 3688-2 165, Sml2 is used to form the six- 
membered B ring via an intramolecular ‘pinacol-type’ coupling reaction.87 The 
cyclisation of 163 progressed under mild conditions to afford the diol 164 in good yield 
and as a 9:1 ratio of diastereoisomers, the desired cis diol being the major product 
(scheme 1.49).
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OH
Sml2
OHTHF, 18°C 
83%
163
1. S i0 2> H2S 0 4
CH2CI2, 20°C, 1.5h, (80%)
2. KOH, MeOH
CH2CI2, 0°C to 20°C, 2h, (20%)
3. CAN, a?Bu4NHS04 
CH2CI2 (70%)
OH
OH
OH
l-deoxy WP 3688-2 165
scheme 1.49
Interestingly, the authors found that problems occurred when the carbonyl of the methyl 
ketone was protected as an acetal, as in 166 (figure 1.20). Instead of the desired 
cyclisation, elimination to form the enolate followed by an intramolecular aldol to form a 
seven-membered ring occurred.
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o SmlgSml2
168167
O
O
OH
OH
170 169
figure 1.20
Cyclisation of diketone 163, with no leaving group in the a  position, was therefore 
studied (scheme 1.49). The mechanism proposed for the formation of 164 is outlined in 
figure 1.21, and also involves an intramolecular aldol of a Sm(III) enolate. The authors 
observed a dependence of diastereoselectivity on reaction temperature. When the reaction 
was cooled to — 100°C the formation of the trans diol was the major product. The diol 
164 was converted to 8-deoxy WP 3688-2 in three steps.
Sm^
163
171
Sm^
172
figure 1.21
Schmalz et. al. have carried out extensive studies on chiral tetralin-Cr(CO)3 complexes 
and have reported the first examples of radical additions to arene Cr(CO)3 complexes.88,89 
In the cyclisation of 173, the bulky Cr(CO)3 group serves not only to control the
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stereoselectivity of the cyclisation but the electron withdrawing nature of the group 
activates the aromatic ring to ketyl radical addition in a system that would otherwise be 
deactivated by the electron-donating methoxy substituents (scheme 1.50). The ketyl 
radical anion was generated by Sml2 and was found to add to the top face of the 
complexed aryl ring. Following a second electron reduction by Sml2, regioselective 
elimination of a methoxyl group gave 174, the skeleton of pseudopterosin G 175 and 
helioporin E (not shown), in moderate yield (scheme 1.50).
OH
OH
Sml2, HMPA
THF
51% OH
174 pseudopterosin G 175
scheme 1.50
OMe
173
A proposed mechanism for the cyclisation is shown in figure 1.22.
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— IMeOH
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,OM e
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figure 1.22
(-)-A dalinine 182 is a piperidine alkaloid isolated from  the Hadybird beetles Adalia  
bipuincta ta and Adalia decempumctaia«In his approach to the natural product, Honda used 
a Snnlz m ediated ring expansion reaction as the key step in a synthesis w hich began from 
(S)-((-)-pyroglutamic acid.90 Upon treatment o*f the- amino* acid derivative 180 with Sm l2, a 
regioselective carbon-nitrogen bond cleavage occurred to give an acyclic amino ester 
intermediate which then underwent lactamisation to* form the 5-lactam  181 in good yield 
(scheme 1.51). The reaction was carried out in the presence of 5 equivalents o f HM PA. 
Using less additive* o*r in its absence, the reaction was considerably slow er and gave 
lower yields of the desired product. The authors also used pivalic acid as a  proton source 
in thie transform ation. Removal o f the silyl protecting group in 5-lactam  181 and TPAP 
oxidation, gave the target alkaloid 182 in good yield-
58:
E t02C  in 
H
TBDMS( Sml2 
pivalic acid, HMPA
THF, 0°C 
70%
T B D M S C L / ^  cone. HCI
I  THF
2. TPAP, NMO
180
H
181 (97% for 2 steps)
H
(-)-adalinine 182
scheme 1.51
1.3.4 Seven-membered rings
Phorbol 189 is a tigliane diterpene isolated from the seeds of Croton tiglium L. The esters 
of this tetracyclic natural product have attracted much attention due to their potent 
biological activity which includes the promotion of tumour growth as well as antitumour 
and anti-HIV activity. In a preliminary disclosure, describing the preparation of the 
carbon framework of the natural product, Little used Sml2 in two key carbon-carbon bond 
forming transformations (scheme 1.52).91 The first involved a chelation controlled 
intermolecular ketyl-olefin coupling which formed the tricyclic structure 186. The 
authors propose that the reaction progressed through the Sm(III) chelate intermediate 185 
to give the observed stereochemistry in the product. After epimerisation, which triggered 
lactonisation, and transformation of the hydroxyl to the iodide, tricyclic 187 was ready 
for the second Sml2 transformation. The lanthanide reagent was used in an intramolecular 
Barbier reaction to construct the seven-membered ring of the target. Although at first the 
reaction was sluggish with mediocre yields, the addition of a catalytic amount of 
nickel(II) iodide, a known promoter of Sml2 halide-carbonyl couplings, resulted in a more 
efficient reaction giving 188 as a single isomer in good yield.15
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BzCX^,,
183
Sml2 
t- BuOH
CO,Me THF, rt 
58%
184
■OH
OH
HO
OH
Phorbol 189
185
HO
188
OH:
186
Sml2 
Nil2 (cat.)
THF, rt, 1h 
88%
1. NaOMe, MeOH 
THF, 85%
2- l2, PPh3, imidazole
THF, 90%
187
scheme 1.52
Ciguatoxin 190 is a complex polycyclic ether believed to be the cause of many reported 
cases of ciguatera (sea food poisoning) (figure 1.23).92 The complex molecule is found in 
the flesh of coral reef fish and originates from the epiphytic dinoflagelate Gambierdiscus 
toxicus. The potent neurotoxicity combined with the extremely complex structure makes 
ciguatoxin an interesting challenge for the synthetic community.
Me
.OH
HO HO Me''OH
Me OBn
ciguatoxin 190 
figure 1.23
In the preparation of the GHIJKLM fragment, Sasaki has used a Sml2 mediated l-exo-\xig 
ketyl-olefin cyclisation to generate the seven membered oxacyclic G ring.93 The 
cyclisation of 191 proceeded selectively to give the anti cycloheptanol product. The crude 
product was reduced directly with LiAlH4 to give diol 192 (scheme 1.53).
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>Ph
2. LiAIH4 
THF, rt 
(72% yield for 2 steps)
1. Sml.
MeOH, HMPA 
THF, 0°C
HG
O
■Ph
191 192
scheme 1.53
An explanation for the high diastereoselectivity of the cyclisation, was not postulated by 
the authors, however, in a report by Nakata, in which he describes the similar Sml2 
mediated 1-exo-tng ketyl-olefin cyclisation of aldehyde 193 to give the anti product 194 
(scheme 1.54), a 12-membered chelate transition state was used to explain the complete 
diastereocontrol in the reaction (figure 1.24).94 Whether such chelation was responsible 
for the diastereoselectivity in Sasaki’s cyclisation is debatable particularly as the 
cyclisation was carried out in the presence of HMPA, a cosolvent which might be 
expected to disrupt chelation.
Several other Sml2 cyclisation reactions have been used to construct 7-membered rings. 
Previously we have discussed two Sml2 cyclisations to form 5-membered rings developed 
by Matsuda in his approach to Grayanotoxin III 121 (scheme 1.35). The final Sml2 
mediated cyclisation in the synthesis involved the construction of the 7-membered B ring 
of Grayanotoxin via a pinacol coupling reaction.72 Initially, Matsuda et. al. examined the 
use of a titanium mediated intramolecular pinacol coupling to form the 7-membered 
carbocycle, however, undesired side-reactions were observed. Instead, the cyclisation of 
dicarbonyl 195 was attempted with Sml2 in the presence of HMPA (scheme 1.55).
Sml2
MeOH
193 194 figure 1.24
scheme 1.54
61
Cyclisation occurred smoothly to give the diol 196 in good yield, with no other 
stereoisomers of 196 being detected. Interestingly the hydroxyl at C3 of 195 appears to 
play an important role in the cyclisation as when the reaction was attempted with the 
hydroxyl protected as the MOM ether, no cyclisation took place. No explanation is given 
by the authors for this observation.
OMOM
THF, —78°C to rt 
54% HO
OMOMHO
196195
scheme 1.55
Balanol 197 is a novel metabolite that was first isolated from the fungus Verticillium 
balanoides in North Carolina in 1993 (figure 1.25). The natural product is of particular 
interest as it has been shown to be a potent inhibitor of Protein Kinase C (PKC) enzymes. 
PKC’s are important enzymes playing a major role in cell growth and function. In 
addition, the enzymes have been associated with a range of diseases which include 
asthma, cancer, cardiovascular ailments, central nervous system problems, diabetes and 
HIV. Therefore PKC inhibitors such as Balanol are lead compounds for potential 
therapeutic agents to alleviate these widespread health problems. The therapeutic 
possibilities combined with the interesting structure of the natural product has prompted 
widespread interest from synthetic chemists.
OH OH
OH
C 0 2H 0 OH
■NH
(-)-Balanol 197
figure 1.25
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In Naito's asymmetric approach to the molecule, Sml2 methodology was used to form the 
hexahydroazepine ring via the ketyl-oxime cyclisation of 198.95,96 Initially, attempts to 
carry out the cyclisation using Bu3SnH led to moderate yields of the hexahydroazepine 
ring with mediocre diastereocontrol, approximately a 3:1 ratio favouring the anti 
cyclisation product 200. The authors then examined the use of Sml2 and found that in the 
presence of HMPA, they obtained an improved yield with a marked increase in 
diastereoselectivity, again favouring the anti product 200 but now by nearly 7:1 (scheme 
1.56). Such stereoselectivity was explained by invoking an 11-membered Sm(III) chelate 
intermediate (figure 1.26).
The important role of HMPA in the cyclisation was highlighted when in its absence, 
treatment of 198 with Sml2 failed to give any of the desired product. Further studies by 
Naito also revealed that the initial geometry of the oxime had no influence on the yield or 
stereoselectivity of the cyclisation. The racemic hexahydroazepine fragment of Balanol 
was resolved using an enzymatic approach. Following the isolation of the anti 
diastereoisomer by column chromatography, reduction then gave the amine which was 
acylated with /?-(benzyloxy)benzoyl chloride to give 201. Enzymatic acetylation of 201 
using the lipase from Pseudomonas sp. resulted in the formation of 202 in good yield and 
excellent enantiopurity.
^Sm'^HMPA),
H ? Bn
figure 1.26
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OBn
198
Sml2 
HMPA, f-BuOH
THF, —78°C tort, 12h 
53%
i^ ~ < _I V—NHOBn
Gto
Boc O ^ J
OBn
199
< ^ O A c  
immobilized lipase
©uOMe, 20°C then 45°C, 20h 
42% (96% ee)
0
1 : 7
NHOBn
200
1. Pt20 , H2
MeOH, rt, 5h
2 . c y ^ c y
NaHCOg, H p  
CH2CI2, rt, 2.5h
(58% for steps)
OBn
OBn
202
scheme 1.56
201
Work by Skrydstrup on the synthesis of Balanol also employs a radical cyclisation to 
form the hexahydroazepine ring.97 Sml2 was used to mediate the intramolecular ketyl- 
hydrazone coupling of 203 to form the seven-membered ring of the target (scheme 1.57). 
The hexahydroazepine ring was formed in good yield and with greater 
diastereoselectivity than for the cyclisation reported by Naito. Skrydstrup proposed that 
HMPA is playing a key role in promoting the cyclisation simply by discouraging 
competitive reactions such as intermolecular pinacol coupling reactions.
*OH
^  + r  /  ^
NPh2 \ __ /  NPh2
1 : 1 0  TS 
\ 205
Unlike Naito, Skrydstrup does not invoke an 11-membered chelate intermediate to 
explain the observed stereoselectivities. Instead he ascribes the anti stereoselectivity to 
steric repulsions between the complexed Sm(III)-ketyl and the bulky diphenylhydrazone
Sml2
HMPA
THF, 20°C, 5 mins 
59%
scheme 1.57
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group in the intermediate transition structure, with the substituents taking up pseudoaxial 
positions (figure 1.27).
Sml, HMPA
OSmyHMPA),
NPh0
conformation A 
favoured
conformation B 
unfavoured
figure 1.27
The Securinega group of alkaloids are tetracyclic compounds isolated from plants of the 
Securinega and the Phyllanthus genera of the Euphorbiaceae family. Securinine 206 is the 
most abundant alkaloid from the family and has a wide range of biological activity which 
includes antibacterial and antimalarial properties (figure 1.28). Recently, it has been 
found to induce apoptosis in human leukaemia cells. In addition, Securinine has been 
shown to be a specific antagonist of the GABA receptor and has significant central 
nervous system activity.
securinine
MeO'
207
phyllanthine
208
(-)-norsecurinine
209
(+)-14,15-dihydronorsecurinine
figure 1.28
In Weinreb's total synthesis of three securinine alkaloids, he used a synthetic strategy in 
which a key bicyclic intermediate 211 was prepared containing the B and C rings from 
which phyllanthine 207, (-)-norsecurinine 208 and (+)-14,15-dihydronorsecurinine 209 
were subsequently accessed (figure 1.28).98 Enantiopure bicyclic 211 was obtained from 
trans-4-hydroxy-L-proline in 9 steps with the key reaction being a Sml2 mediated
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intramolecular ketone-nitrile coupling of 210 (scheme 1.58). The cyclisation occurred 
under mild conditions in the presence of MeOH, giving the imine, which was 
subsequently hydrolysed during an acidic work-up to give 211 in good yield.
TsN
CN
O
210
1. Sml2 
MeOH
THF, —78°C to rt, overnight
2. 5% aq. HCI
(78% for steps)
scheme 1.58
211
1.3.5 Eight-membered rings
Samarium(II) iodide has been used in a variety of ways and to great effect in the 
formation of 8-membered rings. In an alternative approach to that previously discussed to 
vinigrol 152, Matsuda has shown the Sml2 mediated intramolecular Barbier coupling of 
an aldehyde and an allylic chloride to be a viable method for generating the 8-membered 
ring of the diterpene (scheme 1.59)." Remarkably high yields were obtained for the 
formation of cyclooctanol 213 under non-high dilution conditions in the presence of 
HMPA.
OH
vinigrol 152
BnO'
MOMO
212
BnO'
THF, rt
99%
MOMO
213
scheme 1.59
Taxol 214 is a biologically important natural product which has provided arguably the 
greatest challenge to synthetic chemists of recent years (figure 1.29).
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otaxane numbering schem e
14
taxol® (paclitaxel) 214
figure 1.29
In Mukaiyama's approach to the complex molecule, Sml2 was used to instigate an 
intramolecular Reformatsky reaction which formed the 8-membered B ring across the 
C3-C8 bond with the four previously installed stereocentres in the substrate 215 
remaining intact (scheme 1.60).100,101 216 was obtained as an 83:17 ratio of stereoisomers 
at the stereocentre corresponding to C3 of the natural product (see taxane numbering 
scheme in figure 1.29), however, the stereochemistry at this centre and the second newly 
generated stereocentre C8, is irrelevant as in subsequent steps the stereochemistry was 
lost and regenerated in the formation of the C ring. In their most recent paper,101 
Mukaiyama shows that a-chloro ketones can also be employed in analogous cyclisation 
reactions.
In a different approach to the B ring of the taxane skeleton, Swindell has shown how 217 
underwent Sml2 mediated pinacol coupling to close the ring between Cl and C2.102 In a 
previous study Sml2 showed itself to be a superior reagent to a TiCl4-Zn reagent system
TBDMSi
O , 0  OPMB 
TBDMS^
215
BMPO OBn 
216
scheme 1.60
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for a similar transformation. Initial attempts to carry out the pinacol coupling when the C 
ring was saturated failed, however the use of an aromatic C ring which could be 
transformed later, possibly by Birch reduction, resulted in an efficient pinacol cyclisation 
(scheme 1.61).
iMe
Sml2
THF, 25°C, 0.5 h 
63%
OMeOMe
O CHO OH OH
217
scheme 1.61
Swindell later showed that the presence of an aromatic C-ring was not essential as ocp- 
unsaturated aldehyde 219 cyclised in good yield on treatment with Sml2 (scheme 1.62).102 
Employing aldehyde 219 meant that the methyl group at C8 could be present prior to the 
cyclisation. Swindell suggests that the formation of the anti diol product 220 can be 
rationalised by invoking an endo boat-chair transition structure 221 (scheme 1.62).
221
Sml2
THF, 25°C, 0.5 h 
74%
OH OH
O CHO
scheme 1.62
Eight membered rings can also be constructed using other Sml2 methodology. An 8-endo- 
trig ketyl-olefin cyclisation has been utilised in the formation of the 8-membered ring 
system of (-)-Steganone 224 (scheme 1.63).103 Formation of the large carbocycle was 
enhanced by the biaryl system which held four of the carbon atoms in a suitable 
arrangement for cyclisation. Furthermore, the presence of the electron donating
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methylene dioxy group on the same aromatic ring as the aldehyde was beneficial as it 
served to raise the SOMO of the ketyl-radical and so encourage cyclisation of 222. The 
main feature of this approach, however, was the use of a chromium tricarbonyl complex 
to control the stereochemistry of the cyclisation. In what would normally be a labile 
biaryl system, the chromium tricarbonyl group forces the formyl group to occupy a distal 
position. This holds the cyclic precursor in a conformation that gives rise to the desired 
stereochemistry at the stereocentre a  to the lactone carbonyl (figure 1.30). The synthesis 
was finished in two steps from cyclooctanol 223. Oxidation of the alcohol using PCC 
also removed the chromium complex, and epimerisation of the stereocentre a  to the 
newly formed ketone carbonyl group gave the enantiopure natural product 224 (scheme 
1.63).
1. PCC, NaOAc 
CH,CI,
MelMel Mel
2. DBU 
THF, A 
(70% for 2 steps)
THF, HMPA, 0°C 
73% MeOMeO' MeO
OMeOMe OMe
(-)-steganone 224222 223
scheme 1.63
Mel
Mel
OMe
figure 1.30
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1.3.6 Nine-membered rings
We have seen how the Sml2 mediated intramolecular Reformatsky reaction has been 
employed in approaches to the 8-membered B-ring of Taxol, but the reaction has also 
been used to form larger rings. Tachibana used the reaction to good effect in forming the 
9-membered oxonone F ring of ciguatoxin 190 (see figure 1.23).104 In earlier model 
studies, slow addition of bromide 225 to a solution of Sml2 in THF at 0°C led to over 
reduction of the desired product via reductive cleavage of the C -0 bond a  to the 
ketone.105 The problem of over reduction was solved when bromide 225 was added at a 
faster rate to the Sml2 in THF at —78°C (scheme 1.64). Although no yield for the 
cyclisation, followed by in situ acetylation, is reported, the reaction was sufficiently 
efficient enough to allow the crude product 226 to be used in the next step without further 
purification (no yield is given for the cyclisation but it was part of a five step reaction 
sequence which proceeded in 66% overall yield).104
ITBDPS
OTBDPS
225
1. Sml2
THF, —78°C, 45 min
2. Ac20 , DMAP
—78°C to 0°C, 30 min
yield not given
scheme 1.64
ITBDPS
OTBDPS
OAc
226
1.3.7 Eleven-membered rings
Using their previously developed conditions, Inanaga and co-workers have utilised the 
Sml2 promoted Reformatsky reaction to generate the 11-membered ring of Ferrulactone 
229.106 Cyclisation of bromide 227 onto an a,(3-unsaturated aldehyde formed an unstable
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p-hydroxydecadienolide which was isolated as the corresponding benzoate 228 (scheme 
1.65). The next and final step involved the Sml2 reduction of the allylic benzoate.
227
1. Sml2 
THF, 0°C
2- PhCOCI 
DMAP, rt 
47%
pivalic acid 
THF, 0°C, 0.5h 
78%
Ferrulactone 229
scheme 1.65
1.3.8 Tandem reactions
Sml2 has been used to great effect in mediating cascade reactions where complex 
polycyclic systems are constructed in one synthetic operation. Kilburn has used a Sml2 
mediated radical cascade cyclisation of a methylenecyclopropyl ketone in the preparation 
of paeonilactone B 232.107,108 The paeonilactones are monoterpenoids isolated from the 
roots of Paeonia albiflora Pallas, a plant whose roots have been used extensively in 
Chinese folk medicine. In Kilburn's synthesis of the natural product, the 6-membered and 
5-membered rings are generated in one stereoselective transformation. Sml2 is used in the 
presence of HMPA and tert-BuOH to transform methylenecyclopropyl ketone 230 to the 
bicyclic lactone 231, which is obtained as a 10:1 mixture of diastereoisomers (scheme 
1.66).
230
Sml 
HMPA, (BuOH
THF, 0°C to rt, 1.5h 
63%
231
scheme 1.66
paeonilactone B 232
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The reaction mechanism has been postulated to involve the cyclisation of ketyl-radical 
anion 233 onto the methylenecyclopropane moiety in a 5-exo-trig manner (figure 1.31). 
Ring opening of cyclopropane intermediate 234 gives rise to the cyclohexane radical 235 
which then cyclises in a 5-exo-dig fashion to form the second ring.
230 233 234
l2SmO
Sml.
237
l2SmO
Sm^
236
l2SmO II 
5-exo-dig I I
235
figure 1.31
The presence of HMPA was found to have a dramatic effect on the diastereoselectivity of 
the reaction. When HMPA was replaced with the lesser coordinating solvent DMPU, the 
yield and diastereoselectivity decreased. In the absence of any coordinating solvent, the 
yield decreased further and in addition, a switch in diastereoselectivity was observed. The 
authors explain the diastereoselectivity by invoking the transition structures shown in 
figure 1.32. In the presence of a strongly coordinating solvent such as HMPA, the 
effective steric bulk of the samarium alkoxide results in it taking up a more favourable 
pseudo-equatorial position as it seeks to minimise 1,3-diaxial interactions (transition 
structure A in figure 1.32). In a poorer coordinating solvent such as DMPU, or in the 
absence of any coordinating solvent, the effective steric bulk of the samarium alkoxide is 
less and the methyl group adopts an equatorial position as it is the bulkier group
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(transition structure B in figure 1.32). The natural product was obtained in seven steps 
from the cyclisation product 231.
OSmOIDLn
H ) ( OSm^lOLp
transition structure A transition structure B
figure 1.32
A related radical cascade cyclisation has also been used by Kilburn to access the tricyclic 
ether skeleton of the eudemanes.109 Many sesquiterpenoid lactones containing the 
eudesmane carbon framework have been isolated from plants of the Artemesia genra. The 
conditions employed in the sequential process were examined and it was found that a 
THF-MeOH (4:1) solvent system improved the efficiency of the transformation of 238 to 
give tricyclic 239 (scheme 1.67). Interestingly, in the same disclosure, the formation of an 
analogous tricyclic structure is reported where a change in the solvent system could bring 
about a change in the stereochemistry of one of the newly generated stereocentres.
eudesm ane skeleton
THF, —78°C 
60% OH
239
scheme 1.67
238
Curran has also used a Sml2 mediated cascade process in his total synthesis of (±)- 
Hypnophilin 240 and the formal synthesis of (±)-Coriolin 241 (figure 1.33).110 Due to his 
inability to prepare substrates from 242 suitable for tin hydride cyclisation and the failure 
of 242 to cyclise to give the desired products on treatment with Zn/TMSCl or ha), Curran 
chose to examine the reaction of Sml2 with aldehyde 242 (scheme 1.68).
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oH O H O
Hypnophilin 240 Coriolin 241
figure 1.33
Treatment of 242 with Sml2 in the presence of HMPA at 0°C gave 243 (scheme 1.68). 
The reaction proceeded with complete diastereocontrol generating three new 
stereocentres in the sequence, and giving the cis, trans, cis  stereochemistry of the 
tricyclic product. Interestingly, when DMPU was used as cosolvent, the stereoselectivity 
of the reaction decreased and a 10:1 ratio of diastereoisomers of the tricyclic product was 
obtained. When using either HMPA or DMPU, a small amount of the uncyclised, reduced 
aldehyde was also isolated.
It would appear that the mechanism of the reaction involves the generation of a ketyl- 
radical anion which cyclises in a 5-exo-ing manner to form a tertiary cyclopentyl radical 
245 which adds to the alkyne in a 5-exo-dig cyclisation to form the final 5-membered 
ring. Hydrogen atom capture terminates the sequence (figure 1.34).
1. Sml2, THF, HMPA
2. pTSA, acetone 
(63% for 2 steps)
242 243
scheme 1.68
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The authors explain that less than two equivalents of Sml2 are necessary for the cascade 
reaction. Furthermore, when the reaction was quenched with D20 , no deuterium 
incorporation was observed, the authors concluded that the final radical species 247 
undergoes hydrogen atom capture from the solvent before a second Sml2 reduction can 
generate the organosamarium.
1.4 Conclusion
Quite clearly, Sml2 is an incredibly useful reagent, which can mediate a number of C-C 
bond forming transformations. Although only a recent addition to the tools of the 
synthetic chemist, there is no shortage of examples of its use in natural product synthesis. 
The versatility of the reagent has been highlighted by its use in the preparation of a 
variety of highly complex molecules which often bear sensitive structural features and 
functionality. High yields and stereoselectivities are also a feature of reactions mediated 
by the lanthanide reducing agent. Perhaps the most exciting application of Sml2, is in 
mediating sequential reactions where molecular complexity can be assembled rapidly in a 
single synthetic operation. When such tandem processes are applied to complex natural 
products, the results are often staggering with whole carbon skeletons being assembled in 
one step with high levels of stereocontrol. It seems certain that Sml2 will enjoy continued 
application as chemists pursue more and more challenging structures from the natural 
world.
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Chapter 2: Results and discussion
The two principle aims of this investigation were the development of a samarium(II) 
mediated 4-exo-trig ketyl olefin cyclisation and the application of this reaction to the 
synthesis of the biologically active natural product pestalotiopsin A.111,112 The following 
chapter is an account of our investigations.
2.1 Stereoselective synthesis of functionalised cyclobutanols via the 
samarium(II)-mediated 4-^jco-trig cyclisation of unsaturated aldehydes
The samarium(II) mediated reductive cyclisation of unsaturated aldehydes or ketones is a 
particularly powerful cyclisation protocol which allows a variety of cyclic alcohols of 
varying ring size to be assembled under mild conditions with moderate to good 
diastereocontrol. The reaction is atom efficient with functionality present in the starting 
material being retained in the product, albeit in a different oxidation state. In generating 
the new ring junction two new stereocentres are formed and a third stereocentre is 
established when the olefin bears an additional substituent a  to the electron withdrawing 
group. Thus highly functionalised products with multiple stereocentres can be accessed in 
a mild and atom-efficient manner (figure 2.1).
R R
249 250
figure 2.1
The versatility of the reaction has been further highlighted by its use in the preparation of 
heterocycles. When the electron withdrawing group is an ester, the Sml2 cyclisation is
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often followed by spontaneous lactonisation, allowing convenient access to bicyclic 
lactones. For example, the cyclisation of ketone 251, shown in scheme 2.1, gives lactones 
252 in moderate yield.113, ] 14
schem e 2.1
Our initial objective was to see if reductive cyclisations of this type could be used to form 
small ring systems, in particular, cyclobutanols.
2.1.1 Introduction
Radical cyclisations to form cyclobutane rings are reversible and hence few efficient 
reactions employing such processes have been reported.115'118 At the outset of the project, 
we believed that the ability of samarium(II) iodide to not only generate carbon-centred 
radicals but to further reduce such radicals to the corresponding carbanions might provide 
a way of trapping the cyclic product and hence prevent the facile ring-opening process 
(figure 2.2).39 We proposed that this proposed ‘trapping’ mechanism might provide a 
general approach to functionalised cyclobutanols. Following the initial Sml2 reduction, 
the uncyclised ketyl radical anion 254 is in equilibrium with the cyclobutinyl radical 255. 
However, reduction of 255 to the carbanion 256 prevents ring-opening and ‘traps out’ the 
cyclic product, which in effect moves the equilibrium to the right, driving the reaction 
forward.
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COoEt C O ,B
254
Sml2 then 
r  proton source
COoEt
258
xOSml,
Sml,
s s ^ C 0 2Et
255
f  0OSml2 
^ C 02Et
H ©  
256
Sml2 then 
< proton source
3 OH
,C 0 2B
257
figure 2.2
Prior to our investigation there was only one previous example of a samarium(II) 
mediated 4-exo-trig ketyl-olefin cyclisation, which was reported by Weinges,59 and this 
disclosure contained only a single example employing substrate 259 and using relatively 
harsh conditions (scheme 2.2).
Bn<
259
Sml2
HMPA
Bn1 .OH
THF, 10°C, 1 h 
60%
,C 0 2Et
260
scheme 2.2
Despite the limited precedent, we believed the reaction might have considerable potential 
as a general route to cyclobutanols and that the nature of the reaction would result in a 
highly diastereoselective process.
Cyclobutane and cyclobutanol derivatives are important building blocks in organic 
synthesis and constitute a structural motif that is found extensively in natural products. 
For example, pestalotiopsin A 261,112 punctaporonin B 262,119 and plorantinone C 263,^
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122 and non-natural, biologically important molecules, such as the anti-viral, cyclobut-A 
264 (figure 2.3).'23-'25
Ac
OMe
OHHO
OH
261
pestalotiopsin A
262
punctaporonin B
OH
264
cyclobut-A
....OH
263
plorantinone C
figure 2.3
Cyclobutanes are most often prepared using photochemical [2+2] cycloaddition 
processes.126'130 [The preparation of functionalised cyclobutanols using Sml2 mediated 
nucleophilic acyl substitutions has recently been reported].60,131 Although these reactions 
are useful in synthesis, alternative processes, which would allow more substituted 
cyclobutanes, and in particular cyclobutanols, to be prepared stereoselectively, would be 
very useful.
We felt that a samarium(II)-mediated approach to cyclobutanols would follow a well- 
defined stereochemical course, very different to those involved in conventional 
cyclobutane ring-forming reactions. The origin of the expected stereoselectivity can be 
seen in the Beckwith-Houk type transition structures in figure 2.4.132,133 Following the 
formation of the ketyl-radical anion, repulsion between the lone pairs of electrons on the 
oxygen and the developing methylene radical should result in the anti transition structure
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being favoured. Thus we expected the cyclisation, if successful, to yield anti- 
cyclobutanols as the major products.
Sml,
H
EWG
syn-transition structure
X' W 7 s“OSml2
EWG
an//-transition structure 
favoured
figure 2.4
2.1.2 Selection of cyclisation substrates
My early work involved building upon a previous example of a Sml2 mediated A-exo-\xig 
ketyl-olefin cyclisation carried out within the group. Aldehyde 265 had been prepared 
from y-butyrolactone in 6 steps. On treatment with Sml2 265 underwent cyclisation to 
give the corresponding cyclobutanol 266 in 65% yield. Furthermore, only a single 
diastereoisomer was observed, with nOe studies revealing that the cyclobutanol product 
had anti stereochemistry across the newly formed C-C bond.
Sml2
MeOH
CO,Et
THF, 0°C, 5 min 
65%
265
1.9%
.OH
3.7%
3.3%
266
nOe studies on 266
scheme 2.3
Building upon this sole example we decided to prepare five other cyclisation substrates in 
order to develop optimum conditions for the cyclisation and, importantly, to examine the 
scope and generality of the reaction. The cyclisation substrates we selected are shown in 
figure 2.5.
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Substrate 267 was selected as a suitable aldehyde that would enable us to study 
cyclisations which would form 3 contiguous stereocentres in a single step. For example, 
would any stereocontrol be observed at the third stereocentre a- to the ester group? 
Preparation of aldehyde 268 would allow us to examine whether the presence of the gem 
dimethyl group was a precondition for cyclisation. The importance of gem disubstitution 
in certain examples of small ring system formation has previously been observed and 
discussed,115116134'137 although there are other cases where gem disubstitution is not 
required (such as the example reported by Guibe previously discussed in section 1.2.239 
and the example discussed in the later section 2.1.4.117 Scheme 2.4 illustrates results 
obtained by Jung in a study examining the effects of various gem-substituents in a 
tributyltin hydride 4-ejco-trig cyclisation.134 With the unsubstituted bromide 272 (R=H) 
only the acyclic reduction product 273 (R=H) was detected. However, when gem- 
dimethyl groups were introduced, bromide 272 (R=Me) cyclised to give the cyclobutane 
274 (R=Me) in low yield. Interestingly, with bromide 272 (R=OEt), cyclisation was 
highly efficient and gave the cyclobutane 274 (R=OEt) exclusively.
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FT
272
Bu3SnH
AIBN
PhH, A
, 1
CO,Et
,C 0 2Et
273 274
273 : 274
R = H, 100 : 0
R = Me, 7 5 : 25
R = OEt, 0 : 100
scheme 2.4
The importance of the position of the gem dimethyl group was of interest to us and so 
aldehyde substrate 269 was targeted. In order to assess the feasibility of using other 
radical acceptors in the cyclisation, vinyl sulfone substrate 270 was designed. Finally, the 
a-thio methyl substituted vinyl sulfone 271 was also targeted. We envisaged the presence 
of the thio methyl group a  to the sulfone in 271 might facilitate cyclisation by formation 
of a more stable cyclised radical intermediate. This effect is known as the Captodative 
effect and will be discussed in greater detail in section 2.1.4.138
2.1.3 Preparation of cyclisation substrates
Retrosynthetic analysis of the cyclisation substrates revealed that 267, 268, 270 and 271 
could be accessed using a general route starting from y-butyrolactone 278 (figure 2.6).
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R282
MeS
276 R=H 
280 R=CH.
277 R=H 
281 R=CH,
278
283
figure 2.6
Retrosynthetic analysis of aldehyde substrate 269 also revealed that it could also be 
prepared from y-butyrolactone using similar transformations (figure 2.7).
269 >
284 281
278
figure 2.7
Aldehyde substrate 267 was first prepared. y-Butyrolactone 278 was alkylated twice 
using LDA and Mel to give 286 in good yield. Lactone 286 was then converted to lactol 
281 by DIBALH reduction.139 Ring opening of the lactol with 1,3-propanedithiol to give 
alcohol 287 was first attempted in the presence of triflic acid,140 however the yields for 
the reaction were not reproducible and were often unsatisfactory. When the protic acid 
was replaced with the Lewis acid, BF3.OEt2, the reaction was greatly improved giving the
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alcohol 287 in good yield. Subjecting alcohol 287 to a one pot Parikh-Doering 
oxidation141-Wittig reaction sequence, gave the unsaturated ester 279 in excellent yield. 
The expected ^-stereoisomer was formed exclusively. Removal of the thioacetal 
protecting group to unmask the aldehyde group was achieved by refluxing 279 in the 
presence of Mel and CaC03 in a 4:1 mixture of MeCN and H20 .142 Aldehyde 267 was 
obtained in almost quantitative yield and required no further purification (scheme 2.5).
278
1. nBuLi, 'Pr2NH 
THF,—78°C, 2h
2 Mel
THF, -78°C to -20°C, 15h 
87% 285
1. nBuLi, 'Pr2NH 
THF,—78°C, 1.5h
2. Mel
THF, -78°C to rt, 16.5h 
88% 286
CO,Et
1. S 0 3.py, NEt3 
DMSO, CH2CI2 
0°C to rt, 3h_______
2- Ph3P=C(CH3)C 02Et 
CH2CI2, rt, 14h 
98%
279
Mel, C aC 03 
MeCN, H20  
60°C ,21h 
97%
1,3-propanedithiol 
BF3.OEt2, 4A MS
CH2CI2,-20oC to rt, 2h 
59%
287
DIBAL-H
CH2CI2, -78°C, 2h 
98%
281
scheme 2.5
Aldehyde substrate 268 was prepared in a similar fashion with the exception that the 
lactone was only mono-methylated and a different Wittig reagent was used in the 
oxidation-olefination sequence (scheme 2.6).
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1,3-propanedithiol 
CF3C 0 2H, 4A MSDIBAL-H
1. SO3.py.NEt3 
DM SO, CH2CI2 
0°C to rt, 4h
2. Ph3P=CHC02Et 
CH2CI2, rt, 12h 
71%
60°C, 22h 
97%
275268
scheme 2.6
The preparation of the vinyl sulfone substrate 270 was next examined. Our approach 
utilised a stereoselective Horner-Wadsworth-Emmons reaction as the key transformation 
(scheme 2.7). Alcohol 287 was prepared using the route discussed earlier (scheme 2.5). 
Parikh-Doering oxidation of the alcohol gave the aldehyde 280, which was isolated in 
good yield. Using conditions developed by Lee and Oh,143 aldehyde 280 was treated with 
a-phosphorylated-a-lithio methyl phenyl sulfone, prepared in situ by the reaction of the 
dianion of methyl phenyl sulfone and diethylchlorophosphate. The reaction proceeded 
stereoselectively, giving exclusively the E-vinyl sulfone 282 in good yield, the E- 
geometry being assigned by analysis of the NMR coupling constants. Deprotection of 
the aldehyde was achieved using the same conditions as discussed previously and 
aldehyde 270 was obtained in almost quantitative yield, again, with no need for further 
purification.
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S 0 3.py, NEt3 
DMSO, CH2CI,
M eS02Ph 
nBuLi, (Et0)2P(0)CI
Mel, C aC 0 3 
MeCN, H20  
60°C, 15h 
98%
scheme 2.7
Aldehyde substrate 271 was prepared using an olefination reaction developed by Jackson 
and co-workers.144 Aldehyde 280 was added to the stabilised anion formed from 
deprotonation of methylthio methyl p-tolyl sulfone with «BuLi (scheme 2.8). In situ 
acetylation and subsequent elimination gave a single double bond isomer, which we 
assumed to be the £-isomer from Jackson’s precedent (Jackson assigned the ^-geometry 
of his compounds by the chemical shift of the vinylic proton). The mediocre yield was 
disappointing but no attempts were made to optimise the reaction. It is possible the 
problem lay with the acetylation and elimination steps.
The subsequent deprotection step to give the aldehyde 271 was a concern due to the 
perceived similarity of the substituted vinyl sulfone and the thioacetal moieties. However, 
treatment of vinyl sulfone 283 under the usual conditions afforded the aldehyde 271 in 
quantitative yield with no chemoselectivity problems.
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MeSCH2S 0 2pTol 
nBuLi, NEI3 
Ac?0,4-DMAP
THF, -78°C to 0°C, 6h 
41%
MeS
Mel, C aC 03 
MeCN, H20
60°C, 6h 
100% S 0 2pTol
MeS
280 283 271
scheme 2.8
Finally, the preparation of aldehyde 269 was investigated. A Wittig reaction on the lactol 
281, which is in equilibrium with the hydroxy aldehyde, was expected to give the alcohol 
284. However, the transformation provided some interesting results. When the 
transformation was carried out in THF at room temperature, only starting material was 
recovered from the reaction mixture. The reaction was also attempted in refluxing 
CH2C12, however, again no reaction was observed. It is possible the gem dimethyl groups 
were hindering the Wittig reaction. The reaction was then attempted in refluxing toluene. 
After 10 h olefination occurred giving a low yield of the unsaturated alcohol 284 (scheme 
2.9).
281
Ph3P=CHC02Et
PhCH3, A, 10h 
44% CO,Et
284
scheme 2.9
S 0 3. py, NEt3 
DMSO, CH2CI2
0°C to rt, 3h 
99% CO,Et
269
When the reaction was left refluxing for longer periods, the substituted tetrahydrofuran 
289 was the major product arising from 284 by an intramolecular Michael addition 
(scheme 2.10).
281
PhaP=CHC02Et 
PhCH3, A, 5d
COzEt
284
13%
289
scheme 2.10
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Fortunately, Patrikh-Doering oxidation of the unsaturated alcohol 284 was straight 
forward giving the aldehyde substrate 269 in excellent yield.
2.1.4 Sml2 mediated 4-exo-trig cyclisations of substrates 267, 268,269, 270 and 271
The Sml2 solutions used in this study were prepared using a modification of Imamoto’s 
method.145 Samarium metal was dissolved in THF and iodine added. The solution was 
then heated at 60°C for 18h after which time a deep, dark blue solution of Sml2 was 
obtained. We found these solutions could be stored for up to 3 days under Argon.
We first attempted the cyclisation of aldehyde 267. After extensive studies, optimal 
conditions for the cyclisation were found to involve the addition of the substrate to a 
solution of Sml2 (inverse addition) in THF, in the presence of excess MeOH (ratio of 
THF to MeOH, 4:1) as cosolvent (scheme 2.11). I46,147
Sml2 
MeOH: THF (1:4)
scheme 2.11
The MeOH serves not only as a proton source but also appears to promote cyclisation by 
increasing the reduction potential of samarium(II) iodide, a phenomenon which has been 
suggested by Curran,148 but has since received little attention. Cyclisations carried out 
using EtOH or te/t-BuOH as cosolvent were found to be considerably slower, and were 
only successful using the inverse mode of addition. The reaction followed a well defined 
stereochemical course to give exclusively the anti cyclobutanol 290 with no trace of the
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corresponding syn product being detected. Significant stereochemical control at the third 
newly generated stereocentre was observed but will be discussed later in the chapter 
(section 2.1.5.1).
The cyclisation of the mono-methyl substituted aldehyde 268 was next examined. When 
treated with Sml2 under the optimal conditions no cyclisation occurred. Instead, straight 
reduction of the aldehyde and carbon-carbon double bond took place to give the acyclic 
saturated alcohol 292 as the major product (scheme 2.12). Similarly, no cyclobutanol 
291 was formed when the cyclisation was attempted in the presence of LiCl, an additive 
known to increase the reduction potential of Sml2.149 From this result we were able to 
conclude that the quaternary centre was an important factor for the success of the 
cyclisation.
Sml2
MeOH:THF (1:4)
C 0 2Et °°C- 4h
268
schem e 2.12
During this investigation, work carried out by another member of the group provided 
some interesting observations concerning the apparent need for gera-disubstitution 
(scheme 2.13). The aldehyde 293, where a methyl group from 265 has been replaced by a 
benzyloxy group, was also treated with Sml2. Cyclisation occurred in reasonable yield to 
give cyclobutanol 294 as a 5:1 ratio of diastereoisomers (scheme 2.13). The result is of 
interest as it reveals that gem-dialkvl substitution is not necessary for cyclisation. Work is 
currently underway in the group to develop new strategies for facilitating the cyclisation.
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293
Sml2 
/BuOH, HMPA
THF, 0°C, 0.5 h 
57%
BnO OH
| \ / C 0 2Et
294
scheme 2.13
Having established the importance of the quaternary centre it appeared sensible to 
investigate the effect of the position of the quaternary centre. When aldehyde substrate 
269 was treated with Sml2 under the optimal conditions, a complex product mixture was 
obtained (scheme 2.14). Suprisingly, the major product isolated from the mixture was the 
methyl ester cyclobutanol 296. It appears that trans-esterification occurred in the reaction 
either before or after the cyclisation. Interestingly, trans-esterification was rarely a 
problem in the cyclisation of other substrates. No further study of the reaction was 
undertaken, however, further work on the cyclisation is ongoing within the group.
..OH
- \ ^ C 0 2Me 
H
296
scheme 2.14
CO,Et
Sml2
MeOH:THF (1:4) 
0°C, 45 min
269
.OH
"k^-C02B
295
Scheme 2.15 again illustrates a reaction carried out by another member of the group but 
which is of interest here. In the aldehyde 259, the gem-dimethyl group is in the 13- 
position. When treated with Sml2 under our optimum conditions, cyclisation occurred to 
give the corresponding cyclobutanol 260 in good yield (c.f. scheme 2.2).59,147 The result 
suggests that cyclisation occurs regardless of whether the gem-dimethyl group is in the a- 
or (3- position of the substrate.
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scheme 2.15
Following our studies on the effect of the quaternary centre, we began to investigate the 
feasibility of using different radical acceptors in the cyclisation. The vinyl sulfone 270 
was treated with Sml2 under our optimal conditions (scheme 2.16).
270
Sml,  in --0H + n /
MeOH:THF (1:4) j \ ^ S0 2 Ph \ ^
°°C’ 3h H —  SO,Ph
21% 35%
297 298
scheme 2.16
Cyclisation occurred to give the corresponding cyclobutanol 297, however the reaction 
was considerably less efficient than the analogous cyclisations of a,p-unsaturated esters 
265 and 267. As expected, the reaction proceeded stereoselectively to give only the anti 
cyclobutanol product. Various cyclisation conditions were examined to improve the yield 
including the use of HMPA and HMPA/te/t-BuOH cosolvent systems as well as different 
modes of addition, however, the alterations only increased the quantity of unsaturated 
alcohol 298 obtained. It was concluded that vinyl sulfones are generally less efficient 
than a,P-unsaturated esters as radical acceptors in the cyclisation.
We felt that the efficiency of vinyl sulfones as radical acceptors might be improved if an 
electron donating group were introduced a  to the sulfone in the cyclisation substrates. A 
study by Ogura et. al. has demonstrated that the presence of a methylsulfanyl substituent 
a  to the sulfone group resulted in a more efficient radical acceptor in a tin hydride 
mediated 4-exo-trig cyclisation of iodide 299 (scheme 2.17).117 The efficiency of Ogura’s
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cyclisation was attributed to the formation of a cyclised radical stabilised by the 
captodative effect.138
SOgpTol
PhH, A, 2 h
Bu3SnH
ABN
V
SMe
S 0 2pTol +
MeS
.CH.
S 0 2pTol
MeS
48%
300
34%
301
299
scheme 2.17
We decided to prepare aldehyde 271 to see if such a strategy would be helpful in our 
Sml2 mediated 4-exc?-trig ketyl-olefin cyclisation. According to the captodative effectt 
(see Appendix 1) radicals positioned between an electron donating group and an electron 
withdrawing group, i.e. 303, are more stable than the analogous radicals lacking one or 
other these substituents, i.e. 302 (figure 2.8). The reaction is reversible, therefore the 
greater stability of the cyclic radical should result in more of this ring closed radical 
existing at equilibrium, and hence more cyclobutanol product should be formed.
When aldehyde 271 was treated with Sml2 under our standard conditions, cyclisation 
occurred to give cyclobutanol 304 in high yield (scheme 2.18).
■ \^S02Ph
H
302
.OSm"1
MeS
303
figure 2.8
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V - S 0 2pTol
MeS
Sml2 
MeOH:THF (1:4)
0°C, 5 min 
74%
271
S 0 2pTol
304
scheme 2.18
The reaction proceeded with good stereocontrol. Again, giving exclusively anti 
stereochemistry was obtained across the new C-C bond. Furthermore, good selectivity 
was observed at the 3rd new stereocentre, a- to the sulfone, with a 6:1 ratio of 
diastereoisomers being obtained.
The stereochemistry of the major diastereoisomer from the cyclisation was determined by 
X-ray crystallography (figure 2.9).
figure 2.9
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Clearly, the cyclisation of the substituted vinyl sulfone 271 is far more efficient than the 
cyclisation of the unsubstituted vinyl sulfone 270.
2.1.5 Investigation into the mechanism and diastereoselectivity of the cyclisation
2.1.5.1 Examination of the role of the cosolvent
When the cyclisation of 267 was carried out in MeOD, complete deuterium incorporation 
was observed a  to the ester in the cyclobutanol product 305 (scheme 2.19). This clearly 
illustrates that protonation rather than hydrogen atom capture terminates the reaction. 
This agrees with the accepted two step two electron mechanism for ketyl-olefin 
cyclisation reactions with Sml2,50 although it does not rule out an anionic mechanism. [A 
mechanistically ambiguous, magnesium-mediated reductive cyclisation of ketones 
tethered to olefins bearing ester and nitrile groups has been reported].150 In the cyclisation 
of 267, protonation of the intermediate samarium(III) enolate 306 generates a third chiral 
centre. With MeOH as the cosolvent, we found that selectivities at this centre range from 
4.5-3:1.
Sml2
MeOD
scheme 2.19
OEt
306
Little is known about the stereochemistry of processes in which prochiral enolates, 
generated by radical addition to an olefin, followed by further reduction, react with
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electrophiles. Recently, an analogous stereochemical issue involving a 5-^o-trig ketyl- 
olefin cyclisation of 307 mediated by samarium(II) iodide was discussed and selectivities 
slightly lower than our own were observed (scheme 2.20).151
Sml2 
HMPA, MeOH
ChzN'
scheme 2.20
In the vanadium(II) mediated ketyl-olefin cyclisation of aldehyde 309 by Torii et. al., 
similar selectivities were again observed but not discussed (scheme 2.21).152
309 310
scheme 2.21
The intermolecular addition of alkyl radicals to a-substituted-a,p-unsaturated esters 
followed by reduction to enolates, mediated by zinc metal or cobalt complexes has also 
been studied.153 This study concluded that the 1,2-asymmetric induction in enolate 
protonation was comparable to that observed for hydrogen atom capture in the same 
system. It was also observed that the stereoselectivity of protonation could be influenced 
to a small degree by the addition of amines.153
In investigating the cyclisation of 267, we observed that the stereochemistry at the centre 
a- to the ester in the product cyclobutanols was highly dependent on the alcohol 
employed as the cosolvent in the cyclisation. As previously mentioned, cyclisation of 267 
in MeOH led to a diastereoisomeric ratio of 4:1. Remarkably, however, when the reaction
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was repeated using the same conditions but employing tert-BuOH as the cosolvent, the 
diastereoselectivity was reversed, favouring the other diastereoisomer by 2:1. In order to 
rationalise the observed diastereoselectivity, we sought to determine the stereochemistry 
of the major diastereoisomer from the cyclisation of 267 in MeOH. The major 
cyclobutanol was obtained by column chromatography and a crystalline derivative 
pursued. Unfortunately, both the 4-nitrobenzoate, and the 3,5-dinitrobenzoate esters of 
305 were non-crystalline. However, reduction of 305 gave diol 311, and subsequent 
sublimation of the low-melting solid gave crystals suitable for low temperature X-ray 
crystallographic analysis (scheme 2.22).
1 0OH LiAIH4
H P D
305
C 0 2Et
THF, 0°C, 1.5 h 
59%
, .L ..OH
H I D 
311
OH
scheme 2.22
The X-ray structure clearly shows the anti stereochemistry across the new C-C bond and 
the stereochemistry at the position that was a- to the ester in the major cyclobutanol 305 
(figure 2.10).
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figure 2.10
With the relative stereochemistry of the major cyclobutanol from the cyclisation of 267 in 
MeOH established, the cyclisation of 267 using a variety of cosolvents under otherwise 
identical conditions was then carried out and the diastereomeric ratio a -  to the ester 
determined (Table 1).
Sml2
cosolvent
THF, 0°C
CO,Et
,.L 0OH
^ . C O zEt
in = h
L ..OH
H | W
CO,Et
267 290a 290b
cosolvent additive time3
ratio of 
290a290bb
isolated yield 
of 290(%)
H20 < 1 min 5:1 44%
MeOH 5 min 4:1 6 6 %
MeOH HMPAC 5 sec 4:1 35%
EtOH 1 hr 25 min 1:1 84%
ferf-BuOH 9 hr 1:2 53%
table 1: Reaction conditions. 267 in THF (0.25 M) was added to a  solution of 
Sml2 (0.1 M in THF, 2 eq and cosolvent (123 eq) (+ additive) at 0°C. a Time 
taken for Sml2 to decolourise. b From crude 1H NMR. c 12 eq added.
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The use of water as an additive gave the highest selectivities under these specific 
conditions, and the fastest reaction, as indicated by the time taken for the samarium(II) 
iodide solution to decolourise. Unfortunately, additional products arising from over­
reduction prior to cyclisation were formed. The use of EtOH gave a slower reaction and a 
1:1 mixture of diastereoisomers 290a and 290b was formed. As previously mentioned, 
when rm-BuOH was employed as a cosolvent, the reaction was extremely slow and 
showed a switch in selectivity in favour of cyclobutanol 290b.
A possible explanation for the cosolvent dependency of the stereochemistry, lies in the 
degree of solvation about the samarium(III) centres in the key samarium(III) enolate 
intermediate. In figure 2.11 two possible conformations, A and B, of the intermediate 
samarium(III) enolate are shown.
enolate conformation B
290a M % C X ^ O -? S m '"  ----- - 290b
'0 ? trC(OEt)0'
n
ROH
figure 2.11
In the absence of strongly co-ordinating solvents, chelation of the lanthanide centre to 
both the alkoxide on the cyclobutane ring and the enolate would be expected to lock the 
system in conformation B. Protonation of the intermediate whilst in conformation B 
would lead to cyclobutanol 290b. In highly co-ordinating solvents, such as water and 
methanol, however, this chelation will be disrupted and conformation A will 
predominate, due to electronic and steric factors.154 Protonation of the intermediate whilst 
in conformation A will lead to cyclobutanol 290a. Hence, the reactions in EtOH and tert- 
BuOH show a gradual swing towards enolate conformation B as chelation becomes more
enolate conformation A
SrW "0( BO)C^=-^-Mes-Qgmm
ft
ROH
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important. This is only one of several possible explanations and further studies are 
needed to explore this issue further.
An additional observation that the cyclisation of 267 in the presence of only 4 equivalents 
of MeOH gave a low yield of cyclobutanol 290 as a 1:1 ratio, not only supports these 
ideas but also shows the importance of excess alcohol for activation of Sml2 and thus, 
efficient reaction.
2.1.5.2 Does the geometry of the intermediate samarium(III) enolate influence the 
diastereoselectivity of cyclisation?
We were concerned that the cosolvent driven switch in diastereoselectivity observed in 
the cyclisation of 267 might be the result of a switch in enolate geometry in the 
intermediate samarium(III) enolate. We therefore felt it was important to investigate the 
role of the samarium(III) enolate geometry in the process. The cyclisation substrate 312 
was devised where the geometry of the enolate intermediate 313 would be locked (figure 
2.12). If the cyclisation of 312 in MeOH and tert-BuOH showed a similar switch in 
diastereoselectivity, then any role ascribed to the geometry of the samarium(III) enolate 
could be discounted.
For the preparation of the aldehyde 312, it was necessary to prepare the literature 
phosphonium ylide 316 which could then be used in a Wittig reaction on our key
I ^OSm(lll)
i --------1'° n s n
?
312 313
figure 2.12
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aldehyde 280 (scheme 2.23).155 Treatment of a-bromo-y-butyrolactone 314 with 
triphenylphosphine in refluxing DME gave, after recrystallisation, the phosphonium 
bromide salt 315. Subsequent treatment of 315 with Ng^CC^ gave the ylide 316 in good 
yield.
 PPh3 »  P^ S ^ n  ----------------------    Ph3
DME, A tort, 19 h ©  \  r  H20 , MeOH, rt, 10 min 
61% B r  \ 1 63%
314 315 316
scheme 2.23
One pot Parikh-Doering oxidation and Wittig reaction, using 316, on alcohol 287 gave 
the corresponding unsaturated thioacetal 317 as a 4:1 ratio of stereoisomers, which were 
separated by column chromatography (scheme 2.24). To help establish the 
stereochemistry of the major product, nOe studies were undertaken and confirmed the 
major product to possess E-double bond stereochemistry (figure 2.13). Removal of the 
thioacetal protection was achieved using the deprotection conditions described previously 
and gave the cyclisation substrate 312 in excellent yield.
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1. S 0 3.py, NEtg 
DM SO, CH2CI2 
0°C to rt, 4h
2. 316
CH2CI2, rt, 12h 
91%
4:1
287 317-E 317-Z
3%
nOe study on 317-E
figure 2.13
Mel, C aC 03 
MeCN, H20  
60°C,22h 
100%
312
scheme 2.24
When aldehyde 312 was treated with Sml2 in the presence of MeOH, cyclisation occurred 
to give anti cyclobutanol 318 in good yield (scheme 2.25). As with the cyclisation of 
aldehyde 267, a 4:1 ratio of diastereoisomers in favour of cyclobutanol 318a was 
obtained. Significantly, when the cosolvent was changed to terr-BuOH and the 
cyclisation repeated, a switch in stereoselectivity in favour of cyclobutanol 318b was 
observed.
Sml2
ROH
THF, 0°C
312
0nOH
H 
318a
o«0H
H 
318b
R = Me, 79% 4:1
R = ©u, 60% 1:2
scheme 2.25
As previously noted, in this cyclisation the intermediate samarium(III) enolate geometry 
is locked. Since a similar cosolvent dependency is observed in this cyclisation when
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compared to that of 267, it appears that enolate geometry is not an important factor in the 
variation of product stereochemistry with solvent.
2.1.5.3 Does double bond stereochemistry influence the diastereoselectivity of the 
cyclisation?
In order to assess the effect of the initial double bond geometry on the stereochemistry of 
the cyclisation, we next examined the cyclisation of 319 (Scheme 2.26).
Thioacetal 317-Z was obtained as the minor stereoisomer from the Wittig reaction in the 
synthesis of aldehyde 312 (see scheme 2.24). Removal of the aldehyde protecting group 
as before gave the cyclisation substrate 319 in good yield.
Mel, C aC 03 
MeCN,HzO
60°C, 22.5 h 
90%
317-Z 319
scheme 2.26
Interestingly, cyclisation of 319 gave a complex mixture of products (scheme 2.27). In 
stark contrast to the complete anti-selectivity observed in the cyclisation of 312, a 1:1 
mixture of syn and anti-cyclisation products was obtained, the syn products undergoing 
spontaneous trans-lactonisation to give bicyclic lactones 320. In addition, approximately 
2:1 mixtures at the centre a  to the lactone carbonyl group were also obtained.
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Sml2
MeOH
318b
scheme 2.27
It is therefore clear that the initial double bond stereochemistry has a profound effect on 
the relative stereochemistry across the newly formed ring junction but has a less dramatic 
effect on the stereochemistry a  to the lactone carbonyl group. Enholm first observed a 
marked dependence of diastereoselectivity on the olefin-geometry in samarium(II)- 
mediated reductive cyclisations to form 5-membered carbocycles.156'158 Identification of 
the products from the cyclisation was facilitated by the preparation of both bicyclic 
lactones 320a and 320b independently (see section 2.2.6).
The observed stereochemical outcome from the cyclisation of 319 can be explained by 
considering pre-association of the Sm(III) of the ketyl-radical anion with the ester 
carbonyl. On treatment of 312 with Sml2, the anti transition structure 321 is favoured 
over the syn transition structure 322 for two reasons (figure 2.14). Firstly, the structure is 
favoured due to electronic repulsion between the lone pairs of electrons on the oxygen 
and the developing methylene radical, as previously discussed in section 2.1.1. Secondly, 
it appears likely that a 9-membered ring chelate is formed prior to cyclisation: Sm(III) of 
the ketyl-radical anion coordinating to the carbonyl of the lactone. Such chelation is only 
possible in the anti arrangement 321. It is plausible that this chelation to the Lewis acidic
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samarium(III) centre also activates the enoate to radical addition, thus enhancing the 
preference for structure 321 over the syn structure 322. Thereby, only anti cyclobutanol 
products are obtained from the reaction of the ^-substrate 312.
Sm "'0 ‘O
anti syn
322321
figure 2.14
However, in the cyclisation of 319, there is no clear preference for either transition state. 
In the anti transition structure 323, although the electronic arguments are satisfied, 
chelation between the Sm(III) of the ketyl-radical anion and the ester carbonyl cannot 
easily occur (figure 2.15). The syn transition structure 324, on the other hand, does not 
satisfy the electronic arguments but can form a 9-membered chelate with samarium(III). 
The overall result is a mixture of anti and syn cyclobutanol products as no transition state 
is significantly favoured over the other.
,OSmin
anti syn
324323
figure 2.15
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2.1.6 Conclusions
The Sml2 mediated 4-exo-trig cyclisation of unsaturated aldehydes has been shown to be 
an efficient and mild method for the preparation of functionalised cyclobutanols. The 
methanol cosolvent has an important role in the cyclisations and appears to activate Sml2, 
hence removing the need for the highly carcinogenic additive HMPA. In all cases, where 
the olefin has Zs-geometry, the reaction has been shown to proceed with complete anti 
selectivity across the newly formed C-C bond. However, the cyclisation of the Z-olefin 
substrate 319 proceeded to give a mixture of syn and anti cyclobutanols, clearly showing 
the importance of olefin geometry in the cyclisation.
The importance of gera-disubstitution in the reaction was demonstrated by the failure of 
substrate 268 to undergo cyclisation. Furthermore the position of the gera-disubstitution 
has been shown to be of importance by the inefficient cyclisation of 269. However, the 
successful cyclisation of 259 highlights that disubstitution need not be d ia lkyl 
substitution. Work is currently underway in the group to find other strategies for 
facilitating the cyclisation.
a,p-Unsaturated esters were shown to be more efficient radical acceptors in the 
cyclisation than the corresponding vinyl sulfones. Furthermore, the cyclisation of 
aldehyde 271 has illustrated how the captodative effect can be exploited to increase the 
efficiency of the 4-exo-trig cyclisation.
Mechanistic studies on the cyclisation of 267 have shown that the reaction progresses via 
a samarium(III) enolate intermediate. Furthermore, in the cyclisation of substrates 267, 
271 and 312 we have observed significant stereocontrol with respect to the third newly 
generated stereocentre. Further studies on the cyclisation of 267 have illustrated the
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importance of the cosolvent in controlling the stereochemical outcome at this centre, and 
an attempt to rationalise the observed cosolvent dependency of stereochemistry has been 
made.
Finally, in the cyclisation of 312 we have clearly shown that the stereochemical 
dependency on cosolvent does not originate from a change in the stereochemistry of the 
intermediate Sm(III) enolate.
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2.2 A stereocontrolled approach to the core of pestalotiopsin A
2.2.1 Introduction to pestalotiopsin A
The pestalotiopsins are caryophyllene-type sesquiterpenes isolated from an endophytic 
fungus of Taxus brevifolia, the Pacific yew tree.111,112 They were first isolated as a result 
of an intensive screening programme examining secondary metabolites of the tree and 
associated microorganisms, triggered by the discovery of the potent anti-cancer agent 
Taxol®. Pestalotiopsin A 261 is of particular interest as it possesses an oxatricylic 
structure unique amongst natural products and has a high density of functionality around 
the ring system (figure 2.16). [Kende has reported a synthetic intermediate with a related 
structure].159 In addition, the compound has six stereocentres on six contiguous centres all 
combining to make the structure a challenging target for total synthesis. In preliminary 
assays the natural product has been shown to possess immunosuppressive activity and 
cytotoxicity.112 It would appear possible that the activity of this compound originates 
from the 2-oxabicyclo[3.2.0]heptan-3-ol core, as pestalotiopsin B 325, which lacks this 
structural feature, has no reported activity (figure 2.16).
OH
OMe
pestalotiopsin A 
261
pestalotiopsin B 
325
figure 2.16
2.2.2 Retrosynthetic analysis of the natural product
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Retrosynthetic analysis of pestalotiopsin A (figure 2.17) reveals possible disconnections 
of the 9-membered ring at several points between Cl and C6 (pestalotiopsin A numbering 
scheme). Disconnections between C3 and C4, or across the C4-C5 double-bond appear 
particularly attractive and approaches to the final ring will be discussed later. Bicyclic 
lactones 327, therefore, are key intermediates in our approach to pestalotiopsin A. 
Importantly, flexibility in the nature of the ‘R’ group is crucial for the examination of 
several future approaches to the final, 9-membered ring.
Ac<
OMe
OH
h
261 326 327
8
Hd 
328
figure 2.17
We envisaged that the addition of alkylmetal reagents to cyclobutanone 328 would 
proceed selectively from the opposite face to the lactone substituent,159,160 triggering 
trans-lactonisation and releasing the hydroxyethyl side chain necessary for the 
construction of the final ring. We felt that cyclobutanones such as 328, would be 
accessible using our previously described samarium(II) cyclisation chemistry. A feature 
of our strategy is that stereocentres at C8 and C9 can be established directly in the 
samarium(II)-cyclisation step and carried intact through the addition / trans-lactonisation 
sequence.
In this chapter I will describe studies which illustrate the feasibility of our approach and 
represent the first synthetic approach to the core of pestalotiopsin A161.
109
2.2.3 Model studies in our approach to pestalotiopsin A
As previously mentioned in section 2.1.5.2 (scheme 2.25) the Sml2 mediated cyclisation 
of aldehyde 312 proceeded in good yield and gave anti cyclobutanol 318 as a 4:1 mixture 
at the centre a -  to the lactone carbonyl. In this reaction three contiguous stereocentres are 
established in a single step with significant control. We felt cyclobutanone 329 would be 
an excellent model compound for our studies since it lacked only the hydroxy 
functionality at C7 (compare with 328 in figure 2.17). The major cyclobutanol 
diastereoisomer was isolated by column chromatography and subsequent oxidation of 
318a with tetrapropylammonium perruthenate (TPAP) and A-methylmorpholine N-oxide 
(NMO) gave cyclobutanone 329 in quantitative yield (scheme 2.28).
Sm l2
MeOH
.OH
THF, 0°C, 1 h 
79% H / W
312 318a
scheme 2.28
TPAP, NMO 
4A MS
CH2Cl2 , rt, 4h 
100%
329
2.2.4 Alkylmetal additions to cyclobutanone 329
We next turned our attention to the sequential nucleophilic addition / trans-lactonisation 
step. We began by examining the addition of simple alkylmetal reagents to cyclobutanone 
329.
Initial attempts to add MeMgBr and MeLi to 329 led to substantial epimerisation of the 
starting material, giving cyclobutanone 331, although pleasingly, the desired bicyclic
1 1 0
lactone 330 was also obtained in low yield (29% and 15%, respectively; see scheme 2.29 
and table 2).
MeMgBr
THF, 3.5 h. -78°C
OH29%
329 330 331
MeLi
OH15% 28%
329 330 331
scheme 2.29
Organocerium reagents are renowned for their low basicity and hence were next 
investigated.162 329 was added to the methyl cerium reagent generated from the addition 
of MeLi to CeCl3. A poor yield of the desired bicyclic lactone 330 was obtained, although 
crucially, epimer 331 was not detected. Since a large percentage of unreacted 
cyclobutanone was recovered from the organocerium reaction, the addition was repeated 
using 2 equivalents of methylcerium reagent. A slightly lower yield of the desired 
bicyclic lactone 330 was recovered along with unreacted starting material. A quantity of 
unknown by-product was also detected. The use of an even larger excess of methylcerium 
reagent gave even lower yields of desired product 330.
It should be noted that the organocerium reactions were conducted by inverse addition 
following literature procedures.163 Cyclobutanone 329 was therefore initially exposed to a 
large excess of the organocerium reagent. It is possible that after the desired addition 
reaction has taken place, the bicyclic lactone 330 is then reacting further with the excess 
methylcerium reagent. We believed that the reaction should be performed by normal
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addition of the organocerium to the substrate. This was attempted, however, the 
heterogeneous nature of the organocerium made such a procedure problematic and the 
results were often irreproducible. We therefore sought alternative conditions for the 
transformation.
Molander has reported that organoytterbium reagents, prepared by the addition of alkyl 
lithium or Grignard reagents to ytterbium(III) triflate exist as brightly coloured, 
homogeneous solutions in THF and are attractive alternatives to organocerium 
reagents.164"166 Such reagents have also been shown to give enhanced 
diastereoselectivities, when compared to the parent organolithium and magnesium 
reagents in additions to simple carbonyl compounds (scheme 2.30).
Using Molander’s approach, the methylytterbium reagent derived from MeLi and 
Yb(OTf)3 added smoothly to cyclobutanone 329 to give 330 in good yield and with no 
trace of epimerised by-product (scheme 2.31 and table 2). It was essential that the 
Yb(OTf)3 used in the reaction (commercially available “anhydrous” Yb(OTf)3) was dried 
thoroughly by heating at 140°C under vacuum for 20 h.
332 333a 333b
MX = /rBuYb(OTf)2 99:1 
MX = nBuLi 83:17
scheme 2.30
MeLi, Yb(OTf);
329 330
scheme 2.31
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Organometallic
reagent
Number of 
equivalents
reaction 
time (h)
yield of 
330
MeMgBr 1.2a 3.5 29%
MeLi 1.2 2 15%b
"MeCeCI 2 1 1.3 2 53% c
"MeCeCI 2 2 3 49% c
MeYbOTf2 2 0.5 68%
table 2: (a) a  further 1.2 equivalents of MeMgBr 
were added after 2 h. (b) 28% of epimerised 
starting material recovered, (c) isolated yields 
based on recovered starting material.
To confirm the stereochemistry of the bicyclic lactone products, nOe studies were 
initially conducted on 330 (figure 2.18).
c h .
0 .8%
OH
2.7%
2.7%
nOe study on 330
figure 2.18
Further confirmation of the stereochemistry of 330 was obtained by the conversion of 330 
into the corresponding p-nitrobenzoate 334 and structure determination by X-ray 
crystallography (scheme 2.32).
py, rt, 3 days 
88%
334
scheme 2.32
OH
330
113
figure 2.19
Building on the successful addition of the methylytterbium reagent, the addition of more 
structurally and functionally diverse organoytterbiums was examined. Orange-red 
vinylytterbium, generated from vinylmagnesium bromide and Yb(OTf)3 was added to the 
cyclobutanone 329. Addition and in situ trans-lactonisation occurred to give bicyclic 
lactone 335 in good yield.
U ° ^^MgBrYb(OTf)3
THF, -78°C, 1 h 
h /  67%
329
OH
335
scheme 2.33
Next we attempted to use the organoytterbium, generated from 3-methyl-3- 
butenylmagnesium bromide. The bromide 337 was conveniently prepared from the 
corresponding commercially available alcohol 336.167 Treatment of the bromide with 
magnesium metal formed the Grignard which was then added to Yb(OTf)3. After the 
inverse addition of the cyclobutanone, bicyclic lactone 338 was isolated in good yield
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(scheme 2.34). It is thought that the reaction did not go to completion due to the 
incomplete formation of the Grignard from the bromide precursor. Work is ongoing 
within the group to improve the yield of the reaction.
2. Yb(OTf)3 
THF, -78°C, 1 h 
66%
schem e 2.34
The possibility of using an alkylytterbium generated from an a-lithiated sulfone in the 
addition trans-lactonisation sequence was also examined. 3-Butenyl phenyl sulfone was 
deprotonated with n-butyllithium and then added to Yb(OTf)3, generating an orange 
coloured solution. On addition to cyclobutanone 329 the desired bicyclic lactone 339 was 
formed as a mixture of diastereoisomers in very low yield amongst a complex product 
mixture (scheme 2.35).
Yb(OTf)3, n-BuLi
329 339
schem e 2.35
To further increase the number of possible strategies with regard to the closure of the 
final 9-membered ring, an organoytterbium incorporating a protected hydroxyl group was 
required. Lithium-halogen exchange on treatment of vinyl bromide 340 with tert-BuLi,
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followed by addition of Yb(OTf)3 gave an intense red/brown solution of the 
corresponding organoytterbium which underwent addition to cyclobutanone 329 to afford 
341 in moderate yield (scheme 2.36).168
U °
H
329
OBn
Br 340
Yb(OTf)3, /-BuLi
THF, -78°C, 1.5 h 
53%
^ ^ / O B n
schem e 2.36
Clearly, by varying the alkylmetal reagent employed in our addition / trans-lactonisation 
procedure, a wide range of substrates accommodating a variety of approaches to the final 
9-membered ring can be accessed.
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2.2.5 The retro-Brook rearrangement
In the course of studying the reaction shown in scheme 2.36 we made some interesting 
observations. Originally we employed bromide 342 where the hydroxyl group was 
protected by the ter£-butyldimethylsilyl protecting group. When the organoytterbium was 
formed and added to 329 a complex mixture of products was obtained from which 
bicyclic lactone 343 was obtained in low yield (scheme 2.37). The reaction was repeated 
using bromide 344 containing bulkier and more robust terf-butyldiphenylsilyl protection. 
Suprisingly none of the expected bicyclic lactone 345 was detected and the 
cyclobutanone 329 was recovered in good yield. Interestingly, a product from the 
reaction, derived from bromide 344, was found not to correspond to the quenched 
organometallic and was isolated and identified as the vinyl silane 346 (scheme 2.37).
OTBDMS
Br 342
/BuLi
2. Yb(OTf)3
THF, -78°C, 5 h 
26%
329
OTBDMS
OH
343
U °  o
OTBDPS
Br 344
fBuLi
2. Yb(OTf)3
THF, -78°C, 3.5 h
329
^ / \ ^ O T B D P S
0%
OH
345
Ph— S i-P h
346
OH
97%
scheme 2.37
It appears facile migration of the silyl group from oxygen to carbon is occurring. Such an 
anionic 1,4-0 to C silyl migration has been previously documented and is known as the 
retro-Brook rearrangement.169 The retro-Brook rearrangement was first reported by West
117
in 1968 and involves the migration of a silyl group from oxygen to a carbon.170,171 
Examples of [1,2],172 [1,3],170,171 and [1,4]169,173,174 migrations have all been reported in the 
literature and, as the example in scheme 2.38 illustrates, the migration occurs 
stereoselectively with retention of stereochemistry at the carbanion.175
Me3Sk^
3 O DMe
347
nBuLi
scheme 2.38
It is believed the 1,4-0 to C migration proceeds through a 5-membered ring silicate. In a 
paper by Rucker which discusses the 1,4-0 to C migration, he proposes the intermediacy 
of the pentacoordinate silicon species 351 in the retro-Brook rearrangement of 349 
(scheme 2.39).169
OTMS
LiOBB
349 350
OTMS
scheme 2.40
Lithium-halogen exchange on the tertiarybutyldimethylsilyl protected alcohol 342 has 
been previously reported, with no mention of the retro-Brook rearrangement which we 
had observed. We initially felt, therefore, that transmetallation to ‘Yb’ might play a 
significant role in the process, and so decided to investigate further. However, when
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bromide 344 was subjected to lithium-halogen exchange with terf-butyllithium, after a 
short period of time and in the absence of Yb(OTf)3, the retro-Brook rearrangement 
product was obtained in almost quantitative yield (scheme 2.41). Thus it is clear 
transmetallation to ytterbium plays no significant role in the retro-Brook rearrangement. 
It is not clear why rearrangement products were not observed in previous work using the 
vinyllithium derived from 342.
OTBDPS
344 346
scheme 2.41
2.2.6 A summary
To summarise then, table 3 shows the successful alkylytterbium additions to 
cyclobutanone 329 and illustrates the versatility of our route to bicyclic lactones of 
generic structure 352.
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I f  n *  n  Yb(OTf)3
H ' ' °
329
OH
352
alkyl metal product yield
MeLi 330 R = Me 68%
BrM 335 R =  67%
MgBr
338 R =  I n 66%
P h 0 2S ^  P h 0 2
339 R = T  ^  5%
OBn x / s . ° Bn
341 R = 53%
table 3: a summary of alkylytterbium additions to cyclobutanone 329
A similar addition/trans-lactonisation procedure was also observed when reducing 
cyclobutanone 329 with L-Selectride (scheme 2.42). Reduction of cyclobutanone 329 and 
its diastereoisomer 331 with L-Selectride at —78°C was found to give bicyclic lactones 
320a and 320b respectively. Cyclobutanone 331 was obtained from the TPAP oxidation 
of the cyclobutanol 318b.
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H
TPAP, NMO 
4A MS
....L ^ ° L-Selectride O
0  CH2CI2, rt, 5h 
' 100%
'O THF, -78°C, 1 h 
t 88%
OH
318b 331 320b
H
O THF, -78°C, 1 h 
59%
L-Selectride IO
OH
329 320a
scheme 2.42
The successful formation of bicyclic lactones 320a and 320b confirmed our assignment 
of the products from the Sml2 mediated cyclisation of aldehyde 319, discussed previously 
in section 2.1.5.3 (scheme 2.27).
2.2.7 Reduction of the lactone carbonyl group
To complete our approach to models of the pestalotiopsin A core, the primary hydroxyl 
group of 335 was protected, and the lactone 353 reduced to the lactol 354. Treatment of 
the lactone with DIBAL-H gave a 2:1 mixture of lactols (scheme 2.43). We envisaged 
that the major product would arise from reduction from the ‘outside’ of the bicyclic 
system. NOE studies on the lactols did indeed reveal that 354 was the major product from 
the reduction (figure 2.20). The retention of the desired stereochemistry at C4 was clear 
from the lack of coupling between H4 and H5, the dihedral angle between the two 
protons being virtually 90° in the correct C4 epimer (the numbering system referred to 
here is the numbering used for the bicyclic lactones and not pestalotiopsin A; see figure 
2.20 for numbering).
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OH
335
TBDPSCI
imidazole
DMF, rt, 22 h 
73%
OTBDPS
353
DIBALH
86%
scheme 2.43
2 .2%,
yv_yi%
'2%
TBDPSO
nOe study on 354
figure 2.20
major
dr = 2:1
OH
OTBDPS
354
In the above section we have described the first approach to the core of pestalotiopsin A 
utilising our samarium(II) iodide mediated 4-exo-tng cyclisation methodology. In our 
approach, the four contiguous stereocentres of the core have been established using a 
flexible approach which will allow several routes to the target to be pursued.
2.2.8 Conclusions
A route to the bicyclic system found in pestalotiopsin A has been developed. 
Organoytterbiums generated from various alkylmetals have been shown to react with 
cyclobutanone 329 in an efficient addition/trans-lactonisation sequence to form the 
bicyclic lactone moiety. Flexibility in the nature of the organoytterbiums employed will 
allow for a range of different strategies for closure of the final 9-membered ring to be 
examined.
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Chapter 3: Future work
The results discussed in the previous chapter have laid the foundations for further studies. 
The development of the Sml2 mediated 4-exo-trig cyclisation and its application an 
approach to pestalotiopsin A have been discussed. The final ring of the natural product 
has yet to be constructed and also the fully functionalised core (possessing the C7-OH) of 
the natural product has to be prepared. Work to address these issues is currently ongoing 
within the group. This chapter contains a brief account of future approaches to the final 9- 
membered ring of pestalotiopsin A, and includes preliminary results obtained towards the 
end of my studies.
Also discussed in this section are my preliminary studies into a 4-e;t0-trig cyclisation on 
solid phase and future ideas for the development of catalytic Sm(II) ketyl-olefin 
cyclisations.
3.1 Possible approaches to the final ring of pestalotiopsin A
As previously mentioned, our approach to pestalotiopsin A is sufficiently versatile to 
allow disconnections at a number of positions around the final 9-membered ring. We 
decided to initially focus on a ring closing metathesis approach to the pestalotiopsin A 
skeleton. The primary hydroxyl of bicyclic lactone 338 was oxidised to give the aldehyde 
355 in good yield (scheme 3.1). In the preparation of allylic alcohol 356, we chose to use 
a non-basic vinylytterbium reagent again since the substrate contained an acidic proton at 
the C4 stereocentre. Treatment of 355 with the vinylytterbium, derived as before from 
vinylmagnesium bromide and Yb(OTf)3, resulted in smooth addition to give allylic 
alcohol 356 in good yield as an approximately 1:1 ratio of diastereoisomers (scheme 3.1).
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OH
TPAP, NMO 
4A MS
CHjCIj , rt, 3h 
71%
" ^ ^ M g B r
Yb(OTf)3
THF, -78°C, 2h 
67%
338 355
scheme 3.1
356
Alcohol 356, or protected derivatives such as 357, are suitable model substrates on which 
to attempt ring closing metathesis to form the 9-membered ring (scheme 3.2). Olefin 
metathesis is currently an area of great interest to the synthetic community.176' 178 
However, as a recent review on the subject highlights, little is known about the formation 
of medium-sized rings using the reaction and much work needs to be done in this area.179 
Only one example of the preparation of a 9-membered carbocycle using ring closing 
metathesis has been reported,180 hence a study of such a process should be of widespread 
interest. We expect our studies will also provide important information with regards to 
the stereochemistry of the process and also the influence, if any, of potentially directing 
hydroxyl group. Unfortunately, time did not allow for the reaction to be investigated. 
Work is now ongoing within the group to examine whether RCM is a viable method for 
forming the 9-membered ring of the target.
356
protection
metathesis
catalyst
PO
357
scheme 3.2
358
Another possible approach to the 9-membered ring involves the use of novel zirconium 
chemistry. Alkenyl zirconium species, upon transmetallation to the corresponding
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cuprates, have been shown to undergo smooth intermolecular addition to epoxides.181 We 
believe stereo- and regioselective hydrozirconation of epoxyacetylene 359 with in situ 
trans-metallation to copper will result in intramolecular epoxide opening to yield the 9- 
membered ring product 360 (scheme 3.3). Work is ongoing within the group to examine 
this interesting route to pestalotiopsin A.
The above two methods for preparing the final ring (schemes 3.2 and 3.3) are just two of 
many possible approaches. Importantly, the flexibility available in the later stages of our 
approach stems from the convergent nature of earlier steps, in particular the 
organoytterbium mediated addition / trans-lactonisation sequence. Work towards the 
completed carbon skeleton of pestalotiopsin A and towards the fully functionalised 
natural product, is currently underway.
1. CpZr(H)CI
t>
359 360
scheme 3.3
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3.2 Sml2-mediated cyclisations on solid support
In the later stages of my studies, we began to examine the possibility of applying our 
recently developed Sml2 cyclisation methodology to solid supported aldehydes. At 
present no examples of solid supported Sml2 mediated ketyl-olefin couplings exist in the 
literature, hence the study of this potentially useful solid phase cyclisation protocol is of 
great interest. The nature of the Sml2 mediated solid phase cyclisation may also provide 
opportunities for devising a system that is catalytic with respect to the lanthanide reagent.
3.2.1 Why the need for a Sm(II) catalytic system?
Despite the popularity and versatility of Sml2, as highlighted in the Chapter 1, practical 
limitations on its use remain. Stoichiometric amounts of Sml2 are required for 
transformations such as ketyl-olefin cyclisations. Therefore relatively large scale 
reactions are problematic not only due to the expense but also due to the fact that Sml2 is 
used as a 0.1M solution in THF182 resulting in large volumes of the reagent being 
required. The development of a catalytic Sm(II) process would alleviate this problem. A 
less expensive stoichiometric reductant could be employed to reduce the by-product of 
the reaction, Sm(III), back to Sm(II) in situ, thus allowing sub-stoichiometric quantities 
of Sml2 to be used (figure 3.1). Such technology would be appealing to both industry and 
academia due to its convenient, inexpensive and environmentally friendly nature.
Sm(ll) substrate
productSm(lll)reductant
figure 3.1: general representation of a Sm(ll) catalytic cycle
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3.2.2 Previous catalytic Sm(II) systems
The need for a catalytic Sm(II) system has not gone unnoticed, although currently, only 
three examples have been reported. Endo's group has produced a Sml2 catalysed pinacol 
coupling (figure 3.2).183 Activated magnesium was used as the reductant for Sml2 which 
enabled the reaction to proceed smoothly with only 0.05 equivalents of Sml2 for every 
equivalent of the aldehyde substrate. The yield for the coupling reaction was comparable 
to the uncatalysed version of the reaction. An additional feature of the system was the 
inclusion of TMSC1 which was required to liberate Sm(III) from the Sm(III) pinacolate, 
enabling a more efficient reduction back to Sm(II). Although an excellent effort, the 
synthetic value of this catalytic cycle is limited as pinacol coupling of carbonyl 
compounds can be conveniently carried out using existing inexpensive catalytic reagent
184systems.
2 Sm(ll)
2 RCHO
Sm(lll) OSm(lll)
Mg°
2 Sm(lll)
TMS< OTMS 2 TMSCI
figure 3.2
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A second catalytic Sm(II) system has been derived by Corey for use in Sml2 mediated 
intermolecular addition reactions.185 The system developed, however, is not general or 
convenient as the paper reports the use of just a single olefin substrate. In addition, a 
zinc-mercury amalgam is employed as the stoichiometric reductant (prepared from zinc 
powder and the highly toxic mercury dichloride).
More recently a report by Namy advocates the use of mischmetall as a co-reductant for 
Sml2 in Barbier type reactions, simple dehalogenations, pinacol couplings and the 
coupling of acid chlorides.186 The inexpensive alloy of the early lanthanides has proved to 
be a more attractive proposition than magnesium and zinc/mercury amalgam reductants. 
However, even this report has short comings, such as the failure to discuss the reactions 
of more functionally diverse substrates. Also the lack of the ability of mischmetall to 
reduce Sm(III) to Sm(II) in the presence of HMPA is a problem since many Sm(II) 
mediated reactions depend upon the cosolvent.
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3.2.3 Devising a Sm(II) catalytic system using solid supported substrates
We believe there is potential for Sml2 mediated ketyl-olefin cyclisations on solid 
supported substrates to be made catalytic in Sml2. The major problem with Sml2 catalytic 
systems is the background reaction between the stoichiometric reductant and the 
substrate. This leads to undesired side reactions. However, if the reaction substrates are 
resin bound and if, for example, a heterogeneous stoichiometric reductant, is used then 
minimal background reactions should occur. The solution phase Sm(II) species will 
therefore effectively act as a ‘shuttle’ between the two solid phase reactants (figure 3.3). 
Figure 3.3 illustrates this idea for a solid-phase Sm(II)-mediated 4-exo-trig cyclisation of 
an immobilised unsaturated aldehyde.
3.2.4 Preparation of solid supported cyclisation substrates
Building upon our earlier work in developing the Sml2 mediated 4-exo-trig cyclisation, it 
was decided to attempt the 4-exo-trig cyclisation of a suitably designed solid phase 
substrate. Conveniently, the substrate could be attached to the resin through the ester 
functionality. Hydroxy methyl polystyrene resin 361 was used to prepare the solid 
supported Horner-Wadsworth-Emmons reagent 362 with characteristic IR absorption at 
1735 cm '1 (scheme 3.4). Treatment of 362 with aldehyde 280 gave the unsaturated
heterogenous
stoichiometric
reductant
Sm(lll)
O
figure 3.3
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thioacetal 363.187 Removal of the thioacetal to give the unsaturated aldehyde 364 was 
carried out using standard conditions. Unfortunately, time did not allow us to study the 
cyclisation of 364 to be carried out. This work is currently being carried out by others in 
the group. It is hoped that treatment of the solid supported substrate with samarium(II) 
iodide using our standard conditions will yield cyclobutanol 365 which will be cleaved 
from the resin with sodium ethoxide to give cyclobutanol 266.
OH
P(0)(0Et)2CH2C 02H 
DCC, DMAP
CH-CL rt, 5 h
i?
P(OEt),
361
1735 cm-1 
362
280
NEt3, LiBr 
MeCN, rt, 3 days
1719 c m 1
CO,Et
266
C P
h o  ;XT '
365
Mel, C aC 03 
MeCN, H20  
60°C, 4 days
1735 cm-1 & 1719 cm-1 
364
scheme 3.4
Studies into the analogous 5-exo-trig cyclisation of unsaturated aldehydes were also 
initiated. Treatment of the Homer-Wads worth-Emmons reagent 362 with 8-valerolactol 
yielded the unsaturated alcohol 366 (scheme 3.5). Swern oxidation of the alcohol gave 
the aldehyde 367.188 Previously, similar solution phase cyclisations have yielded a 
mixture of both syn and anti cyclopentanol products, the syn under going spontaneous 
lactonisation.113 One of the proposed benefits of the cyclisation on solid support is that 
separation of the two isomers will occur in situ. While the anti cyclopentanol remains
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attached to the polystyrene support 368, spontaneous lactonisation of the syn isomer 369 
results in cleavage from the resin.
i? cx
P(OEt)2 V
OH
1735 cm-1 
362
NEt3, LiBr 
MeCN, rt, 4 days 1656 cm-1 
366
H DMSO, NEt3
so3. py
CH2CI2, rt, 6 day
1703 cm*1 & 1735 cm-1 
367
! Sm^
369 368
scheme 3.5
Initial studies into the samarium(II) iodide mediated cyclisation of 367 have proved 
interesting. No bicyclic lactone 369 was detected in the solution phase, yet IR of the resin 
showed the absence of both the aldehyde absorption at 1703 cm '1 and the olefin 
absorption at 1651 cm '1. Cleavage of the solid supported material was then attempted 
using sodium methoxide, however a complex product mixture was obtained. Studies are 
ongoing within the group to further develop this solid-phase chemistry.
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Chapter 4: Experimental 
General considerations
All reactions were performed under argon or nitrogen atmospheres with anhydrous 
solvents unless otherwise stated. THF was distilled from sodium and benzophenone. 
CH2C12 was distilled from CaH2. Toluene was distilled from sodium wire. MeOH, EtOH 
and tert-BuOH were distilled from the corresponding magnesium alkoxide and stored 
under argon. HMPA was dried by refluxing with CaH2 followed by fractional distillation 
under reduced pressure. Sml2 was prepared by the method of Imamoto and Ono with the 
modification that the samarium-iodine-THF solution was heated at 60°C rather than at 
reflux.
Melting points were measured on a Kofler hot stage apparatus and are uncorrected. 'H 
NMR and 13C NMR were recorded on Bruker AM 360 or DPX 400 spectrometers with 
chemical shift values being reported in ppm relative to residual chloroform (8H = 7.27 or 
8C = 77.2) as internal standard unless otherwise stated. All coupling constants (/) are 
reported in hertz (Hz). Infrared spectra were recorded using JASCO FT/IR 410 and 
Impact 400 spectrometers and mass spectra were obtained using a JEOL JMS-700 
spectrometer. Microanalyses were carried out at the University of Glasgow using an 
Elemental Analyser MOD 1106.
Column chromatography was carried out using Fisher Matrex silica 60. Macherey-Nagel 
aluminium backed plates pre-coated with silica gel 60 (UV254) were used for thin layer 
chromatography and were visualised by UV or staining with iodine or alkali KMn04.
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278 285
c 4H6o2 c 5h 80 2
Mol. Wt.: 86.09 Mol. Wt.: 100.12
(g-methvl-Y-butvrolactone 285189
A  solution of LDA was prepared by the dropwise addition of /i-butyllithium (1.42 M in 
Ihexane, 48.6 ml, 66.3 mmol, 1.2 eq) to a stirred solution of diisopropylamine (9.60 ml, 
66.3 mmol, 1.2 eq) in THF (70 ml) at -78°C. After 40 min, y-butyrolactone (4.20 ml, 55.2 
mmol, 1 eq) in THF (50 ml) was addded dropwise and the mixture left for 2 h before the 
addition of Mel (17.9 ml, 276 mmol, 5 eq). The reaction was then allowed to warm to 
— 20°C and stirred for 15 h before quenching with aqueous saturated NH4CI (4 ml). The 
aqueous layer was then separated and extracted with EtOAc (3 x 40 ml), dried (NaS04), 
and concentrated in vacuo. Filtration through a short column of silica gel (eluting with 
50% EtOAc in hexane) gave 285 (4.81 g, 48.0 mmol, 87%) as a pale yellow oil: 8h (400 
MHz, CDCI3) 4.36 (1H, td, J  2.6, 8.8, 1H from CH20), 4.23-4.17 (1H, m, 1H from 
CH20), 2.67-2.57 (1H, m, 1H from C //2CH), 2.49-2.41 (1H, m, 1H from C7/2CH), 1.99- 
1.89 (1H, m, CH), and 1.30 (3H, d, 77.1, CH3).
285 286
C5H80 2 C6H i0O 2
Mol. Wt.: 100.12 Mol. Wt.: 114.14
a. a-dimethv l-y-butvrolactone 286190,191
A solution of LDA was prepared by the dropwise addition of «-butyllithium (1.34 M in 
hexane, 88.9 ml, 119 mmol, 1.3 eq) to a stirred solution of diisopropylamine (16.7 ml,
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119 mmol, 1.3 eq) in THF (150 ml) at —78°C. After 30 min, a solution of q-methyl-y- 
butyrolactone 285 (9.17 ml, 91.6 mmol, 1 eq) in THF (100 ml) was addded dropwise and 
the mixture left for 1.5 h before the addition of Mel (22.8 ml, 366 mmol, 4 eq). The 
reaction was then allowed to warm to rt and stirred for 16.5 h before quenching with 
aqueous saturated NH4CI (4 ml). The aqueous layer was then separated and extracted 
with Et20  (5 x 50 ml), dried (NaSO^, and concentrated in vacuo to give 286 (9.18 g, 80.4 
mmol, 88%) as an orange oil which was used without further purification: 8h (400 MHz, 
CDCI3) 4.27 (2H, t, J  7.0, CH20), 2.11 (2H, t, J  7.0, C //2CH20), and 1.27 (6H, s, 2 x 
CH3).
CeHio0 2 ^6^12^2
Mol. Wt.: 114.14 Mol. Wt.: 116.16
a. q-dimethvl-y-butvrol actol 281190,191
To a stirred solution of q,q-dimethyl-y-butyrolactone 286 (9.34 g, 81.8 mmol, 1 eq) in 
CH2C12 (207 ml) at —78 °C was added dropwise DIBAL-H (1.5 M in toluene, 54.5 ml,
81.8 mmol, 1 eq) and the reaction stirred for 2 h at that temperature. The mixture was 
then added dropwise to a stirred solution of K/Na tartrate (69.3 g, 94.3 mmol, 3 eq) in 
H20  (16.5 ml) and CH2C12 (207 ml). The aqueous layer was separated and extracted with 
CH2C12 (5 x 150 ml), and the combined organic extracts dried (MgS04) and concentrated 
in vacuo to give lactol 281 (9.32 g, 80.2 mmol, 98%) as a pale yellow oil which was used 
without further purification: SH (400 MHz, CDCI3) 4.90 (1H, d, J  3.4, CHOU), 4.09 (1H, 
td, /  8.4, 3.4, 1H from CH20), 3.92 (1H, apparent q, J  8.4, 1H from CH20), 2.58 (1H, d, 
J 3.4, OH), 1.99-1.92 (1H, m, 1H from C/72CH20 ), 1.68-1.62 (1H, m, 1H from 
CH2CU20), 1.13 (3H, s, CH3), and 1.03 (3H, s, CH3).
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281
^6^ 10^2 
Mol. Wt.: 114.14
OH
287
C9H18OS2 
Mol. Wt.: 206.37
3-(l,3-Dithian-2-yl)-3-methyI-butan-l-ol 287
To a stirred solution of lactol 281 (1.45 g, 12.5 mmol, 1 eq) in CH2CI2 (24 ml) at —20 °C 
was added activated 4A molecular sieves and 1,3-propanedithiol (1.50 ml, 15.0 mmol,
1.2 eq) before the dropwise addition of BF3#OEt2 (1.58 ml, 12.5 mmol, 1 eq). The 
reaction was left for 2 h and then aqueous saturated NaHC03 (5 ml) was added. The 
aqueous layer was then separated and extracted with CH2CI2 (4 x 50 ml). The organic 
layers were dried (MgSC^) and concentrated in vacuo. Purification of the residue by 
column chromatography (eluting with 30% EtOAc in hexane) yielded 287 (1.51 g, 7.32 
mmol, 59%) as a clear pale yellow oil: Umax (neatVcm*1 3369s (O-H), 2961s, 2930s, 
2899s, 1465m, 1388m, 1367m, 1277m, 1055m, and 1026m; 5H (400 MHz, CDCI3) 4.13 
(1H, s, SCHS), 3.77 (2H, apparent q, J  6.9, C //2OH), 2.91-2.89 (4H, m, 2 x SCH2), 2.09 
(1H, d quintets, J  14.0, 3.3, 1H from CH2), 1.88-1.76 (1H, m, 1H from CH2), 1.81 (2H, t, 
J  6.9, C //2CH2OH) and 1.15 (6H, s, 2 x CH3); 8C (100 MHz, CDC13) 60.9 (SCHS), 59.6 
(CH2OH), 43.0 (CH2CH2OH), 38.0 (C), 31.5 (2 x SCH2), 26.2 (CH2), and 26.1 (2 x 
CH3); m/z (El mode) 206 (82%), 119 (100), 99 (19), 85 (14), 69 (14), and 55 (17) (Found 
M+, 206.0797. C9H18OS2 requires M, 206.0799) (Found: C, 52.11; H, 8.77. C9Hi8OS2 
requires, C, 52.38; H, 8.79%).
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287
CgH18OS2 
Mol. Wt.: 206.37
279
C14H240 2S 2 
Mol. Wt.: 288.47
Ethyl (2s)-2,5-dimethyl-5-[l,3-dithian-2-yI]-hex-2-enoate 279
To a solution of 287 (500 mg, 2.42 mmol, 1 eq) in CH2CI2 (25 ml) at 0°C was added 
DMSO (1.72 ml, 24.2 mmol, 10 eq) and then triethylamine (1.65 ml, 16.0 mmol, 6.6 eq). 
After 5 min, pyridine-sulfur trioxide complex (1.47 g, 9.21 mmol, 3.8 eq) was added and 
the reaction stirred for a further 45 min before being allowed to slowly warm to rt and left 
for 2 h. To the golden coloured solution was then added (1- 
ethoxycarbonylethylidene)triphenylphosphorane (2.63 g, 7.26 mmol, 3 eq) and the 
reaction mixture stirred for 13 h. The reaction mixture was then poured onto a short 
column of silica gel and eluted with 40% EtOAc in hexane. Concentration in vacuo gave 
crude 279 as a brown solid. The residue was purified by column chromatography (eluting 
with 10% EtOAc in hexane) which yielded 279 (684 mg, 2.37 mmol, 98%) as a clear 
colourless oil: \)max (nea^/cm1 2964s, 2900s, 2828m, 1712s (C=0), 1647s (C=C), 1465s, 
1422m, 1388s, 1367s, 1261s, 1177m, and 1101m; 5H (400 MHz, CDC13) 6.84 (1H, t, J
7.8, CH2CH=), 4.21 (2H, q, J 7.1, CH2CH3), 4.03 (1H, s, SCHS), 2.91-2.88 (4H, m, 2 x 
SCH2), 2.38 (2H, d, 7 7.8, CH2CH=), 2.09 (1H, m, 1H from CH2), 1.87 (3H, s, =CCH3), 
1.87-1.76 (1H, m, 1H from CH2), 1.31 (3H, t, 77.1, CH2C773), and 1.13 (6H, s, 2 x CH3); 
6C (100 MHz, CDC13) 168.3 (C=0), 138.0 (CH=), 130.3 (=CCH3), 60.8 (SCHS), 60.7 
(CH2CH3), 39.7 (C), 39.1 (CH2CH=), 31.5 (2 x SCH2), 26.2 (CH2), 25.5 (2 x CH3), 14.5 
(CCH3), and 12.9 (CH2CH3); m/z (El mode) 288 (26%), 243 (8), 162 (17), 123 (12), 119 
(100), 99 (5), and 55(5) (Found M+, 288.1220. Ci4H240 2S2 requires M, 288.1218).
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C 0 2Et
279 267
1^4^ 24®2S2
Mol. Wt.: 288.47 Mol. Wt.: 198.26
Ethyl (£)-2,5,5-trimethyl-6-oxo-hex-2-enoate 267
To a stirred solution of 279 (692 mg, 2.40 mmol, 1 eq) in acetonitrile (9 ml) and distilled 
water (2.3 ml) was added CaCO3 (721 mg, 7.20 mmol, 3 eq) and iodomethane (2.99 ml,
48.0 mmol, 20 eq). The mixture was then refluxed for 21 h at 60°C with more 
iodomethane (1.49 ml, 24.0 mmol, 10 eq) being added after 6 h. The reaction mixture 
was then allowed to cool before being poured onto a short column of silica gel and eluted 
with 20% EtOAc in hexane. Concentration in vacuo yielded 267 (461 mg, 2.33 mmol, 
97%) as a clear colourless oil which was stored at —20°C under nitrogen, and used 
without further purification: VmaxOieatycrn*1 2976s, 2935s, 2809m, 2705m, 1716s (C=0), 
1650s (C=C), 1390s, 1367s, 1255s, 1109s, and 1082s; SH (400 MHz, CDC13) 9.51 (1H, s, 
CHO), 6.70 (1H, t, J  7.8, CH2CH=), 4.19 (2H, q, J 7.1, C//2CH3), 2.35 (2H, d, J  7.8, 
CH2CH=), 1.85 (3H, s, CH3C=), 1.29 (3H, t, 7 7.1, CH2Cff3), and 1.11 (6H, s, 2 x CH3); 
6C (100 MHz, CDC13) 205.3 (C=0), 167.9 (C02Et), 136.3 (CH=), 130.7 (C=), 60.8 
(CH2CH3), 46.5 (C), 35.7 (CH2), 21.6 (2 x CH3), 14.4 (CH2CH3), and 12.8 (=CCH3); m/z 
(Cl mode, NH3) 216 (100%), 199 (8), 134 (7), 96 (6), and 79 (4) (Found (M + H)+, 
199.1332. Cn Hi90 3 requires M, 199.1329).
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o,0
Mol. Wt.: 100.12
285
C5H80 .
277
C5H10O2 
Mol. Wt.: 102.13
a-methvl-y-butvrolactol 277189
To a stirred solution of oc-methyl-y-butyrolactone 285 (2.99 g, 29.9 mmol, 1 eq) in 
CH2CI2 (80 ml) at -78 °C was added DIBAL-H (1.5 M in toluene, 23.9 ml, 35.9 mmol,
1.2 eq) and the reaction left for 1 h. The mixture was then added dropwise to a stirred 
solution of K/Na tartrate (25.8 g, 89.7 mmol, 3 eq) in H2O (8 ml) and CH2CI2 (80 ml). 
The aqueous layer was then separated and extracted with CH2CI2 (3 x 20 ml) and the 
combined organic extracts dried (NajSC^). Concentration in vacuo gave lactol 277 (2.82 
g, 27.6 mmol, 92%) as a pale yellow oil (2:1 mixture of cis:trans diastereoisomers) which 
was used without further: 8h (400 MHz, CDCI3) 5.29 (1H, t, J  3.6, C//OH of cis isomer),
5.13 (1H, dd, J 3.3, 1.3, C//OH of trans isomer), 4.14-4.04 (2H, m, 1H from CH2O of cis 
isomer and 1H from CH2O of trans isomer), 4.01-3.95 (1H, m, 1H from CH2O of trans 
isomer), 3.87-3.81 (1H, m, 1H from CH2O of cis isomer), 2.83 (1H, d, J 3.3, OH of trans 
isomer), 2.64 (1H, d, J  3.6, OH of cis isomer), 2.29-2.22 (2H, m, 1H from CH2 of cis 
isomer and 1H from CH2 of trans isomer), 2.18-2.12 (1H, m, 1H from CH2 of cis isomer) 
and 2.05-1.97 (1H, m, 1H from CH2 of trans isomer), 1.81-1.71 (1H, m, CHCH3 of cis 
isomer), 1.58-1.52 (1H, m, CHCR3 of trans isomer), 1.12 (3H, d, J  6.8, CH3 of cis 
isomer), and 1.05 (3H, d, /7 .1 , CH3 of trans isomer).
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,0
OH
277
C5H10O2 
Mol. Wt.: 102.13
288
CgHi6OS2 
Mol. Wt.: 192.34
3-(l,3-Dithian-2-yI)butan-l-ol 288
To a stirred solution of lactol 277 (2.82 g, 27.6 mmol, 1 eq) in CH2CI2 (3 ml) at 0 °C was 
added 1,3-propanedithiol (3.30 ml, 33.1 mmol, 1.2 eq) and 4A molecular sieves. 
Trifluoromethanesulfonic acid (0.98 ml, 11.0 mmol, 0.4 eq) was then added and the 
reaction mixture allowed to warm to room temperature and stirred for 19 h. Aqueous 
saturated NaHCC>3 (1 ml) was added and the aqueous layer separated and extracted with 
EtOAc (4 x 20 ml). The combined organic extracts were then dried (MgS04) and 
concentrated in vacuo. The residue was purified by column chromatography (eluting with 
20% EtOAc in hexane) to give alcohol 288 (3.32 g, 17.3 mmol, 63%) as a pale yellow 
oil: \)max(neat)/cm' 1 3397br s (O-H), 2930s, 1276s, 1185s, 1053s, 1011s, and 907s; 8h 
(400 MHz, CDCI3) 4.17 (1H, d, /  4.1, SCHS), 3.77-3.67 (2H, m, C //2OH), 2.95-2.82 
(4H, m, 2 x SCH2), 2.14-2.06 (2H, m, 1H from CH2 and 1 H from CtfCH3), 1.95-1.80 
(2H, m, 1H from C //2CH and 1H from CH2), 1.64-1.56 (1H, m, 1H from CHCH2), 1.34 
(1H, s, OH), and 1.12 (3H, d, J  6.9, C //3CH); 8C (100 MHz, CDC13) 60.8 (CH2OH), 55.3 
(SCHS), 36.9 (CHCH2), 35.3 (CHCH3), 31.0 (SCH2), 30.8 (SCH2), 26.3 (CH2), and 17.1 
(CH3); m/z (El mode) 192 (26%), 119 (100), 106 (4), 86 (10), 75 (6), and 74 (4) (Found 
M+, 192.0643. C8Hi6OS2 requires M, 192.0639).
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275
CaH16OS2 C12H20O2S2
Mol. Wt.: 192.34 Mol. Wt.: 260.42
Ethyl (E)-5-(l,3-dithian-2-yl)hex-2-enoate 275
To a solution of 288 (500 mg, 2.60 mmol, 1 eq) in CH2CI2 (25 ml) at 0°C was added 
DMSO (1.84 ml, 26.0 mmol, 10 eq) and then triethylamine (1.77 ml, 17.2 mmol, 6.6 eq). 
After 5 min pyridine-sulfur trioxide complex (1.57 g, 9.88 mmol, 3.8 eq) was added and 
the reaction stirred for 30 min before being allowed to slowly warm to rt and left for 4 h. 
To th e  g o l d e n  c o l o u r e d  s o l u t i o n  was  t h e n  a d d e d
(carbethoxymethylene)triphenylphosphorane (1.81 g, 5.20 mmol, 2 eq) and the reaction 
mixture left for a further 11 h. The reaction mixture was then poured onto a short column 
of silica gel and eluted with 40% EtOAc in hexane. Concentration in vacuo then gave 
crude 275 as a red oil. The residue was purified by column chromatography (eluting with 
10% EtOAc in hexane) to give oc,p-unsaturated ester 275 (482 mg, 1.85 mmol, 71%) as a 
clear yellow oil: \)max(neat)/cm_1 2978m, 2930m, 2898m, 1717s (C=0), 1653s (C=C), 
1367m, 1175s, 1042s, and 983s; SH (400 MHz, CDC13) 6.90 (1H, dt, J  15.5, 7.5, 
Ci7=CHC02Et), 5.87 (1H, d, J 15.5, CH=C//C02Et), 4.19 (2H, q, J  7.1, C7f2CH3), 4.09 
(1H, d, J 4.6, SCHS), 2.94-2.82 (4H, m, 2 x SCH2), 2.55 (1H, dt, J  14.4, 7.5, 1H from 
CH2CH=), 2.27-2.19 (1H, dt, J 14.4, 7.5, 1H from CH2CH=), 2.15-2.02 (2H, m, 1H from 
CH 2 and 1H from C/7CH3), 1.86-1.80 (1H, m, 1H from CH2), 1.29 (3H, t, J  7.1, 
CH2CH3), and 1.10 (3H, d, J 6.9, C //3CH); 5C (100 MHz, CDC13) 166.6 (C=0), 146.8 
(CH=CHC02Et), 123.5 (CH=CHC02Et), 60.4 (CH2CH3), 54.5 (SCHS), 38.1 (CHCH3),
36.8 (CH2CH=), 31.1 (SCH2), 30.8 (SCH2), 26.4 (CH2), 17.2 (CHCH3), and 14.4 
(CH2CH3); m/z (El mode) 260 (14%), 215 (7), 147(36), 119(100), 114 (12), and 73 (10) 
(Found M+, 260.0905. Ci2H2qS20 2 requires M , 260.0900).
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C 0 2Et
275 268
^ 12^20^2 ^ 2  ^ 9^ 1 4 ^ 3  
Mol. Wt.: 260.42 Mol. Wt.: 170.21
Ethyl (E)-5-methyl-6-oxohex-2-enoate 268
To a stirred solution of 275 (458 mg, 1.76 mmol, 1 eq) in acetonitrile (6.5 ml) and 
distilled water (1.6 ml) was added CaCC>3 (556 mg, 5.55 mmol, 3 eq) and iodomethane 
(1.15 ml, 18.5 mmol, 10 eq). The mixture was refluxed for 22 h before being allowed to 
cool to rt. The mixture was then poured onto a short column of silica gel and eluted with 
20% EtOAc in hexane. Concentration in vacuo gave the aldehyde 268 (289 mg, 1.70 
mmol, 97%) as an oil which was stored at —20°C under nitrogen, and used without 
further purification: 'omax(neat)/cnr1 2980s, 2936s, 2816m, 2719m, 1716s (C=0), 1655s 
(C=C), 1270s, 1179s, and 1044s; 6H (400 MHz, CDC13) 9.67 (1H, d, J  1.2, CHO), 6.90 
(1H, dt, J  15.6, 7.0, C//=CHC02Et), 5.89 (1H, dt, J  15.6, 1.5, C H =07C 02Et), 4.20 (2H, 
q, J 7.1, C772CH3), 2.73-2.59 (1H, m, 1H from CH2 CH=), 2.59-2.50 (1H, m, CH3C#), 
2.30-2.22 (1H, m, 1H from C//2CH=), 1.30 (3H, t, J  7.1, CH2CJ73), and 1.17 (3H, d, J
7.2, C //3CH); 6C (100 MHz, CDC13) 203.4 (CHO), 166.3 (C=0), 145.2 (CH2CH=), 123.9 
(=CHC02Et), 60.6 (CH2CH3), 45.4 (CH3CH), 33.0 (CH2), 14.4 (CH2CH3), and 13.4 
(CH3CH): m/z (Cl mode, isobutane) 171 (100%), 169 (4), 125 (22), 111 (4), 95 (6), and 
85 (19) (Found: (M + H)+, 171.1021. C9H15O3 requires M, 171.1017).
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287
C9Hi8OS2 
Mol. Wt.: 206.37
280
C9Hi6OS2 
Mol. Wt.: 204.35
3-(l,3-Dithian-2-yl)-3-methylbutan-l-al 280
To a solution of 3-(l,3-dithian-2-yl)-3-methylbutan-l-ol 287 (127 mg, 0.62 mmol, 1 eq) 
in CH2C12 (6.5 ml) at 0°C was added DMSO (0.44 ml, 6.17 mmol, 10 eq) and 
triethylamine (0.42 ml, 4.07 mmol, 6.6 eq). After 5 min, pyridine-sulfur trioxide complex 
(373 mg, 2.34 mmol, 3.8 eq) was added and the reaction mixture stirred for 1 h before 
being allowed to warm to rt and stirred for a further 45 min. The reaction mixtue was 
then poured onto a short column of silica gel and eluted with 40% EtOAc in hexane. 
Concentration in vacuo gave 280 (123 mg, 0.60 mmol, 98%) as a pale yellow oil which 
was stored at —20°C under nitrogen, and used without further purification: \)max 
(neatycnr1 2963s, 2931s, 2900s, 2829m, 2734m, 1718s (C=0), 1389m, 1369m, 1046m, 
and 907m; 6H (400 MHz, CDC13) 9.86 (1H, d, J  2.0, CHO), 4.24 (1H, s, SCHS), 2.94- 
2.89 (4H, m, 2 x SCH2), 2.60 (2H, d, J 2.0, CH2CHO), 2.13-2.08 (1H, m, 1H from 
SCH2C //2), 1.88-1.76 ( 1H, m, 1H from SCH2C/72), and 1.27 (6H, s, 2 x CH3); 6C (100 
MHz, CDCI3) 201.9 (CHO), 60.1 (SCHS), 53.1 (CH2CHO), 38.7 (CH3), 31.5 (2 x SCH2),
26.1 (CH2), and 26.0 (2 x CH3); m/z (El mode) 204 (11%), 160 (89), 145 (8), 119 (100), 
85 (12), 59 (8), and 41 (23) (Found M+, 204.0643. C9H16OS2 requires M, 204.0639).
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280
c9H16os2
Mol. Wt.: 204.35
2-[(Zi)-(l,l-Dimethyl-4-phenylsulfonylbut-3-enyl)]-l,3-dithiane 282
To a stirred solution of M eS02Ph (321 mg, 2.05 mmol, 2 eq) in THF (16 ml) at 0°C was 
added «-butyllithium (1.55 M in hexane, 2.92 ml, 4.52 mmol, 4.4 eq) and the mixture left 
for 30 min before the dropwise addition of a solution of diethylchlorophosphate (0.30 ml,
2.05 mmol, 2 eq) in THF (4 ml). The reaction was stirred for a further 30 min before 
being cooled to —78°C and a solution of 3-[l,3-dithian-2-yl]-3-methyl-butan-l-al 280 
(210 mg, 1.03 mmol, 1 eq) in THF (4 ml) was added. After a further lh, the reaction 
mixture was allowed to warm to rt and stirred for 12 h. Aqueous saturated NaHC03 (1 
ml) was added and the aqueous layer separated and extracted with CH2CI2 (3 x 10 ml). 
The combined organic extracts were then dried (Na2S04) and concentrated in vacuo. The 
residue was purified by column chromatography (eluting with 20% EtOAc in hexane) to 
give vinyl sulfone 282 (244 mg, 0.71 mmol, 69%) as a pale yellow oil: X>max(neat)/cm' 1 
3023s, 2968m, 2903m, 1631m (C=C), 1526m, 1451m, 1426m, 1321s (S 02), 1226s, 
1201s, 1146s (S02), and 1086s; 8H (400 MHz, CDCI3) 7.91 (2H, apparent d, J  7.7, 2 x 
ArH), 7.64-7.54 (3H, m, 3 x ArH), 7.00 (1H, dt, J 14.9, 8.0, 07=C H S02Ph), 6.45 (1H, d, 
J  14.9, =Cf/S02Ph), 3.85 (1H, s, SCHS), 2.87-2.72 (4H, m, 2 x SCH2), 2.40 (2H, d, J
8.0, CH2CH=), 2.07-2.01 (1H, m, 1H from CH2), 1.81-1.71 (1H, m, 1H from CH2), and
1.13 (6H, s, 2 x CH3); 5c (100 MHz, CDC13) 143.0 (CH=CHS02Ph), 141.1 (ArC), 133.6 
(CH=CHS02Ph), 133.5 (ArCH), 129.5 (2 x ArCH), 127.8 (2 x ArCH), 60.1 (SCHS), 42.1 
(CH2CH=), 39.4 (C), 31.4 (2 x SCH2), 26.0 (CH2), and 25.7 (2 x CH3); m/z (Cl mode,
SO,Ph
282
1^6^22®2®3
Mol. Wt.: 342.54
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isobutane) 343 (100%), 271 (9), 237 (15), 201 (12), and 119 (5) (Found (M + H)+, 
343.0860. C 16H23O2S3 requires M, 343.0855).
282 270
C16H220 2S3 c 13h 16o 3s
Mol. Wt.: 342.54 Mol. Wt.: 252.33
(Z?)-2,2-DimethyI-5-phenylsulfonylpent-4-enal 270
To a stirred solution of 282 (244 mg, 0.71 mmol, 1 eq) in acetonitrile (4 ml) and distilled 
water (1 ml) was added CaCC>3 (214 mg, 2.13 mmol, 3 eq) and iodomethane (0.89 ml,
14.2 mmol, 20 eq). The mixture was refluxed at 60°C for 15 h and then allowed to cool 
before being poured onto a short column of silica gel and eluted with 20% EtOAc in 
hexane. Concentration in vacuo gave the aldehyde 270 (181 mg, 0.72 mmol, 100%) as a 
clear, pale yellow oil which was used without further purification: u max (neatycm' 1 
3049w, 2968m, 2932m, 2873m, 2813w, 2713w, 1725s (C=0), 1632m (C=C), 1379w, 
1368w, 1317s (S02), 1147s (S02), 1086s, and 750s; 6H (400 MHz, CDC13) 9.46 (1H, s, 
CHO), 7.88 (2H, apparent d, J  7.9, 2 x ArH), 7.65-7.62 (1H, m, ArH), 7.58-7.54 (2H, m, 
2 x ArH), 6.91 (1H, dt, J 15.0, 7.8, CH2C//=), 6.39 (1H, d, J  15.0, =CtfS02Ph), 2.39 (2H, 
d, 77.8, CH2CH=), and 1.11 (6H, s, 2 x CH3); 6C (100 MHz, CDCI3) 204.0 (CHO), 142.1 
(CH2CH=), 140.5 (ArC), 133.8 (=CHS02Ph), 133.6 (ArCH), 129.5 (2 x ArCH), 127.8 (2 
x ArCH), 46.0 (C), 38.4 (CH2), and 21.7 (2 x CH3). m/z (Cl mode, isobutane) 253 
(100%), 183 (6), 111 (4), 81 (3), and 69 (3) (Found (M + H)+, 253.0898. C 13Hi7S 03 
requires M, 253.0894).
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280
O9H16OS2 
Mol. Wt.: 204.35
MeS
283
1^8^ 26 ®2®4
Mol. Wt.: 402.66
2-[l,l-dimethyl-4-methyIsulfanyl-4-(toIuene-4-suIfonyl)-but-3-enyl]-[l,3]dithiane
283
To a stirred solution of methylthiomethyl-p-tolylsulfone (153 mg, 0.71 mmol, 1.2 eq) in 
THF (3.0 ml) at -78°C was added «-butyllithium (1.2M in hexane, 0.57 ml, 0.71 mmol,
1.2 eq) and the reaction stirred for 15 min before warming to 0°C for 30 min. The 
reaction mixture was then cooled to -78°C and a solution of aldehyde 280 (120 mg, 0.59 
mmol, 1 eq) in THF (1.5 ml) added via cannula. The reaction was stirred for 30 min 
before Ac20  (0.08 ml, 0.82 mmol, 1.4 eq) was added. After a further 10 min 
triethylamine (0.12 ml, 1.65 mmol, 2.8 eq) and 4-dimethylaminopyridine (14 mg, 0.12 
mmol, 0.2 eq) were added. After 4 h the reaction was quenched with aqueous saturated 
NaHC03 (2 ml) and the aqueous layer separated and extracted with CH2CI2 ( 4 x 1 5  ml). 
The combined organic layers were dried (MgS04) and concentrated in vacuo to give 
crude 283 as a yellow sticky oil. Purification of the residue by column chromatography 
(eluting with 15% EtOAc in pet. ether (40-60)°C) gave 283 (98 mg, 0.24 mmol, 41%) as 
a clear yellow oil: Dmax (CDC13 soln.ycnr1 3154s, 2975s (C-H), 2902s (C-H), 2870m (C- 
H), 2833m (C-H), 1819s, 1793s, 1646m (C=C), 1598s (Ar-H), 1561m (Ar-H), 1467s, 
1383s (S02) and 1152s (S02); 5H (400 MHz, CDC13) 7.82 (2H, apparent d, J  8.2, 2 x 
ArH), 7.60 (1H, t, J  7.6, CH2CH=), 7.33 (2H, apparent d, J  8.2, 2 x ArH), 4.03 (1H, s, 
SCHS), 2.91-2.88 (4H, m, 2 x SCH2), 2.72 (2H, d, 77.6, CH2CR=), 2.45 (3H, s, PhCH3), 
2.29 (3H, s, SCH3), 2.13-2.06 (1H, m, 1H from SCH2C //2), and 1.16 (6H, s, C(CH3)2); 
6C (100 MHz, CDCI3) 148.9 (CH2CH=), 144.5 (ArC), 140.6 (CH=C), 136.2 (ArC), 129.7
145
(2 x ArCH), 128.9 (2 x ArCH), 60.4 (SCHS), 40.5 (CH2CH=), 39.6 (C(CH3)2), 31.5 (2 x 
SCH2), 26.1 (SCH2CH2), 25.8 (2 x CH3), 21.8 (PhCH3), and 19.5 (SCH3); m/z (CI+ 
mode, isobutane) 403 (100%), 247 (25), 241 (4), 189 (8), 187 (3), and 119 (7) (Found (M 
+ H)+, 403.0894. Ci8H270 2S4 requires M, 403.0888).
MeS
283
C18H2602S4 
Mol. Wt.: 402.66
S 0 2pTol
MeS
271
1^5^20®3®2
Mol. Wt.: 312.45
2,2-Dimethyl-5-methylsulfanyl-5-(toluene-4-sulfonyI)-pent-4-enal 271
To a stirred solution of 283 (34 mg, 0.08 mmol, 1 eq) in acetonitrile (1 ml) and distilled 
water (0.25 ml) was added CaCC>3 (25 mg, 0.25 mmol, 3 eq) and iodomethane (0.11 ml, 
1.69 mmol, 20 eq). The mixture was refluxed for 30 h with a further quantity of Mel 
(0.06 ml, 1.69 mmol, 10 eq) being added after 23 h. The reaction mixture was then 
allowed to cool and filtrated through a short column of silica gel (eluting with 20% 
EtOAc in hexane). Concentration in vacuo gave the aldehyde 271 (25 mg, 0.08 mmol, 
100%) as a clear yellow oil which was stored at —20°C under nitrogen: \)max (CDCI3 
soln.ycm"1 3154s, 2975s (C-H), 2896m (C-H), 2870w (C-H), 2712m (CHO), 1819m, 
1793s, 1730s (C=0), 1646m (C=C), 1598s (Ar-H), 1561m (Ar-H), 1383s (S02) and 
1146s (S02); 5h (400 MHz, CDCI3) 9.49 (1H, s, CHO), 7.80 (2H, apparent d, J  8.3, 2 x 
ArH), 7.47 (1H, t, J  7.6, CH2Ctf=), 7.34 (2H, apparent d, J  8.3, 2 x ArH), 2.69 (2H, d, J  
7.6, C/72CH=), 2.45 (3H, s, PhCH3), 2.28 (3H, s, SCH3), and 1.14 (6H, s, C(CH3)2; 8C 
(100 MHz, CDCI3) 204.2 (CHO), 147.5 (CH2CH=), 144.7 (ArC), 141.4 (CH=Q, 135.9 
(ArC), 129.8 (2 x ArCH), 128.9 (2 x ArCH), 46.4 (C(CH3)2), 36.8 (CH2CH=), 21.8
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(PhCH3), 21.8 (C(CH3)2) and 19.4 (SCH3); m/z (CI+ mode, isobutane) 313 (100%), 203 
(12), 187 (61), 157 (68), 139 (26), 127 (8) and 81 (7) (Found M+, 312.0855. Ci5H2o03S2 
requires M, 312.0849).
281
C6Hi202 
Mol. Wt.: 116.16
CO,Et
284
C10H18O3 
Mol. Wt.: 186.25
CO,Et
289
C10Hi8O3 
Mol. Wt.: 186.25
6-Hydroxy-4,4-dimethyl-hex-2-enoic acid ethyl ester 284
To a stirred solution of a,a-dimethyl-y-butyrolactol 281 (108 mg, 0.93 mmol, 1 eq) in 
toluene (9 ml) was added (carbethoxymethylene)triphenylphosphorane (650 mg, 1.86 
mmol, 2 eq) and the reaction mixture refluxed for 4 days. The mixture was then allowed 
to cool to rt and aqueous saturated NaHC03 (3 ml) added. The aqueous layer was 
separated and extracted with CH2C12 (4 x 10 ml), the combined organic layers dried 
(MgSC>4) and concentrated in vacuo to give a clear orange/yellow oil. Purification of the 
residue by column chromatography (eluting with 40% EtOAc in Pet. Ether (40-60°C)) 
gave 284 as a clear yellow oil (77 mg, 0.41 mmol, 44%): \)max (CHC13 soln.ycm' 1 3627s 
(O-H), 3154s (O-H), 2965s (C-H), 2933m (C-H), 2896m (C-H), 1703s (C=0), 1646s 
(C=C), 1467s, 1378s, 1309s, and 1178s; 5H (400 MHz, CDC13) 6.98 (1H, d, J  15.9, 
CH=), 5.75 (1H, d, J 15.9, =CHCO), 4.20 (2H, q, J  7.1, C/72CH3), 3.65 (2H, t, J 7.4, 
Ctf2OH), 1.71 (2H, t, J 1 A, Ctf2CH2OH), 1.30 (3H, t, J  7.1, CH2C //3) and 1.11 (6H, s, 
C(CH3)2); 5c (100 MHz, CDC13) 167.2 (C=0), 157.6 (CH=), 118.2 (=CHCO), 60.5 
(CH2CH3), 59.9 (CH2OH), 44.8 (CH2CH2OH), 36.0 (C(CH3)2), 26.9 (C(CH3)2) and 14.5 
(CH2CH3); m/z (CI+ mode, isobutane) 187 (27%), 181 (8), 169 (4), 141 (100), 127 (7),
147
117 (7), 95 (12), 83 (14) and 70 (13) (Found (M + H)+, 187.1330. C10H19O3 requires M, 
187.1329).
Further elution then gave (3,3-Dimethyl-tetrahydro-furan-2-yl)-acetic acid ethyl ester
289 (65 mg, 0.35 mmol, 38%) as a clear colourless oil: \)max (filmVcm'1 2959s (C-H), 
2874s (C-H), 2678s (C-H), 1740s (C=0), 1389s, 1369s, 1309s, 1185s, 1157s, 1033s and 
907s; 5h (400 MHz, CDC13) 4.18 (2H, q, J  7.1, C tf2CH3), 3.92-3.81 (3H, m, 2H from 
CH2CH20  and 1H from CH), 2.39-2.37 (2H, m, CH2CO), 1.85-1.71 (2H, m, Ci72CH20), 
1.28 (3H, t, J  7.1, CH2Ctf3), 1.07 (3H, s, CH3) and 0.93 (3H, s, CH3); 5C (100 MHz, 
CDC13) 172.2 (C=0), 83.2 (CH), 65.9 (CH2CH20), 60.8 (CH2CH3), 41.0 (CH2CH20),
40.6 (C(CH3)2), 36.1 (CH2CO), 25.4 (CH3), 21.9 (CH3) and 14.4 (CH2CH3); m/z (CI+ 
mode, isobutane) 187 (100%), 169 (6), 158 (8), 141 (3), 99 (10) and 70 (3) (Found (M + 
H)+, 187.1334. C10H19O3 requires M, 187.1329).
284 269
CioHi803 C10Hi6O3
Mol. Wt.: 186.25 Mol. Wt.: 184.23
4,4-Dimethyl-6-oxo-hex-2-enoic acid ethyl ester 269
To a stirred solution of alcohol 284 (123 mg, 0.66 mmol, 1 eq) in CH2CI2 (7 ml) at 0°C 
was added DMSO (0.47 ml, 6.61 mmol, 10 eq) and triethylamine (0.45 ml, 4.37 mmol,
6.6 eq). After 5 min pyridine-sulfur trioxide complex (400 mg, 2.51 mmol, 3.8 eq) was 
added and the reaction stirred at 0°C for 45 min before being allowed to warm to rt and 
stirred for a further 6 h. The reaction mixture was then passed through a short column of 
silica gel (eluting with 40% EtOAc in Pet Ether (40-60°C)). Concentration in vacuo gave 
the aldehyde 269 (121 mg, 0.66 mmol, 99%) as a clear colourless oil: v max (CDCI3 
soln.ycm' 1 2972s (C-H), 2902s (C-H), 2831m (CHO), 2737m (CHO), 1792s (CHO),
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1716s (C=0), 1651s (C=C), 1469s, 1381s, 1310s and 1093s; 6H (400 MHz, CDCI3) 9.71 
(1H, t, 7 2.8, CHO), 7.02 (1H, d, 7 15.9, CH=), 5.80 (1H, d, 7 15.9, =CHCO), 4.20 (2H, q,
77.1, C //2CH3), 2.45 (2H, d, 7 2.8, CH2CHO), 1.30 (3H, t, 77.1, CH2C773) and 1.22 (6H, 
s, C(CH3)2); 8c (100 MHz, CDC13) 201.6 (CHO), 166.8 (C=0), 155.4 (CH=), 119.1 
(=CHCO), 60.7 (CH2CH3), 54.4 (CH2CHO), 36.0 (C(CH3)2), 27.0 (C(CH3)2) and 14.4 
(CH2CH3); m/z (CI+ mode, isobutane) 185 (72%), 171 (8), 155 (16), 139 (100), 125 (6), 
113 (7), 95 (5), 85 (10) and 69 (18) (Found (M + H)+, 185.1178. C10H 17O3 requires M, 
185.1173).
Preparation of SmL145
To a stirred suspension of samarium (l.OOg, 6.65 mmol, 1.2 eq) in THF (55 ml) inside a 
brown bottle wrapped in foil was added iodine (1.41g, 5.54 mmol, 1 eq). The reaction 
mixture was heated to 60°C and stirred for 23 h before being cooled to room temperature. 
The resultant deep blue 0 .1M Sml2 solution was then stored under Argon.
267
..OH
co,aiN<W2 h r*H
CnH1803 
Mol. Wt.: 198.26
290a
CiiH2o03
Mol. Wt.: 200.27
..OH
CO,Et
290 b
CiiH2o03
Mol. Wt.: 200.27
Ethyl rel-(2R)-{rel-{AR9 2/£)-2-hydroxy-3,3-dimethyl-cyclobutyl}-propionate 290a and 
ethyl rel-(2S)-{rel-(lR, 2/?)-2-hydroxy-3,3-dimethyl-cyclobutyl}-propionate 290b
To a stirred solution of Sml2 (0.1M in THF, 10.1 ml, 1.01 mmol) in MeOH (2.70 ml, 66.4 
mmol) at 0°C was added dropwise a solution of aldehyde 267 (100 mg, 0.50 mmol) in 
THF (2 ml). After 2.5 h the reaction mixture was added to a stirred solution of aqueous
149
saturated NaCl (2 ml) before adding citric acid (128 mg, 0.61 mmol). The aqueous layer 
was separated and extracted with EtOAc (3 x 25 ml) and the combined organic layers 
dried (MgSOa). Concentration in vacuo gave crude 290 as an orange oil. The residue was 
purified by column chromatography (eluting with 30% EtOAc in hexane) to give 
cyclobutanol 290 (67 mg, 0.33 mmol, 66%) as a clear, colourless oil: u max (neatj/cm' 1 
3448s (O-H), 2957s, 2867s, 1731s (C=0), 1461m, 1368m, 1272m, 1132m, 1096m, and 
1025m; (major diastereoisomer 290a) 8h (400 MHz, CDCI3) 4.13 (2H, q, J  7.1, 
CH2CH3), 3.60 (1H, dd, J  7.6, 3.5, CHOH), 2.49 (1H, d, J  3.5, OH), 2.42-2.34 (1H, m, 
CHCH3), 2.18-2.08 (1H, m, CH), 1.71 (1H, apparent t, J  10.1, 1H from CH2), 1.28 (3H, t, 
J 7.1, CH2CH3), 1.10 (3H, d, J  7.0, CHC//3), 1.08 (3H, s, CH3), 1.07 (3H, s, CH3), and
1.00 (1H, apparent t, J 10.1, 1H from CH2); 8C (100 MHz, CDCI3) 176.6 (C02Et), 78.4 
(CHOH), 60.8 (CH2CH3), 44.2 (CHCH3), 43.8 (CH), 37.6 (C), 32.9 (CH2), 28.8 (CH3),
21.1 (CHCH3), 14.8 (CH3), and 14.4 (CH2CH3).
(minor diastereoisomer 290b) mp 57-60 °C (hexane); 8h (400 MHz, CDCI3) 4.13 (2H, q, 
J 7.1, C/72CH3), 3.57 (1H, t, J 13, CHOH), 2.49-2.41 (1H, m, CHCH3), 2.24-2.15 (1H, 
m, CH), 1.80 (1H, d, J  7.3, OH), 1.64 (1H, apparent t, J  10.2, 1H from CH2), 1.26 (3H, t,
77.1, CH2C//3), 1.21 (3H, d, J 7.0, CHCH3), 1.13 (1H, apparent t, J  10.2, lH from C H 2),
1.07 (3H, s, Me), and 1.06 (3H, s, Me); 8C (100 MHz, CDCI3) 176.1 (CO), 78.0 (CHOH),
60.4 (CH2CH3), 44.4 (CH), 43.9 (CHCH3), 38.3 (C), 32.3 (CH2), 28.5 (Me), 20.9 (Me),
15.0 (CHCH3), and 14.5 (CH2CH3).
For deuterated 305a: 8h (400 MHz, CDC13) as for 290a except 2.42-2.34 (1H, m, 
CHCH3) missing; 8c (100 MHz, CDC13) as for 290a except 44.2 (CHCH3) missing; m/z 
(Cl mode, NH3) 219 (100%), 184 (56), 96 (79), and 79 (34) (Found (M+H)+. 202.1553. 
C11H20O3D requires M, 202.1548).
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For deuterated 305b: 5 H (400 MHz, CDCI3) as for 290b except 2.49-2.41 (1H, m, 
CHCH3) missing; 8c (100 MHz, CDCI3) as for 290b except 43.9 (CHCH3) missing 
(Found: C, 65.67; H, 9.61. C nH 190 3D requires, C, 65.64; H, 9.51%).
V
c o 2b
268
CgH1403 
Mol. Wt.: 170.21
o0H
—i \ / C 02B +
H
291
c 9h 16o 3
Mol. Wt.: 172.22
292
9^^ 18^ 3
Mol. Wt.: 174.24
Attempted cyclisation of 268 - ethyl 6-hydroxy-5-methyMiexanoate 292
To a stirred solution of 268 (20 mg, 0.12 mmol, 1 eq) in methanol (0.60 ml, 29.6 mmol) 
at 0°C was added Sml2 (0.1 M in THF, 2.35 ml, 0.24 mmol, 2 eq) dropwise over 1 min. A 
third equivalent of Sml2 (1.13 ml, 0.12 mmol, 1 eq) was added after 20 min and a fourth 
equivalent of Sml2 (1.13 ml, 0.12 mmol, 1 eq) after a further 30 min. The reaction 
mixture was then stirred for 1 h before quenching with aqueous saturated NaHCC>3 (1 
ml), followed by the addition of citric acid (29.6 mg, 0.14 mmol, 1.2 eq). The aqueous 
layer was separated and extracted with EtOAc (3 x 30 ml) and the combined organic 
layers dried (MgSO/O and concentrated in vacuo to give an orange solid. The residue was 
then purified by column chromatography (eluting with 30% EtOAc in hexane) to give the 
alcohol 292 (11 mg, 0.07 mmol, 31%) as a clear, colourless oil: 'Drnax(soln. in CHCl3)/cnr 
1 3154m (O-H), 3012s, 2983w, 1731m (0=0), 1467m, and 1217s; 8H (400 MHz, CDC13)
4.13 (2H, q, 77.1, CH2CH3), 3.53-3.43 (2H, m, C//2OH), 2.32 (2H, m, Ctf2C 0 2Et), 1.73- 
1.57 (3H, m, 2H from CH2 and 1H from CH3CH), 1.49-1.40 (1H, m, 1H from CH2), 1.26 
(3H, t, 7 7.1, CH2C//3), 1.21-1.09 (1H, m, 1H from CH2), and 0.93 (3H, d, 7 6.7, 
CH3CU); 5C (100 MHz, CDCI3) 174.1 (C=0), 68.2 (CH2OH), 60.5 (CH2CH3), 35.7 
(CH), 34.7 (CH2C 02Et), 32.7 (CH2), 22.4 (CH2), 16.6 (CH3CH), and 14.4 (CH2CH3);
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m/z (Cl mode, NH3) 192 (100%), 175 (18), 146 (10), and 52 (8) (Found (M + H)+, 
175.1334. C9H19O3 requires Af, 175.1329).
270
... OH
.SO ,Ph
297 298
1^3^ 16 Qs® 
Mol. Wt.: 252.33
^13^18 0 3S 
Mol. Wt.: 254.35
C-^H-jg O3S 
Mol. Wt.: 254.35
rel-(lR , 4S)-2,2-Dimethyl-4-(phenylsuIfonylmethyl)-cyclobutan-l-ol 297 and (E)-2,2- 
dimethyl-5-phenylsulfonyl-pent-4-en-l-ol 298
To a stirred solution of Sml2 (0.1 M in THF, 1.59 ml, 0.16 mmol, 2 eq) in methanol (0.43 
ml, 10.6 mmol) at 0°C was added a solution of aldehyde 270 (20 mg, 0.08 mmol, 1 eq) in 
THF (0.5 ml) via cannula. After 2 h, a further quantity of S111I2 (0.80 ml, 0.08 mmol, 1 
eq) was added before quenching the reaction with aqueous saturated NaCl (1 ml). Citric 
acid (20 mg, 0.10 mmol, 1.2 eq) was then added before the aqueous layer was separated 
and extracted with EtOAc (3x15  ml) and dried (MgS04). Concentration in vacuo gave a 
dark red oil. The residue was then purified by column chromatography (eluting with 30% 
EtOAc in hexane), which gave 297 (4 mg, 0.02 mmol, 21%) as a clear, colourless oil: 
Vmax (soln. in CD C^/cm ' 1 3606m, 3159m, 3070m, 3033m, 2970s, 2928m, 2865m, 
1709s, 1598s, 1451s, 1309s (S02), and 1152s (S02); 5H (400 MHz, CDCI3) 7.94 (2H, 
apparent d, J  7.2, 2 x ArH), 7.71-7.67 (1H, m, ArH), 7.62-7.58 (2H, m, 2 x ArH), 3.71 
(1H, d, J 7.7, CT/OH), 3.26 (2H, apparent d, J  7.4, CH2S 02Ph), 2.69 (1H, br s, CHOH),
2.50-2.40 (1H, m, CHCH2), 1.72 (1H, apparent t, J  10.1, 1H from CH2), 1.11 (6H, s, 2 x 
CH3), and 1.07 (1H, obscured 1H from CH2); 6C (100 MHz, CDCI3) 139.4 (ArC), 134.0 
(ArCH), 129.6 (2 x ArCH), 128.3 (2 x ArCH), 79.0 (CHOH), 60.8 (CH2S 0 2Ph), 39.6
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(C), 35.1 (CH), 33.7 (CH2), 28.7 (CH3), and 20.8 (CH3); m/z (Cl mode, NH3) 272 
(100%), 254 (10), 237 (5), and 95 (2) (Found (M + NH4)+, 272.1320. C 13H22NO3S 
requires M, 272.1315).
Further elution then gave 298 (7 mg, 0.03 mmol, 35%) as a colourless oil: vmax (CHCI3 
soln.)/cm-‘ 3627m, 3017s, 2965s, 2928m, 2875m, 1630m, 1519m, 1446m, 1320s (S02), 
1309s, 1215s, and 1146s (S02); 6H (400 MHz, CDCI3) 7.89 (2H, apparent d, J  8.6, 2 x 
ArH), 7.64-7.60 (1H, m, ArH), 7.57-7.53 (2H, m, 2 x ArH), 7.03 (1H, dt, J  14.9, 8.0, 
CH2C/7=), 6.36 (1H, d, J  14.9, =CHS02Ph), 3.34 (2H, s, C #2OH), 2.22 (2H, d, J  8.0, 
0 / 2CH=) and 0.93 (6H, s, 2 x CH3); 6C (100 MHz, CDCI3) 144.5 (CH2CH=), 140.9 
(ArC), 133.5 (ArCH), 132.6 (=CHS02Ph), 129.4 (2 x ArCH), 127.7 (2 x ArCH), 71.3 
(CH2OH), 40.7 (CH2CH=), 36.5 (C), 24.1 (2 x CH3); m/z (Cl mode, isobutane) 255 
(100%), 237 (73), 198 (2), 154 (2), 143 (2), 125 (3), 113 (4), 95 (14), and 81 (12) (Found 
(M + H)+, 255.1055. Ci3H 190 3S requires M, 255.1050).
S 0 2pTol 
e
3S 2 
14.47
rel- ( 1 R  , 2S )-2,2-Dimethyl-4-[r^/-(S)-methylsulfanyl-(toluene-4-sulfonyl)-methyl]- 
cyclobutan-l-ol 304
To a stirred solution of Sml2 (0.1M in THF, 3.53 ml, 0.35 mmol, 2 eq) in CH3OH (0.88 
ml, 22.7 mmol) at 0°C, was added a solution of aldehyde 271 (55 mg, 0.18 mmol, 1 eq) in 
THF (1 ml) via cannula. After 0.5 h another quantity of Sml2 (1.77 ml, 0.18 mmol, 1 eq) 
was added and the reaction left for a further 0.5 h before aqueous saturated NaCl (1.5 ml) 
and citric acid (111 mg, 0.53 mmol, 3 eq) were added. The aqueous layer was then
C i s H o q O q S o  C-ieHooO'
Mol. Wt.: 312.45 Mol. Wt.: 3
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separated and extracted with 80% EtOAc in Pet. Ether (40-60°C) (4 x 25 ml) and the 
combined organic layers dried (MgS0 4 ). Concentration in vacuo then gave crude 304 as 
a 6:1 ratio of diastereoisomers. The residue was then purified by column chromatography 
(eluting with 25% EtOAc in Pet. Ether (40-60°C)) to give the major diastereomer 304 (33 
mg, 0.11 mmol, 60%) as a white crystalline solid mp 140-141°C (CHC13 / hexane): \)max 
(CDC13 soln.ycm' 1 3690m (O-H), 3154s, 2975s (C-H), 2928s (C-H), 2896s (C-H), 
2865m (C-H), 1814s, 1793s, 1598s, (Ar-H), 1383s (S02) and 1141s (S02); 8H (400 MHz, 
CDCI3) 7.88 (2H, apparent d, J  8.1, 2 x ArCH), 7.38 (2H, apparent d, J  8.1, 2 x ArCH), 
3.94 (1H, dd, J  7.3, 2.9, CtfOH), 3.75 (1H, d, J  10.8, C//SCH3), 3.31 (1H, d, J  2.9, OH),
2.51-2.42 (1H, partially hidden multiplet, CCH2CH), 2.48 (3H, s, PhCH3), 2.17 (3H, s, 
SCH3), 1.78-1.73 (1H, dd, J  10.5, 9.2, 1H from CCH2CH), 1.29-1.23 (1H, dd, J  10.5, 1H 
from CCH2CH), 1.15 (3H, s, CH3) and 1.13 (3H, s, CH3); 8C (100 MHz, CDC13) 145.4 
(ArC), 132.9 (ArC), 130.4 (2 x ArCH), 129.6 (2 x ArCH), 79.0 (CHOH), 73.9 
(CHSCH3), 39.5 (CCH2CH), 37.4 (C(CH3)2), 33.7 (CCH2CH), 28.8 (CH3), 21.9 
(PhCH3), 21.0 (CH3) and 14.7 (SCH3); m/z (CI+ mode, isobutane) 315 (2%), 297 (20), 
267 (3), 229 (2), 199 (9), 197 (9), 159 (100), 157 (37), 131 (20) and 87 (27) (Found (M + 
H)+, 315.1089. Ci5H230 3S2 requires M, 315.1083).
.OH
OH
305a 311
C11 H.| g D O 3 C9H17DO2
Mol. Wt.: 201.28 Mol. Wt.: 159.24
rel-(lR, 4/?)-4-(2-Hydroxy-(lR)-l-deutero-methyl-ethyl)-2,2-dimethyl cyclobutanol 
311
154
To a stirred solution of deuterated cyclobutanol 305a (30 mg, 0.15 mmol, 1 eq) in THF (1 
ml), at 0 °C was added LiAltL* (11 mg, 0.30 mmol, 2 eq). After 1.5 h the reaction mixture 
was transferred to a solution of K/Na tartrate (421 mg, 1.49 mmol, 10 eq) in H2O (1 ml) 
and the resulting mixture stirred for 10 min. The aqueous layer was then separated and 
extracted with EtOAc ( 4 x 5  ml) and the combined organic extracts dried (Na2S04). 
Concentration in vacuo gave crude 311 as a clear colourless oil. The residue was then 
purified by sublimation which gave 311 as a white crystalline solid (14 mg, 0.09 mmol, 
59%), mp 61-63°C: a ^ n e a O /c n r 1 3685m (O-H), 3601w, 3017s, 2954s, 2933m, 1604w, 
1525m, 1477m, 1420m, 1078m, and 1020m; 8H (400 MHz, CDC13) 3.65 (1H, dd, J  11.0,
8.3, 1H from C //2OH), 3.58 (1H, dd, J  7.6, 5.8, C//OH), 3.37 (1H, dd, J  11.0, 4.0, 1H 
from C//2OH), 2.60 (1H, dd, J  8.3, 4.0, CH20 //) , 2.37 (1H, d, J 5.8, CHO//), 1.79-1.69 
(1H, m, CH), 1.67 (1H, apparent t, J  9.9, 1H from CH2), 1.09 (3H, s, CH3), 1.08 (3H, s, 
CH3), 1.01 (1H, apparent t, J  9.9, 1H from CH2), and 0.73 (3H, s, CDCH3); 8C (100 MHz, 
CDC13) 79.3 (CHOH), 68.9 (CH2OH), 46.3 (CH), 37.7 (C), 32.1 (CH2), 28.6 (CH3), 20.8 
(CH3), and 14.1 (CDCH3) ['CD' signal not observed]; m/z (Cl mode, NH3) 177 (16%), 159 
(10), 142 (4), 124 (1), 88 (1), and 77 (1) (Found (M + NH4)+, 177.1713. C9H21DN02 
requires M, 177.1708).
314 315 316
C4H5B r02 C22H20BrO2P C22H19 0?^
Mol. Wt.: 164.99 Mol. Wt.: 427.27 Mol. Wt.: 346.36
1-butvrolactonvlidene triphenvlphosphorane 316155
To a stirred solution of a-bromo-y-butyrolactone 314 (10.0 g, 60.6 mmol, 1 eq) in DME 
(24 ml) at rt, was added triphenylphosphine (15.9 g, 60.6 mmol, 1 eq). The reaction
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mixture was then heated at reflux for 4 h before being allowed to cool to rt and stirred for 
a further 15 h. The brown crusty reaction mixture was dissolved in ethanol (10 ml) and a 
small quantity of EtOAc (0.5 ml) added. The mixture was cooled to —20°C for 3 days 
during which a pinky-brown crystalline solid formed. Phosphonium bromide salt 315 
(15.9 g, 37.2 mmol, 61%) was then collected by filtration. A quantity of phosphonium 
bromide salt (2.00 g, 4.68 mmol) was then dissolved in H20  (30 ml) and methanol (8ml) 
and the mixture stirred for 10 min, during which time gentle warming of the mixture was 
required to dissolve the salt. After that time aqueous saturated Na2C 0 3 (6 ml) was added, 
resulting in the instantaneous formation of a white precipitate which was collected by 
filtration, washed with H20  (3 x 10 ml) and dried to give a white chalky solid. 
Recrystallisation from DMF gave 316 as a pale yellow crystalline solid (1.02 g, 2.95 
mmol, 63%): SH (400 MHz, CDC13) 7.69-7.49 (15H, m, 15 x aromatic CH), 4.34 (2H, t, 7
7.8, CH20) and 2.67 (2H, t, 77.8, C //2CH2Q).
2-[(E)-l,l-Dimethyl-3-(2-oxodihydrofuran-3-ylidene) propyl]-1,3-dithiane 317-E and
2-[(Z)-l,l-Dimethyl-3-(2-oxodihydrofuran-3-ylidene) propyl]-l,3-dithiane 317-Z
To a solution of 287 (1.02 g, 4.94 mmol, 1 eq) in CH2CI2 (50 ml) at 0°C was added 
DMSO (3.51 ml, 49.4 mmol, 10 eq) and triethylamine (3.37 ml, 32.6 mmol, 6.6 eq). 
After 5 min, pyridine-sulfur trioxide complex (2.99 g, 18.8 mmol, 3.8 eq) was added and 
the reaction stirred for a further 30 min before being allowed to slowly warm to rt and left 
for a further 30 min. 1-Butyrolactonylidene triphenylphosphorane 316 (3.08 g, 8.89
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mmol, 1.8 eq) was then added and the reaction mixture stirred for 13 h before the 
addition of aqueous saturated NaHCC>3 (5 ml). The aqueous layer was then separated and 
extracted with CH2CI2 (5 x 50 ml), dried (Na2SC>4) and concentrated in vacuo. 
Purification of the residue by column chromatography (eluting with 30% EtOAc in 
hexane) gave 317 (1.23 g, 4.51 mmol, 91%) as a 4:1 mixture of (E) and (Z) isomers: vmax 
(neatycnr1 2965s, 2929s, 2828m, 1755s (C=0), 1679s, 1483m, 1465s, 1422s, 1387s, 
1368s, 1216s, and 1034s; m/z (El mode) 272 (10%), 161 (35), 119 (100), 112 (5), 83 (5), 
and 41 (5) (Found M+, 272.0905. C13H20S2O2 requires M, 272.0900). The two isomers 
were isolated by further chromatography (eluting with CH2CI2): (E ) isomer 317-E', 8h 
(400 MHz, CDCI3) 6.82 (1H, tt, J  7.8, 2.9, CH2Ctf=), 4.38 (2H, t, J 7.4, CH2CH20), 4.03 
(1H, s, SCHS), 2.96-2.88 (6H, m, 2H from CH2CU20  and 4H from 2 x SCH2), 2.39 (2H, 
d, J  7.8, CH2CH=), 2.13-2.06 (1H, m, 1H from SCH2CH2), 1.86-1.77 (1H, m, 1H from 
SCH2Ci/2), and 1.17 (6H, s, 2 x CH3); Sc (100 MHz, CDCI3) 171.3 (C=0), 136.8 
(CH2CH=), 127.9 (C H =0, 65.7 (CH2CH20), 60.2 (SCHS), 41.1 (CH2CH=), 39.7 (C),
31.5 (2 x SCH2), 26.1 (SCH2CH2), 25.7 (CH2CH20), and 25.7 (2 x CH3): (Z) isomer 
317-Z; 8h (400 MHz, CDC13) 6.38-6.33 (1H, m, CH2CH=), 4.32 (2H, t, J 7.4, CH20),
4.06 (1H, s, SCHS), 2.99-2.94 (4H, m, 2H from Ctf2CH20  and 2H from CH2CH=), 2.91- 
2.88 (4H, m, 2 x SCH2), 2.13-2.06 (1H, m, 1H from SCH2CH2), 1.88-1.77 (1H, m, 1H 
from SCH2C//2), and 1.13 (6H, s, 2 x CH3); 8C (100 MHz, CDC13) 170.0 (C=0), 140.0 
(CH2CH=), 125.9 (CH=C), 65.4 (CH20), 60.7 (SCHS), 39.6 (C), 37.4 (CH2CH=), 31.6 
(2 x SCH2), 29.7 (CH2CH20), 26.2 (SCH2CH2), and 25.3 (2 x CH3).
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317-E
C 1 3 H 2 0 O 2 S  2
Mol. Wt.: 272.43
312
Ci0H14O3 
Mol. Wt.: 182.22
(£')-2,2-Dimethyl-4-(2-oxo-dihydro-furan-3-yIidene)-butyraldehyde 312
To a stirred solution of 317-Z? (117 mg, 0.43 mmol, 1 eq) in acetonitrile (4 ml) and 
distilled water (1 ml), was added CaCC>3 (129 mg, 1.28 mmol, 3 eq) and iodomethane 
(0.53 ml, 8.56 mmol, 20 eq). The mixture was refluxed for 20 h and then allowed to cool 
before filtration through a short column of silica gel (eluting with 50% EtOAc in hexane). 
Concentration in vacuo gave aldehyde 312 (80 mg, 0.43 mmol, 100%) as a clear yellow 
oil which was stored at —20°C under nitrogen, and used without further purification: 
Vmax (neatycm' 1 2969s, 2930s, 2873s, 2816m, 2712m, 1752s, 1725s, 1681s, 1366m, 
1354m, 1214s, and 1034s; 5H (400 MHz, CDC13) 9.49 (1H, s, CHO), 6.71 (1H, tt, J 7.9,
3.0, CH2CH=), 4.39 (2H, t, 77.4, CH2Ctf20), 2.92-2.87 (2H, m, Ctf2CH20), 2.35 (2H, d, 
J 7.9, CH2CH=), and 1.15 (6H, s, 2 x CH3); 5C (100 MHz, CDC13) 204.6 (CHO), 170.9 
(C=0), 135.4 (CH2CH=), 128.3 (CH=C), 65.6 (CH2CH20), 46.5 (C), 37.2 (CH2CH=), 
25.4 (CH2CH20 ) and 21.7 (2 x CH3); m/z (Cl mode, isobutane) 183 (100%), 169 (3), 165 
(2), 154 (2), 121 (1), and 99 (1) (Found (M + H)+, 183.1019. Q 0H15O3 requires M, 
183.1017).
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312
1^0^ 14^ 3
Mol. Wt.: 182.22
318a
C10H16O3 
Mol. Wt.: 184.23
318b
c 10h 16o 3
Mol. Wt.: 184.23
rel-(3R)-(rel-(lR, 2/?)-2-Hydroxy-3,3-dimethyl-cyclobutyl)-dihydro-furan-2-one 318a 
and rel-(3S)-(rel-(lR , 2Z?)-2-Hydroxy-3,3-dimethyl-cycIobutyl)-dihydro-furan-2-one 
318b
To a stirred solution of Sml2 (0.1M in THF, 11.8 ml, 1.18 mmol, 2 eq) in CH3OH (2.94 
ml) at 0°C was added dropwise a solution of aldehyde 312 (108 mg, 0.59 mmol, 1 eq) in 
THF (1.5 ml). After 0.5 h, another quantity of Sml2 (0.1 M in THF, 2.96 ml, 0.30 mmol, 
0.5 eq) was added and the reaction stirred for a further 1 h. To the reaction mixture was 
then added aqueous saturated NaCl (5 ml) and citric acid (310 mg, 1.48 mmol, 2.5 eq). 
The aqueous layer was separated and extracted with 80% EtOAc in hexane (4 x 30 ml) 
and the combined organic layers dried (MgS04). Concentration in vacuo gave crude 318 
as a red oil. Purification of the residue by column chromatography (eluting with 50% 
EtOAc in hexane) gave 3{R/S)-{rel-{\R, 2/?)-2-hydroxy-3,3-dimethyl-cyclobutyl)- 
dihydro-furan-2-one (86 mg, 0.47 mmol, 79%) as a 4:1 mixture of diastereoisomers; vmax 
(soln. in CH C^/cm ' 1 3548m, 3025s, 2961s, 2925s, 2867s, 1762s (C=0), 1375s, 1216s, 
1105s, and 1028s; m/z (Cl mode, isobutane) 185 (41%), 167 (100), 149 (1), 128 (3), and 
113 (2) (Found (M + H)+, 185.1178. C10H17O3 requires M, 185.1173). The epimers were 
separated by further chromatography (eluting with 50% EtOAc in hexane): major 
cyclobutanol 318a; 8H (400 MHz, CDCI3) 4.40 (1H, td, J  8.8, 2.6, 1H from CH2Ctf20), 
4.27-4.20 (1H, m, 1H from CH2C//20), 3.76 (1H, d, J  7.7, CffOH), 2.81 (1H, br s,
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CHOH), 2.60 (1H, q, J  9.6, CHC(O)O), 2.38-2.30 (1H, m, 1H from CH2CH20), 2.23-
2.14 (1H, m, CH), 1.99-1.88 (1H, m, 1H from CH2CH20), 1.71 (1H, apparent t, 79.9, 1H 
from CH2), 1.16 (1H, obscured, 1H from CH2), 1.13 (3H, s, CH3), and 1.12 (3H, s, CH3); 
6C (100 MHz, CDCI3) 180.0 (C=0), 78.1 (CHOH), 67.6 (CH2CH20), 44.0 (CHC02),
41.6 (CH), 38.8 (C), 32.4 (CH2), 28.8 (CH3), 27.7 (CH2CH20), 21.0 (CH3); minor 
cyclobutanol 318b; 5H (400 MHz, CDCI3) 4.33 (1H, dt, J 8.7, 4.2, 1H from CH2CH20), 
4.26-4.19 (1H, m, 1H from CU2CH20), 3.78 (1H, d, J  8.0, CHOH), 2.66 (1H, apparent q, 
J 8.5, CHC(O)O), 2.43-2.28 (2H, m, 1H from CH2CH20  and 1H from CCH2CH), 2.17-
2.05 (1H, m, 1H from Ctf2CH20), 1.82 (1H, apparent t, J  10.3, 1H from CCH2CH), 1.20 
(1H, app. t, J  10.3, 1H from CCH2CH) and 1.09 (6H, s, C(CH3)2); 6C (100 MHz, CDC13)
178.7 (C=0), 77.0 (CHOH), 66.9 (CH2CH20), 42.2 (CHC(O)O), 41.5 (CCH2CH), 39.2 
(C(CH3)2), 32.1 (CCH2CH), 28.3 (CH3), 27.2 (CH2CH20 ) and 20.7 (CH3).
(Z)-2,2-Dimethyl-4-(2-oxo-dihydro-furan-3-ylidene)-butyraIdehyde 319
To a stirred solution of 317-Z (246 mg, 0.90 mmol, 1 eq) in acetonitrile (5.6 ml) and 
distilled water (1.4 ml) was added CaC03 (271 mg, 2.71 mmol, 3 eq) and iodomethane 
(1.13 ml, 18.1 mmol, 20 eq). The mixture was then heated at reflux for 19 h before a 
further quantity of iodomethane (0.28 ml, 4.52 mmol, 5 eq) was added. The reaction was 
left for another 5 h and then allowed to cool to room temerature before being poured onto 
a short column of silica gel and eluted with 50% EtOAc in hexane. Concentration in
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vacuo gave the aldehyde 319 (147 mg, 0.81 mmol, 90%) as a clear pale yellow oil which 
was used without further purification: Dmax (neatycm' 1 2969s (C-H), 2930s (C-H), 2873s, 
2816m (CHO), 2712m (CHO), 1752s (lactone C=0), 1725s (aldehyde C=0), 1681s 
(C=C), 1366m (C(CH3)2), 1354m (C(CH3)2), 1214s, 1034s; 5H (400 MHz, CDC13) 9.48 
(1H, s, CHO), 6.17 (1H, t, 7 7.9, CH2Ctf=), 4.33 (2H, t, 77.3, CH20), 2.97-2.92 (4H, m, 
2H from C/72CH20  and 2H from CT/2CH=) and 1.13 (6H, s, C(CH3)2); 6C (100 MHz, 
CDC13) 205.5 (CHO), 170.1 (C=0), 138.4 (CH=C), 126.5 (CH=C), 65.5 (CH20), 46.8 
(C(CH3)2), 34.1 (CH2CH=), 29.3 (CH2CH20) and 21.5 (C(CH3)2); m/z (CI+ mode, 
isobutane) 183 (100%), 165 (6), 153 (7), 101 (3), 81 (6) and 69 (12) (Found (M + H)+, 
183.1021. CiqHi503 requires M, 183.1017).
OH
320a
Ci0Hi6O3 
Mol. Wt.: 184.23
OH
320b
Ci0Hi6O3 
Mol. Wt.: 184.23
Cyclisation of (Z)-2,2-Dimethyl-4-(2-oxo-dihydro-furan-3-ylidene)-butyraldehyde 
319
To a stirred solution of Sml2 (0.1M in THF, 4.70 ml, 0.47 mmol, 2 eq) in CH3OH (1.17 
ml) at 0°C was added dropwise a solution of aldehyde 319 (43 mg, 0.23 mmol, 1 eq) in 
THF (0.6 ml). After 10 min, another quantity of Sml2 (0.1 M in THF, 2.30 ml, 0.23
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mmol, 1 eq) was added and the reaction stirred for a further 1 h. To the reaction mixture 
was then added aqueous saturated NaCl (2 ml) and citric acid (148 mg, 0.70 mmol, 3 eq). 
The aqueous layer was separated and extracted with 80% EtOAc in hexane (4 x 1 5  ml) 
and the combined organic layers dried (MgS04). Concentration in vacuo gave the crude 
product mixture as a red oil. Purification of the residue by column chromatography 
(eluting with 50% EtOAc in hexane) gave an approximately 2:1:2:1 mixture of 
compounds 318a:318b:320a:320b (29 mg, 0.16 mmol, 68% (combined yield)). 
Elucidation of the product mixture was achieved by the preparation of bicyclic lactones 
320a and 320b by an independent method (vide infra).
.OH
318b 331
C10Hi6O3 c 10h 14o 3
Mol. Wt.: 184.23 Mol. Wt.: 182.22
reZ-(3SMre/-(lK)-3,3-Dimethyl-2-oxo-cycIobutyl)-dihydrofuran-2(3H)-one 331
To a stirred solution of cyclobutanol 318b (70 mg, 0.38 mmol, 1 eq) in CH2C12 (3.8 ml) at 
room temperature was added 4A molecular sieves, NMO (177 mg, 1.51 mmol, 4 eq), and 
TPAP (7 mg, 0.02 mmol, 0.05 eq). After 5 h, the reaction mixture was poured onto a 
short column of silica gel and eluted with 50% EtOAc in Pet. Ether (40-60°C). 
Concentration in vacuo gave the cyclobutanone 331 (67 mg, 0.37 mmol, 97%) as a clear 
colourless oil: \)max (CHC13 soln.ycnr1 3028s (C-H), 2949s (C-H), 2875s (C-H), 1756s 
(lactone C=0), 1709s (ketone C=0), 1656m, 1530m, 1467m, and 1367m; 8H (400 MHz, 
CDC13) 4.37 (1H, td, J  8.8, 2.9, lH from CH 20), 4.21 (1H, dt, J  9.3, 6.7, lH from C H 20), 
3.66-3.60 (1H, m, CCH2Ctf), 2.89-2.82 (1H, m, CHC(0 )0 ), 2.49-2.41 (1H, m, 1H from 
CH2CH20), 2.18 (1H, apparent t, J  11.2, 1H CCtf2CH), 2.15-2.04 (1H, m, 1H from
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C//jCH,0), 1.78 (1H, dd, J  11.2, 8.4, 1H from CCtf2CH), 1.27 (3H, s, CH3) and 1.19 
(3H, s, CH3); 8C (100 MHz, CDCI3) 214.4 (C=0, ketone), 177.2 (C=0, ester), 67.0 
(CH20 ), 58.5 (C(CH3)2), 54.2 (CCH2CH), 39.6 (CHC(O)O), 31.5 (CCH2CH), 27.3 
(CH2CH20), 24.1 (CH3) and 21.9 (CH3); m/z (CI+ mode, isobutane) 182 (22%), 154 (9), 
126 (27), 111 (12), 83 (36), 70 (100) and 41 (21) (Found M+, 182.0943. C10H14O3 
requires M, 182.0939).
331
1^0^ 14^ 3
Mol. Wt.: 182.22
OH
320b
Ci0Hi6O3 
Mol. Wt.: 184.23
rel-(lS , 4S, 5/?)-4-(2-Hydroxy-ethyl)-7,7-dimethyl-2-oxa-bicyclo[3.2.0]heptan-3-one 
320b
To a stirred solution of cyclobutanone 331 (22 mg, 0.12 mmol, 1 eq) in THF (0.5 ml) at 
—78°C was added L-Selectride (1.0 M in THF, 0.13 ml, 0.13 mmol, 1.1 eq) dropwise. 
After 1 h, aqueous saturated NaHCC>3 (1 ml) was added and the aqueous layer separated 
and extracted with EtOAc (4 x 10 ml). The combined organic layers were dried (MgS04) 
and concentrated in vacuo to give the crude as a clear colourless oil. Purification by 
column chromatography (eluting with 60% EtOAc in Pet. Ether (40-60°C)) gave bicyclic 
lactone 320b (20 mg, 0.11 mmol, 88%) as a clear colourless oil: Dmax (CHCI3 soln.ycm' 1
3681s (O-H), 3020s (C-H), 2959s (C-H), 2869s (C-H), 1761s (C=0), 1520s, 1425s, 
1021s and 932s; 8H (400 MHz, CDCI3) 4.44 (1H, dd, J  5.2, 3.0, HCOC(O)), 3.83-3.77 
(1H, m, 1H from Ctf2OH), 3.70-3.64 (1H, m, 1H from CH2OH), 3.24-3.17 (1H, m, 
CCH2CH), 2.85-2.79 (1H, apparent q, /  8.0, CHC(O)O), 2.11-2.01 (1H, m, 1H from 
O 72CH20H), 1.87-1.76 (1H, m, 1H from CCH2CH), 1.73-1.65 (2H, m, 1H from 
CH2CH2OH and 1H from CCtf2CH), 1.23 (3H, s, CH3) and 1.13 (3H, s, CH3); 8C (100
163
MHz, CDCI3) 199.1 (C=0), 85.1 (CHOC(O)), 61.4 (CH2OH), 41.1 (CHCO), 38.3 
(C(CH3)2), 33.3 (CCH2CH), 33.2 (CCH2CH), 29.0 (CH2CH2OH), 26.4 (CH3) and 22.4 
(CH3); m/z (CI+ mode, isobutane) 185 (100%), 167 (8), 128 (2) and 111 (2) (Found (M + 
H)+, 185.1176. Cl0Hl7O3 requires M, 185.1173).
1^0^ 16^ 3
Mol. Wt.: 184.23
...u °
'1 0  14 3
Mol. Wt.: 182.22
re/-(3/?Mre/-(lK)-3,3-Dimethyl-2-oxo-cyclobutyI)-dihydrofuran-2(3//)-one 329
To a stirred solution of 318a (101 mg, 0.55 mmol, 1 eq) in CH2CI2 (5.5 ml) at room 
temperature was added 4A molecular sieves (10 mg), NMO (256 mg, 2.19 mmol, 4 eq), 
and TPAP (16 mg, 0.05 mmol, 0.09 eq). After 4 h the reaction mixture was filtered 
through a short column of silica gel (eluting with 50% EtOAc in Pet. Ether (40-60°C)). 
Concentration in vacuo gave cyclobutanone 329 (100 mg, 0.55 mmol, 100%) as a clear 
colourless oil: \)max (CHC13 soln.ycm' 1 3028s (C-H), 2949s (C-H), 2875s (C-H), 1756s 
(lactone C=0), 1709s (ketone C=0), 1656m, 1530m, 1467m, and 1367m; 8h (400 MHz, 
CDCI3) 4.41 (1H, td, J  8.9, 1.9, 1H from CH20), 4.24-4.18 (1H, m, 1H from CH20), 
3.98-3.92 (1H, m, CCH2CH), 3.00-2.94 (1H, m, CHC(O)), 2.39-2.32 (1H, m, 1H from 
CH2CH20), 2.19-2.08 (1H, m, 1H from CH2CH20), 2.05 (1H, t, J  11.0, 1H from 
CCH2CH), 1.91-1.86 (1H, m, 1H from CC/72CH), 1.30 (3H, s, 3H from C(CH3)2), and 
1.16 (3H, s, 3H from C(CH3)2); 5C(100 MHz, CDC13) 214.8 (C=0 of ketone), 177.5 
(C=0 of lactone), 66.8 (CH20), 58.1 (C(CH3)2), 53.7 (CCH2CH), 37.7 (CHC(O)), 28.7 
(CCH2CH), 26.1 (CH2CH20), 24.0 (CH3), and 21.2 (CH3); m/z (EI+ mode) 182 (26%),
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154 (11), 126 (35), 111 (12), 82 (35), 70 (100), and 41 (27) (Found M+, 182.0943. 
C10H14O3 requires M, 182.0939).
rel~(lS, 4R , 5/?)-4-(2-Hydroxy-ethyl)-7,7-dimethyl-2-oxa-bicyclo[3.2.0]heptan-3-one 
320a
To a stirred solution of cyclobutanone 329 (22 mg, 0.12 mmol, 1 eq) in THF (0.5 ml) at 
—78°C was added L-Selectride (1.0 M in THF, 0.14 ml, 0.14 mmol, 1.1 eq) dropwise. 
After 1 h, aqueous saturated NaHCC>3 (0.5 ml) was added and the aqueous layer 
separated and extracted with EtOAc (4 x 1 0  ml). The combined organic layers were dried 
(MgS04) and concentrated in vacuo to give a colourless cloudy oil. Purification by 
column chromatography (eluting with 60% EtOAc in Pet. Ether (40-60°C)) gave bicyclic 
lactone 320a (13 mg, 0.07 mmol, 59%) as a clear colourless oil: \)max (CHCI3 soln.ycm' 1 
3619s (O-H), 3149s, 2959s (C-H), 2931s (C-H), 2863s (C-H), 1755s (C=0), 1637m, 
1559m, 1464s, 1380s, 1167s and 1094s; 5H (400 MHz, CDCI3) 4.50-4.48 (1H, dd, 7 5.8,
2.6, HCOC(O)), 3.84-3.71 (2H, m, C //2OH), 2.85-2.79 (1H, m, CCH2CH), 2.65 (1H, dt, 
7 7.4, 1.4, CHC(O)O), 2.10-2.04 (1H, m, 1H from CC//2CH), 1.92-1.74 (2H, m, 
CH2CH2OH), 1.63-1.58 (1H, dd, 7 12.2, 6.8, 1H from CC//2CH), 1.20 (3H, s, CH3) and 
1.15 (3H, s, CH3); 5c (100 MHz, CDCI3) 181.8 (C=0), 85.6 (CHOC(O)), 60.5 (CH2OH),
44.9 (CHCO), 39.0 (C(CH3)2), 38.7 (CCH2CH), 34.6 (CCH2CH), 34.5 (CH2CH2OH),
27.0 (CH3) and 22.6 (CH3); m/z (CI+ mode, isobutane) 185 (100%), 167 (21), 149 (2), 
139 (1), 128 (4), 110 (2), 95 (1) and 83 (1) (Found (M + H)+, 185.1178. C10H17O3 requires 
M, 185.1173).
Mol. Wt.: 182.22
329 320a
c 10h 16o 3
Mol. Wt.: 184.23
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Mol. Wt.: 182.22
1^1^ 18^ 3
Mol. Wt.: 198.26
rel-(lS , 4R , 5/?)-4-(2-HydroxyethyI)-l,7,7-trimethyl-2-oxa-bicyclo[3.2.0]heptane-3- 
one 330
Method A-using MeMgBr.
To a stirred solution of cyclobutanone 329 (18 mg, 0.10 mmol, 1 eq), in THF (0.5 ml) at 
—78°C was added MeMgBr (3.0 M in Et20, 0.04 ml, 0.12 mmol, 1.2 eq) dropwise. The 
reaction mixture was allowed to stir at this temperature for 2 h before a further quantity 
of MeMgBr (3.0 M in Et20, 0.04 ml, 0.12 mmol, 1.2 eq) was added. After another 1 h, 
aqueous saturated NH4CI (1 ml) was added and the aqueous layer separated and extracted 
with EtOAc (4 x 10 ml). The combined organic layers were dried (MgSOzO and 
concentrated in vacuo to give crude 330 as a clear colourless oil. Purification of the 
residue by column chromatography (eluting with 50% EtOAc in hexane) gave the pure 
bicyclic lactone 330 (6 mg, 0.03 mmol, 29%) as a clear colourless oil.
Method B-using MeLi
To a stirred solution of cyclobutanone 329 (27 mg, 0.15 mmol, 1 eq), in THF (0.8 ml) at 
—78°C was added MeLi.LiBr (1.26 M in Et20, 0.14 ml, 0.18 mmol, 1.2 eq) dropwise. 
The reaction mixture was allowed to stir at this temperature for 2 h before aqueous 
saturated NH4CI (1 ml) was added and the aqueous layer separated and extracted with 
EtOAc (4 x 1 0  ml). The combined organic layers were dried (MgS04) and concentrated 
in vacuo to give a cloudy colourless oil. Purification of the residue by column
166
chromatography (eluting with 50% EtOAc in hexane) gave the pure bicyclic lactone 330 
(0.5 mg, 0.003 mmol, 2%) as a clear colourless oil and cyclobutanone 329 (6.3 mg, 0.03 
mmol, 28%).
Method C-using ‘MeLi-CeCl3’
CeCl3.7H20 (49 mg, 0.13 mmol, 1.3 eq) was dried at 140°C, 0.1 mmHg for 2 h. The 
resultant white powder was then allowed to cool, THF (0.5 ml) added, and the resulting 
solution stirred for 30 min before being cooled to —78°C. MeLi.LiBr (1.26 M in Et20, 
0.1 ml, 0.13 mmol, 1.3 eq) was then added dropwise and the reaction mixture left for a 
further 45 min. A solution of cyclobutanone 329 (18 mg, 0.10 mmol, 1 eq) in THF (0.2 
ml) was then added via cannula and the reaction mixture left to stir at that temperature for 
2 h. Aqueous saturated NH4CI (1 ml) was then added and the aqueous layer separated and 
extracted with CHCI3 (4 x 10 ml). The combined organic extracts were dried (MgS04) 
and concentrated in vacuo. Purification of the residue by column chromatography 
(eluting with 50% EtOAc in hexane) gave the pure fused lactone 330 (7 mg, 0.04 mmol, 
53%). [Yield based on recovered starting material].
Method D-using “MeLi-Yb(OTf)3”
To a stirred solution of dried Yb(OTf)3 (185 mg, 0.30 mmol, 2 eq) in THF (7.2 ml) at 
—78°C was added MeLi.LiBr (1.26 M in THF, 0.24 ml, 0.30 mmol, 2 eq) and the 
mixture left for 40 min. The intensely coloured burgandy solution was then added 
dropwise via cannula to a stirred solution of cyclobutanone 329 (27 mg, 0.15 mmol, 1 eq) 
in THF (0.4 ml) also at —78°C. After 35 min, aqueous saturated NaHCC>3 (1 ml) was 
added and the aqueous layer separated and extracted with CHCI3 (4 x 15 ml), dried 
(MgSC>4) and concentrated in vacuo to give a clear, colourless oil. Purification by column 
chromatography (eluting with 50% EtOAc in Pet. Ether (40-60°C)) gave the pure bicyclic 
lactone 330 as a clear colourless oil (20 mg, 0.10 mmol, 68%): \)max (CHCI3 soln.)/cm_1
167
3685s (O-H), 3028s, (C-H), 2959s (C-H), 2933s (C-H), 2870m (C-H), 1750s (C=0), 
1519s, 1477s and 1425s; 8H (400 MHz, CDCI3) 3,86-3.74 (2H, m, CH2OH), 2.66 (1H, t, 
J  7.7, CHCO), 2.55 (1H, td, J  8.0, 1.0, CCH2Ctf), 2.02 (1H, dd, J  12.2, 8.0, 1H from 
CCtf2CH), 1.93-1.85 (1H, m, 1H from Ctf2CH2OH), 1.83-1.74 (1H, m, 1H from 
Ctf2CH2OH), 1.54 (1H, dd, J  12.2, 8.0, 1H from CCH2CH), 1.36 (3H, s, CH3C), 1.15 
(3H, s, 3H from C(CH3)2), and 1.04 (3H, s, 3H from C(CH3)2); 8C (100 MHz, CDC13)
181.0 (C=0), 92.3 (COC(O)), 77.4 (C(CH3)2), 60.8 (CH2OH), 46.3 (CHCO), 40.9 
(CCH2CH), 38.1 (CCH2CH), 35.4 (CH2CH2OH), 25.8 (CH3), 22.4 (CH3), and 19.7 
(CH3C); m/z (CI+ mode, isobutane) 199 (100%), 181 (18), 155 (4), 142 (5), 115 (15), 
and 69 (3) (Found (M + H)+, 199.1334. Cu Hi90 3 requires M, 199.1329).
OH
330
1^1^ 18^ 3
Mol. Wt.: 198.26
334 NO,
Mol. Wt.: 347.36
/7-N itro  benzoic ac id -2 -(re /-(lS , 4R  , 5/?)-l,7,7-trimethyI-2-oxa-3-oxo-
bicyclo[3.2.0]hept-4-yl)ethyl ester 334
To a stirred solution of bicyclic lactone 330 (15 mg, 0.08 mmol, 1 eq) in pyridine (0.5 ml) 
at room temperature was added p-nitrobenzyl chloride (21 mg, 0.12 mmol, 1.5 eq) and 
the reaction mixture stirred at that temperature for 3.5 days. Aqueous saturated NaHCC>3 
(1 ml) was then added and the aqueous layer separated and extracted with CHCI3 (4 x 10 
ml). The combined organic layers were dried (MgSOzO and concentrated in vacuo to give 
crude 334 as a yellow solid (23 mg, 0.07 mmol, 88%). Recrystallisation from EtOH gave 
white crystals suitable for crystallographic analysis (mp 146-147°C): a)max (CDCI3
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soln.ycm 1 3154s, 2980s (C-H), 2933s (C-H), 2902s (C-H), 2870m (C-H), 1756s (C=0, 
lactone), 1724s (C=0, ester), 1646m, 1614m, 1567m (NO2), 1530s (NO2) and 1383s 
(NO2); 6h (400 MHz, CDCI3) 8.31-8.29 (2H, apparent d, J  8.8, 2 x ArH), 8.22-8.20 (2H, 
apparent d, J  8.8, 2 x ArH), 4.56-4.46 (2H, m, CH2O), 2.66-2.58 (2H, m, 1H from COCH 
and 1H from CCH2C/f), 2.24-2.16 (1H, m, 1H from C772CH2OH), 2.08-1.96 (2H, m, 1H 
from CCH2CB and 1H from CH2CH2OH), 1.55 (1H, dd, J  12.2, 7.0, 1H from CC772CH), 
1.37 (3H, s, CH3COC(0)), 1.16 (3H, s, 3H from C(CH3)2), and 1.06 (3H, s, 3H from 
C(CH3)2); 5c (100 MHz, CDC13) 179.5 (C=0, lactone), 164.5 (C=0, ester), 150.6 (ArC),
135.4 (ArC), 131.0 (2 x ArCH), 123.8 (2 x ArCH), 91.8 (CCH3), 63.4 (CH2CH20), 46.0 
(CHCO), 41.0 (C(CH3)2), 40.2 (CCH2CH), 38.1 (CCH2CH), 31.4 (CH2CH20 ), 25.8 
(CCH3), 22.5 (C(CH3)2) and 19.8 (C(CH3)2); m/z (CI+ mode, isobutane) 348 (100%), 
318 (6), 291 (2), 181 (5), 163 (2) and 150 (2) (Found (M + H)+, 348.1450. C18H2206N 
requires M, 348.1441) (Found: C, 62.29; H, 6.10; N, 3.91. C l8H2l0 6N requires, C, 62.24; 
H, 6.09; N, 4.03%).
...
329
C 1 0 H 1 4 O 3
Mol. Wt.: 182.22
OH
335
Ci2Hi803
Mol. Wt.: 210.27
rel-(lS , 4R, 5/?)-4-(2-Hydroxyethyl)-7,7-dimethyl-l-vinyl-2-oxa-bicyclo[3.2.0]heptan-
3-one 335
To a stirred solution of Yb(OTf)3 (359 mg, 0.58 mmol, 3.2 eq) in THF (14 ml) at —78°C 
was added vinylmagnesium bromide (1.0 M in THF, 0.58 ml, 0.58 mmol, 3.2 eq) and the 
mixture left for 15 min. Half of the orange coloured solution (7ml, 0.29 mmol, 1.6 eq) 
was then added dropwise via cannula to a stirred solution of cyclobutanone 329 (33 mg,
169
0.18 mmol, 1 eq) in THF (0.4 ml) also at —78°C. After 20 min, the remaining 
vinylytterbium (7 ml, 0.29 mmol, 1.6 eq) was added to the reaction mixture and the 
reaction left for another 20 min. Aqueous saturated NaHCC>3 (2 ml) was then added 
followed by citric acid (122 mg, 0.58 mmol, 3.2 eq). The aqueous layer was separated 
and extracted with EtOAc (4 x 20 ml), dried (MgS04) and concentrated in vacuo. The 
residue was then purified by column chromatography (eluting with 20% EtOAc in 
CH2CI2) to give the bicyclic lactone 335 (26 mg, 0.12 mmol, 67%) as a clear colourless 
oil: Umax (CDCI3 soln.ycnr1 3685s (O-H), 3022s (C-H), 2959s (C-H), 2933m (C-H), 
2870m (C-H), 1756s (C=0), 1604m (C=C), 1519s, 1425s and 1335m; 5H (400 MHz, 
CDCI3) 6.02 (1H, dd, J  17.3, 11.0, CH=CH2), 5.34 (1H, d, J 17.3, trans 1H from 
CH=CH2), 5.23 (1H, d, J  11.0, cis 1H from CH=CH2), 3.80-3.72 (2H, m, CH2OH), 2.83 
(1H, apparent t, J 8.2, CCH2CH), 2.67 (1H, t, J  7.8, CHCO), 2.01 (1H, dd, J  12.0, 8.8, 1H 
from CCH2CH), 1.86-1.68 (2H, m, Ctf2CH2OH), 1.57 (1H, dd, J  12.0, 7.6, 1H from 
CCH2CH), 1.15 (3H, s, CH3) and 1.06 (3H, s, CH3); 6C (100 MHz, CDCI3) 180.6 (C=0),
134.4 (CH=CH2), 116.5 (CH=CH2), 93.2 (COC(O)), 60.7 (CH2OH), 45.5 (CHCO), 42.3 
(C(CH3)2), 39.3 (CCH2CH), 37.4 (CCH2CH), 34.5 (CH2CH2OH), 26.1 (CH3) and 22.3 
(CH3); m/z (CI+ mode, isobutane) 211 (100%), 193 (17), 167 (5), 154 (7), 136 (3), 115 
(9), 107 (2) and 79 (2) (Found (M + H)+, 211.1334. Q 2H 19O3 requires M, 211.1329).
336 337
C5H10O C5 H9Br
Mol. Wt.: 86.13 Mol. Wt.: 149.03
4-Bromo-2-methvl-l-butene 337167
To a stirred solution of 4-hydroxy-2-methyl-but-l-ene 336 (5.05 ml, 50.0 mmol, 1 eq) 
and triphenylphosphine (14.4 g, 55.0 mmol, 1.1 eq) in CH2C12 (15 ml) at 0°C, was added
170
iV-bromosuccinimide (9.79 g, 55.0 mmol, 1.1 eq) slowly over 10 min. After 1 h the 
purple coloured reaction mixture was allowed to warm to room temperature and left to 
stir at that temperature for a further 15 h. The mixture was then diluted with pentane (30 
ml) and passed through a short column of silica gel, eluting with pentane. After 
concentration in vacuo, the resultant oil was distilled under reduced pressure (29°C/water 
pump pressure) to give the title compound 337 (3.60g, 24.2 mmol, 48%) as a clear 
colourless oil: 8h (400 MHz, CDCI3) 4.87 (1H, apparent s, 1H from =CH2), 4.79 (1H, 
apparent s, 1H from =CH2), 3.49 (2H, t, J 1.4, CH2Br), 2.59 (2H, t, J  7.4, C //2CH2Br) and 
1.76 (3H, s, CH3).
. . . l y
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C 1 0 H 1 4 O 3
Mol. Wt.: 182.22
OH
338
C 1 5 H 2 4 Q 3
Mol. Wt.: 252.35
reUilS, 4R, 5/f)-4-(2-HydroxyethyI)-l-[3-methyl-but-3-enyl]-7,7-dimethyl-2-oxa- 
bicyclo[3.2.0]heptan-3-one 338
To a stirred solution of Yb(OTf)3 (170 mg, 0.27 mmol, 2 eq) in THF (6 ml) at —78°C 
was added 3-methyl-3-butenylmagnesium bromide (1.0 M in THF, 0.41 ml, 0.41 mmol, 3 
eq) dropwise and the mixture left for 15 min. After that time a solution of cyclobutanone 
329 (25 mg, 0.14 mmol, 1 eq) in THF (2.5 ml) also at —78°C was added to the lilac 
coloured mixture. The reaction mixture was left at that temperature for 3 h before 
aqueous saturated NaHCC>3 (1 ml) was added followed by citric acid (58 mg, 0.27 mmol,
3.2 eq). The aqueous layer was then separated and extracted with Et20 ( 4 x 1 5  ml) and 
the combined organic layers dried (MgSO.*) and concentrated in vacuo to give a cloudy, 
colourless oil. Purification by column chromatography (eluting with 40% EtOAc in Pet.
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Ether (40-60°C) gave bicyclic lactone 338 (23 mg, 0.09 mmol, 66%) as a clear colourless 
oil: u max (CDCI3 soln.)/cm-‘ 3616m (O-H), 3154 (O-H), 2965s (C-H), 2933s (C-H), 
2902s, 2865s, 1751s (C=0), 1651m (C=C), 1467s, 1383s and 1099s; 8H (400 MHz, 
CDCI3) 4.73 (1H, s, 1H from C=CH2), 4.69 (1H, s, 1H from C=CH2), 3.83-3.74 (2H, m, 
CH2OH), 2.66 (1H, t, J  7.9, CHCO), 2.53 (1H, apparent t, J  7.9, CCH2CH), 2.19-2.12 
(1H, m, 1H from CH2A), 2.06-1.88 (4H, m, 1H from CCH2CH, 1H from CH2CH20 ,  1H 
from CH2a and 1H from CH2B), 1.81-1.64 (2H, m, 1H from CH2CH20  and 1H from 
CH2b), 1.74 (3H, s, =CCH3), 1.51 (1H, dd, J  12.2, 6.9, 1H from CCH2CH), 1.22 (3H, s, 
CH3) and 1.11 (3H, s, CH3); 8C (100 MHz, CDCI3) 181.3 (C=0), 145.3 (C=CH2), 110.1 
(C=CH2), 93.9 (COC(O)), 61.0 (CH20), 46.4 (CHCO), 41.3 (C(CH3)2), 39.8 (CCH2CH),
38.3 (CCH2CH), 35.2 (CH2CH20 ), 33.2 (CH2B), 31.7 (CH2A), 25.5 (CH3), 23.7 (CH3) 
and 22.8 (=CCH3); m/z (CI+ mode, isobutane) 253 (100%), 235 (22), 196 (30), 179 (19), 
149 (14), 127 (10), 115 (15), 109 (4), 95 (4) and 81 (2) (Found (M + H)+, 253.1800. 
Ci5H250 3 requires M, 253.1797).
329
C10H14Q3 
Mol. Wt.: 182.22
PhO-
OH
339
2^0^ 26 O5S 
Mol. Wt.: 378.48
rel-(lR , 4R , 5/£)-l-(l-Benzenesulfonyl-but-3-enyl)-4-(2-hydroxy-ethyl)-7,7-dimethyl-
2-oxa-bicycIo[3.2.0]heptan-3-one 339
To a stirred solution of 3-butenyl phenyl sulfone (95 mg, 0.48 mmol, 3 eq) in THF (0.5 
ml) at —78°C was added n-butyllithium (2.5 M in hexanes, 0.19 ml, 0.48 mmol, 3 eq). 
After 25 min the golden coloured mixture was added via cannula to a stirred solution of 
Yb(OTf)3 (300 mg, 0.48 mmol, 3 eq) in THF (11.7 ml) also at —78°C. After a further 25
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min a portion of the orange organoytterbium (5.9 ml, 0.24 mmol, 1.5 eq) was added to a 
stirred solution of cyclobutanone 329 (29 mg, 0.16 mmol, 1 eq) in THF (0.36 ml) at the 
same temperature. After a further 35 min, another portion of the organoytterbium (5.9 ml,
0.24 mmol, 1.5 eq) was added to the reaction mixture. After 20 min aqueous saturated 
NaHCC>3 (2 ml) was added followed by citric acid (102 mg, 0.48 mmol, 3 eq). The 
aqueous layer was separated and extracted with Et20 (4 x 20 ml). The combined organic 
layers were dried (MgS04) and concentrated in vacuo. The residue was then purified by 
column chromatography (eluting with 40% EtOAc in Pet. Ether (40-60°C), gradually 
increased to 70% EtOAc in Pet. Ether (40-60°C)) which yielded bicyclic lactone 339 (3 
mg, 0.01 mmol, 5%) as a clear, colourless oil: Umax (CDCI3 soln.ycm' 1 3695m (O-H), 
3154s (O-H), 2984s (C-H), 2937m (C-H), 2902s (C-H), 1792s, 1786s (C=0), 1639m 
(C=C), 1557m (aryl-H), 1469s, 1381s (S02), 1304s, 1222s and 1093s (S 0 2); 6H (400 
MHz, CDCI3) 8.00-7.97 (2H, m, 2 x ArCH), 7.69-7.63 (1H, m, ArCH), 7.61-7.53 (2H, m, 
2 x ArCH), 5.79 (1H, ddt, J 17.1, 10.2, 6.4, CH= CH2), 5.09 (1H, dd, J 10.2, 1.2, cis 1H 
from CH=C//2), 4.72 (1H, dd, J  17.1, 1.2, trans 1H from CU=CH2), 3.85-3.71 (3H, m, 
2H from CH2OH and 1H from C //S02Ph), 2.94-2.90 (1H, m, CCH2CH), 2.71 (1H, td, J
7.7, 2.2, CHCO), 2.44-2.38 (1H, m, 1H from CH2CH=CH2), 2.29-2.23 (1H, m, 1H from 
CH2CH=CH2), 2.15 (1H, dd, J  12.5, 9.7, 1H from CCH2CU), 1.97-1.91 (1H, m, 1H from 
CH2CH2OH), 1.76-1.72 (1H, m, 1H from CH2CH2OH), 1.51-1.47 (1H, partially 
obscured, 1H from CCH2CU), 1.47 (3H, s, CH3) and 1.30 (3H, s, CH3); 6C (100 MHz, 
CDCI3) 180.1 (C=0), 139.1 (ArCH), 134.3 (CH=CH2), 134.0 (ArCH), 130.0 (2 x ArCH),
128.9 (2 x ArCH), 118.1 (CH=CH2), 91.9 (COC(O)), 67.9 (CHS02Ph), 61.2 (CH2OH),
47.0 (CHCO), 43.4 (C(CH3)2), 40.0 (CCH2CH), 38.7 (CCH2CH), 34.5 (CH2CH2OH),
30.4 (CH2CH=CH2), 27.2 (CH3) and 23.9 (CH3); m/z (CI+ mode, isobutane) 379 (83%), 
361 (60), 277 (7), 266 (8), 219 (100), 180 (48), 155 (8), 125 (18), 109 (9) and 81 (8) 
(Found (M + H)+, 379.1575. C2oH2705S requires M , 379.1572).
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341
Mol. Wt.: 182.22
C21 h 28o 4 
Mol. Wt.: 344.44
r e l - ( lR , 4R, 5/?)-4-(2-HydroxyethyI)-l-[l-(2-benzyloxyethyl)vinyl]-7,7-dimethyI-2- 
oxa-bicyclo[3.2.0]heptan-3-one 341
To a stirred solution of l-benzyloxy-3-bromo-but-3-ene 340 (102 mg, 0.42 mmol, 2.8 eq) 
in THF (1.4 ml) at —78°C was added te/t-butyllithium (1.48 M in pentane, 0.57 ml, 0.84 
mmol, 5.5 eq) slowly over 2 min. After 30 min the orange/brown solution was added 
dropwise to a stirred solution of Yb(OTf)3 (285 mg, 0.46 mmol, 3 eq) in THF (10 ml) 
also at —78°C. After a further 10 min, a solution of cyclobutanone 329 (28 mg, 0.15 
mmol, 1 eq) in THF (3.3 ml) at —78°C was added. After 1 h at —78°C, aqueous 
saturated NaHCC>3 (1 ml) was added followed by citric acid (97 mg, 0.46 mmol, 3 eq). 
The aqueous layer was separated and extracted with Et20 ( 4 x 1 5  ml) and the combined 
organic layers dried (MgS04) and concentrated in vacuo. Purification of the residue by 
column chromatography (eluting with 50% EtOAc in Pet. Ether (40-60°C) yielded 
bicyclic lactone 341 (28 mg, 0.08 mmol, 53%) as a clear colourless oil: Dmax (CDCI3 
soln.)/cm-' 3617m (O-H), 3154s (Ar C-H), 2981s (C-H), 2963s (C-H), 2901s (C-H), 
1758s (C=0), 1641m (C=C), 1604m, 1468s and 1382s; §H (400 MHz, CDCI3) 7.39-7.28 
(5H, m, 5 x ArCH), 5.15 (1H, s, 1H from C=CH2), 5.02 (1H, s, 1H from C=CH2), 4.55 
(AB system, 1H, d, J  11.9, 1H from PhC//2), 4.51 (AB system, 1H, d, J 11.9, 1H from 
PhCtf2), 3.83-3.71 (2H, m, CH2C772OH), 3.70-3.59 (2H, m, CCH2Ctf20 ), 3.02 (1H, 
apparent t, J  8.2, CCH2CH), 2.67 (1H, apparent t, J  7.9, CHCO), 2.51-2.44 (1H, m, 1H 
from CCH2CH2), 2.36-2.28 (1H, m, 1H from CCH2CH2), 1.94 (1H, dd, J 12.0, 8.2, 1H
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from CCff2CH), 1.87-1.66 (2H, m, C //2CH2OH), 1.51 (1H, dd, J  12.0, 8.2, 1H from 
CCH2CH), 1.15 (3H, s, CH3) and 1.02 (3H, s, CH3); 8C (100 MHz, CDC13) 180.2 (C=0),
143.4 (C=CH2), 138.5 (ArC), 128.6 (2 x ArCH), 127.9 (2 x ArCH), 127.8 (ArCH), 113.8 
(C=CH2), 96.8 (COC(O)), 73.1 (CH2Ph), 69.0 (CCH2CH20), 60.7 (CH2CH2OH), 45.8 
(CHCO), 41.5 (C(CH3)2), 37.1 (CCH2CH), 36.8 (CCH2CH), 34.3 (CH2CH2OH), 31.8 
(CCH2CH2), 25.5 (CH3) and 23.1 (CH3); m/z (CI+ mode, isobutane) 345 (13%), 327 
(13), 270 (11), 253 (20), 235 (49), 223 (19), 197 (22), 167 (11), 149 (11), 138 (16), 109 
(11) and 91 (100) (Found M+, 344.1989. C21H2804 requires M, 344.1980).
329
C10Hi4O3 
Mol. Wt.: 182.22
OH
343
2^0^ 36^ 4^
Mol. Wt.: 368.58
rel- ( 1R , 4R , 5 R ) - 1 - [ 3 - (terf-ButyI-dimethyl-siIanyloxy)-l-methylene-propyl]-4-(2- 
hydroxy-ethyl)-7,7-dimethyl-2-oxa-bicyclo[3.2.0]heptan-3-one 343
As for the preparation of 341, except l-tert-butyldimethylsiloxy-3-bromo-but-3-ene 342 
was used. Purification of the crude product mixture by column chromatography (eluting 
with 15% EtOAc in CH2C12) gave 343 as a white crystalline solid (20 mg, 0.05 mmol, 
26%): \)max (CDC13 soln.)/cm_1 3154s (O-H), 2954s (C-H), 2928s (C-H), 2902s (C-H), 
1761s (C=0), 1640s (C=C), 1604m, 1467s and 1383s; 6H (400 MHz, CDCI3) 5.13 (1H, s, 
1H from C=CH2), 5.01 (1H, s, 1H from C=CH2), 3.84-3.69 (4H, m, 2H from CH2OR and 
2H from CH2OSi), 3.01 (1H, apparent t, J 8.2, CCU2CH), 2.66 (1H, apparent t, /  7.9, 
CHCO), 2.37-2.30 (AB system, 1H, m, 1H from Gtf2CH2OSi), 2.26-2.18 (AB system, 
1H, m, 1H from CH2CH2OSi), 1.93 (1H, dd, J  12.0, 8.2, 1H from CCH2CH), 1.87-1.70 
(2H, m, C/72CH2OH), 1.50 (1H, dd, J  12.0, 8.2, 1H from CCH2CH), 1.16 (3H, s,
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C(CH3)2), 102 (3H, s, C(CH3)2), 0.89 (9H, s, C(CH3)3) and 0.06 (6H, s, Si(CH3)2); 6C 
(100 MHz, CDC13) 180.2 (C=0), 143.3 (C=CH2), 113.9 (C=CH2), 96.9 (COC(O)), 61.8 
(CH20), 60.7 (CH20), 45.9 (CHCO), 41.5 (C(CH3)2), 37.1 (CCH2CH), 36.8 (CCH2CH),
35.1 (CH2CH2OSi), 34.3 (C H 2CH2OH), 26.1 (C(CH3)3), 25.5 (C (C H 3)2), 23.1 
(C(CH3)2), 18.4 (C(CH3)3) and —5.1 (Si(CH3)2); m/z (CI+ mode, isobutane) 369 (16%),
351 (16), 311 (58), 283 (60), 255 (54), 227 (100), 219 (42), 183 (27), 145 (38), 133 (50), 
109 (46) and 75 (71) (Found (M + H)+, 369.2458. C20H37OSi requires M, 369.2451).
...L v °
Br
OTBDPS
329
C10H14O3
Mol. Wt.: 182.22
344
CajHasBrOSi 
Mol. Wt.: 389.40
OH
TBDPS
...
346
2^0^ 26®®’ 
Mol. Wt.: 310.51
329
C10H14O3 
Mol. Wt.: 182.22
3-(tert-Butyl-diphenyl-silanyl)-but-3-en-l-ol 346
As for the preparation of 341 except the vinyllithium was formed from \-tert-bwty\ 
diphenylsiloxy-3-bromo-but-3-ene 344. Purification of the crude product mixture by 
column chromatography (eluting with 20% EtOAc in Pet. Ether (40-60°C)) gave 
cyclobutanone starting material 329 (31mg, 0.17 mmol, 100%) and vinyl silane 346 (152 
mg, 0.49 mmol, 97%) as a white crystalline solid: v max (CHCI3 soln.)/cm-1 3616m (O-H), 
3022s (C-H), 2965s (C-H), 2949s (C-H), 2933s (C-H), 1604m (C=C), 1525s, 1472s, 
1367m (C(CH3)2) and 1335m (C(CH3)2); § h  (400 MHz, CDC13) 7.63-7.61 (4H, m, 4 x 
oArCH), 7.44-7.35 (6H, m, 4 x mArCH and 2 x /?ArCH), 6.06 (1H, d, J  2.6, 1H from 
C=CH2), 5.78 (1H, d, 7 2.6, 1H from C=CH2), 3.55 (2H, t, J  6.7, Ctf2OH), 2.47 (2H, t, J
6.7, CH2CH2OH), 1.32 (1H, bs, OH) and 1.17 (9H, s, C(CH3)3); 8C (100 MHz, CDC13)
143.4 (C=CH2), 136.4 (4 x oArCH), 134.5 (2 x ArC), 131.9 (C=CH2), 129.4 (2 x 
pArCH), 127.9 (4 x mArCH), 61.6 (CH2OH), 40.4 (CH2CH20), 28.8 (C(CH3)3) and 18.7
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(C(CH3)3); m/z (FAB+ mode, sodium) 333 (28%), 253 (73), 199 (100), 175 (33), 135 
(52) and 105 (15) (Found (M + Na)+, 333.1647. C20H26OSiNa requires M, 333.1644) 
(Found: C, 77.26; H 8.43. C20H26OSi requires C, 77.36; H, 8.44%).
Preparation of vinyl silane 346 in a test reaction
To a stirred solution of bromide 344 (117 mg, 0.30 mmol, 1 eq) in THF (9.4 ml) at 
—78°C was added terr-butyllithium (1.32 M in pentane, 0.46 ml, 0.60 mmol, 2 eq). After 
1.5 h aqueous saturated NaHC03 (1 ml) was added at —78°C and the aqueous layer 
separated and extracted with Et^O (4 x 10 ml). The combined organic layers were then 
dried (MgS04) and concentrated in vacuo to give the crude vinyl silane 346 as a cloudy 
colourless oil. No further purification was carried out.
OH
335
OTBDPS
353
Ci2Hi803 C28H3603Si
Mol. Wt.: 210.27 Mol. Wt.: 448.67
re/-(lS, 4R, 5/?)-4-(2-terf-butyIdiphenylsilyIoxyethyl)-7,7-dimethyl-l-vinyl-2-oxa- 
bicyclo[3.2.0]heptan-3-one 353
To a stirred solution of bicyclic lactone 335 (9 mg, 0.04 mmol, 1 eq) in DMF (0.2 ml) at 
rt was added imidazole (9 mg, 0.13 mmol, 3 eq) and TBDPSC1 (0.017 ml, 0.07 mmol, 1.5 
eq). After 4 days, a further quantity of imidazole (4 mg, 0.06 mmol, 1.5 eq) and 
TBDPSC1 (0.008 ml, 0.03 mmol, 0.75 eq) was added. The reaction mixture was stirred 
for a further 12 h before aqueous saturated NaHC03 (0.5 ml) was added and the aqueous 
layer extracted with 50% EtOAc in Pet. Ether (40-60°C). The combined organic extracts
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were dried (MgS04) and concentrated in vacuo to give a cloudy oil. Purification of the 
residue by column chromatography (eluting with 5% EtOAc in Pet. Ether 40-60°C) gave 
the bicyclic lactone 353 oil (14 mg, 0.03 mmol, 73%) as a clear colourless: X)max (CDCI3 
solnO/cm-1 3154s (C-H), 3072w (Ph-H), 2990s (C-H), 2961s (C-H), 2931s (C-H), 2902s, 
2861m, 1815s, 1792s, 1762s (C=0), 1645s (C=C), 1610m, 1563s, 1475s, 1387s 
(C(CH3)3), 1216s , 1169s  and 1099s (Si-O); 5H (400 MHz, CDC13) 7.67-7.63 (4H, m, 4 x 
ArCH), 7.47-7.37 (6H, m, 6 x ArCH), 5.95 (1H, dd, J  17.3, 11.0, C//=CH2), 5.27 (1H, 
dd, J  17.3, 1.3, trans 1H from CH=C//2), 5.16 (1H, dd, J  11.0, 1.3, cis 1H from 
CH=C//2), 3.80-3.74 (1H, m, 1H from CH2OH), 3.71-3.66 (1H, m, 1H from C //2OH), 
2.84 (1H, t, J  8.2, CCH2CH), 2.68 (1H, dd, J  10.3, 4.9, CHCO), 2.00-1.91 (2H, m, 1H 
from CH2CR2OH and 1H from CCH2CK), 1.60-1.52 (2H, m, 1H from CH2CH2OH and 
1H from CCH2CH), 1.11 (3H, s, CH3), 1.06 (9H, s, C(CH3)3) and 1.05 (3H, s, CH3); 6C 
(100 MHz, CDCI3) 180.5 (C=0), 135.7 (4 x ArCH), 134.5 (CH=CH2), 133.6 (2 x ArC),
129.9 (2 x ArCH), 127.9 (4 x ArCH), 116.3 (CH=CH2), 92.7 (COC(O)), 61.9 (CH20),
45.4 (CHCO), 42.1 (C(CH3)2), 38.3 (CCH2CH), 37.4 (CCH2CH), 34.2 (CH2CH2OH), 
27.0 (C(CH3)3), 26.1 (CH3), 22.3 (CH3) and 19.4 (C(CH3)3); m/z (CI+ mode, isobutane) 
449 (27%), 391 (30), 371 (100), 335 (7), 293 (4), 199 (6) and 107 (3) (Found (M + H)+, 
449.2513. C2gH3703Si requires M, 449.2502).
OTBDPS
353
OH
OTBDPS
354
C 28 H 3 6 0 3S i  C 28H 380 3S i
Mol. Wt.: 448.67 Mol. Wt.: 450.69
rel-(lS, 4R, 5/?)-4-(2-terf-butyldiphenyIsiIyloxyethyl)-7,7-dimethyl-l-vinyl-2-oxa-
bicyc!o[3.2.0]heptan-3-oI 354
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To a stirred solution of lactone 353 (39 mg, 0.09 mmol, 1 eq) in CH2CI2 (0.45 ml) at 
—78°C was added DIBAL-H (1.5 M in PhCH3, 0.076 ml, 0.11 mmol, 1.3 eq) dropwise. 
After 3.5 h aqueous saturated NaHC03 (1 ml) was added and the aqueous layer separated 
and extracted with CH2CI2 (3 x 10 ml) and dried (MgS04). Concentration in vacuo gave 
the clear colourless oil lactol 354 (34mg, 0.08 mmol, 86%) as a 2:1 mixture of 
diastereoisomers: Dmax (CDCI3 soln.)/cm_1 3602s (O-H), 3155s, 3071m, 2959s (C-H), 
2925s (C-H), 2903s (C-H), 2858s, 1816m, 1794s, 1643s (C=C), 1559s, 1464s, 1425m, 
1380s (C(CH3)3), 1212m, 1167m and 1094s (Si-O); 8H (400 MHz, CDCI3) 7.69-7.65 (8H, 
m, 4H from 4 x ArCH of major, 4H from 4 x ArCH of minor), 7.46-7.38 (12H, m, 6H 
from 6 x ArCH of major, 6H from 6 x ArCH of minor), 6.10 (1H, dd, 7 17.3, 10.8, 
CH=CH2 of minor), 5.97 (1H, dd, 7 17.2, 10.8, CH=CH2 of major), 5.69 (1H, dd, 7 6.6, 
5.0, CtfOH of minor), 5.50 (1H, dd, 7 3.7, 1.2, CHOU of major), 5.26 (1H, dd, 7 17.3, 
1.9, trans 1H from CH=C7f2 of minor), 5.18 (1H, dd, 7 17.2, 2.0, trans 1H from CU=CH2 
of major), 5.10 (1H, dd, 7 10.8, 1.9, cis 1H from CU=CH2 of minor), 5.03 (1H, dd, 7 
10.8, 2.0, cis 1H from CU=CH2 of major), 3.74-3.65 (4H, m, 2H from CH2O of major, 
2H from CH20  of minor), 3.08 (1H, d, 7 6.6, OH of minor), 2.93 (1H, d, 7 3.7, OH of 
major), 2.58-2.51 (2H, m, 1H from CCU2CH  of major, 1H from CCU2CH  of minor), 
2.37-2.25 (1H, m, 1H from C//CHOH of minor), 2.20 (1H, t, 7 7.7, CTTCHOH of major),
2.03 (1H, dd, 7 11.4, 7.6, 1H from CCH2CH of major), 1.87-1.79 (2H, m, 1H from 
Ci72CH2OH, 1H from CCH2CU both minor), 1.72 (1H, dd, 7 11.4, 9.0, 1H from 
CCH2CU of major), 1.68-1.59 (1H, m, 1H from CH2CU2OU of major), 1.52-1.41 (3H, 
m, 1H from CH2CU2OU of major, 1H from CH2CU2OU of minor, 1H from CCH2CU of 
minor), 1.06 (18H, s, 9H from C(CH3)3 of major, 9H from C(CH3)3 of minor), 1.07-1.05 
(9H, obscured singlets, 6H from C(CH3)2 of major, 3H from C(CH3)2 from minor) and
1.01 (3H, s, 3H from C(CH3)2 of minor); 5C (100 MHz, CDC13) 138.8 (CH= from minor), 
137.8 (CH= from major), 135.6 (8 x ArCH, 4C from major and 4C from minor), 133.8 (2 
x ArC from major), 133.5 (2 x ArC from minor), 129.7 (2 x ArCH from minor), 129.6 (2
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x ArCH from major), 127.7 (4 x ArCH from minor), 127.6 (4 x ArCH from major), 113.4 
(=CH2 from major), 113.3(=CH2 from minor), 107.7 (CHOH from major), 102.1 (CHOH 
from minor), 94.7 (COCH(OH) from major), 90.3 (COCH(OH) from minor), 62.9 (CH20  
from minor), 62.5 (CH20  from major), 49.5 (CHCH(OH) from major), 48.6 (CHCH(OH) 
from minor), 42.3 (CCH2CH from major), 41.5 (CCH2CH from minor), 40.4 (C(CH3)2 
from minor), 39.3 (C(CH3)2 from major), 37.1 (CCH2CH from minor), 36.4 (CCH2CH 
from major), 35.2 (CH2CH20  from major), 31.6 (CH2CH20  from minor), 28.7 (CH3 from 
major), 26.9 (C(CH3)3 from major), 26.8 (C(CH3)3 from minor and CH3 from minor),
23.4 (CH3 from minor), 22.5 (CH3 from major) and 19.2 (2 x C(CH3)3 1C from major and 
1C from minor); m/z (FAB+ mode, sodium) 473 (43%), 433 (64), 393 (13), 375 (7), 319 
(40), 259 (7), 239 (8), 199 (93), 177 (71), 135 (100), 107 (47), 94 (23) and 76 (17) 
(Found (M + Na)+, 473.2490. C28H3s03SiNarequires M, 473.2488).
OH
338
Ci5H2403 
Mol. Wt.: 252.35
355
c 15h 220 3
Mol. Wt.: 250.33
rel-(lS, 4 R , 5/?)-[7,7-Dimethyl-l-(3-methyl-but-3-enyl)-3-oxo-2-oxa-
bicyclo[3.2.0]hept-4-yl]-acetaldehyde 355
To a stirred solution of alcohol 338 (23 mg, 0.09 mmol, 1 eq) in CH2CI2 (1 ml) at 0°C 
was added 4A molecular sieves (5 mg), NMO (43 mg, 0.36 mmol, 4 eq), and TPAP (4 
mg, 0.01 mmol, 0.1 eq). After 2 h, the reaction mixture was allowed to warm to room 
temperature for 30 min before being filtered through a short column of silica gel (eluting 
with 40% EtOAc in Pet. Ether (40-60°C)). Concentration in vacuo gave aldehyde 355 (16
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mg, 0.06 mmol, 71%) as a colourless oil; v>max (CHCI3 soln.J/cm"1 3031s (C-H), 3015s 
(C-H), 2964m (C-H), 2863w (CHO), 1755s (C=0, lactone), 1733s (C=0, aldehyde), 
1649w (C=C), 1593w, 1419m and 1369m; 8h (400 MHz, CDCI3) 9.79 (1H, s, CHO), 
4.73 (1H, apparent s, 1H from C=CH2), 4.68 (1H, apparent s, 1H from C=CH2), 3.03-2.97 
(2H, m, 1H from Ctf2CHO and 1H from CHCHCO), 2.62 (1H, dd, J  11.2, 18.9, 1H from 
C/7,CHO), 2.44-2.40 (1H, m, CCH2CH), 2.17-1.96 (4H, m, 2H from CH2B, 1H from 
CH2a and 1H from CCH2CH), 1.73 (3H, s, CH3C=), 1.73-1.61 (1H, m, 1H from CH2A), 
1.58 (1H, dd, 7 6.5, 12.3, 1H from CCH2CH), 1.19 (3H, s, CH3) and 1.10 (3H, s, CH3); 5C 
(100 MHz, CDCI3) 198.7 (CHO), 179.9 (C=0, lactone), 145.1 (C=CH2), 110.3 (C=CH2),
93.5 (COC(O)), 46.0 (CH2CHO), 43.1 (CHCO), 41.2 (C(CH3)2), 39.6 (CCH2CH), 38.4 
(CCH2CH), 33.0 (CH2a), 31.7 (CH2B), 25.5 (CH3), 23.9 (CH3) and 22.8 (CH3C=); m/z 
(CI+ mode, isobutane) 251 (17%), 233 (26), 205 (13), 194 (62), 166 (38), 152 (37), 139 
(100), 111 (25), 83 (52) and 69 (30) (Found M+, 250.1564. C15H22O3 requires M, 
250.1563).
^ 1 5 ^ 2 2 0 3  C 17H 260 3
Mol. Wt.: 250.33 Mol. Wt.: 278.39
rel-(lS , 4R  , 5/?)-4-(2-Hydroxy-but-3-enyl)-7,7-dimethyI-l-(3-methyl-but-3-enyI)-2- 
oxa-bicyclo[3.2.0]heptan-3-one 356
To a stirred solution of Yb(OTf)3 (87 mg, 0.14 mmol, 3.2 eq) in THF (4 ml) at —78°C 
was added vinylmagnesium bromide (1.0 M in THF, 0.14 ml, 0.14 mmol, 3.2 eq) and the 
mixture left for 15 min. Half of the orange coloured solution (2 ml, 0.07 mmol, 1.6 eq) 
was then added dropwise to a stirred solution of aldehyde 355 (11 mg, 0.04 mmol, 1 eq)
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in THF (0.2 ml) also at —78°C. After 20 min the remaining vinylytterbium solution (2 
ml, 0.07 mmol, 1.6 eq) was added to the reaction mixture and the reaction then left 
stirring at that temperature for 1 h. Aqueous saturated NaHCC>3 (1 ml) was then added 
before the addition of citric acid (30 mg, 0.14 mmol, 3.2 eq). The aqueous layer was 
separated and extracted with EtjO ( 4 x 1 5  ml). The combined organic layers were then 
dried (MgSC>4) and concentrated in vacuo to give the crude 356 as a 1:1 mixture of 
diastereoisomers. The residue was purified by column chromatography (eluting with 5% 
EtOAc in CH2CI2) to give one diastereoisomer of the ally lie alcohol 356 (2 mg, 0.01 
mmol, 16%) as a clear oil; 6H (400 MHz, CDCI3) 5.91-5.83 (1H, m, CH=CH2), 5.30 (1H, 
apparent d, 7 17.1, trans 1H from CH=CH2), 5.17 (1H, apparent d, 7 10.4, cis 1H from 
CH=CH2), 4.73 (1H, apparent s, 1H from C=CH2), 4.69 (1H, apparent s, 1H from 
C=CH2), 4.38 (1H, m, CHOH), 2.72 (1H, t, 7 7.7, CHCO), 2.55 (1H, t, 7 7.5, CCH2CH), 
2.19 (1H, d, 74.8, CHOH), 2.15-2.12 (1H, m, 1H from CH2A), 2.06-1.97 (3H, m, 2H from 
CH2b and 1H from CCH.CH), 1.93-1.83 (lH ,.m , 1H from CH2CHOH), 1.74 (3H, s, 
=CCH3), 1.72-1.61 (2H, m, 1H from CH2A and 1H from CH2CHOH), 1.50 (1H, dd, 7 
12.2, 7.5, 1H from CCH2CH), 1.21 (3H, s, CH3) and 1.10 (3H, s, CH3); m/z (CI+ mode, 
NH3) 279 (100%), 261 (3), 222 (3), 204 (2), 176 (2), 140 (2), 96 (10) and 79 (13) (Found 
M+, 278.1878. C17H26O3 requires M, 278.1875). ,3C NMR not obtained.
Further elution then gave the other diastereoisomer of allylic alcohol 356 as a clear oil (2 
mg, 0.01 mmols, 18%); 5H (400 MHz, CDCI3) 5.93 (1H, m, CH=CH2), 5.32 (1H, 
apparent d, 7 17.2, trans 1H from CH=CH2), 5.18 (1H, apparent d, 7 10.4, cis 1H from 
CH=CH2), 4.73 (1H, apparent s, 1H from C=CH2), 4.69 (1H, apparent s, 1H from 
C=CH2), 4.31-4.28 (1H, m, CHOH), 2.71 (1H, t, 7 7.0, CHCO), 2.55 (1H, t, 7 7.4, 
CCH2CH), 2.23 (1H, d, 74.2, CHOH), 2.14-2.10 (1H, m, 1H from CH2A), 2.06-1.90 (4H, 
m, 2H from CH2B, 1H from CCH2CH, 1H from CH2CHOH), 1.74 (3H, s, =CCH3), 1.72- 
1.62 (2H, m, 1H from CH2CHOH and 1H from CH2A), 1.50 (1H, dd, 7 12.2, 7.4, 1H from 
CCH2CH), 1.21 (3H, s, CH3) and 1.10 (3H, s, CH3). I3C NMR not obtained.
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361 362
Solid supported Homer-Wadsworth-Emmons reagent 362
Diethylphosphonoacetic acid (0.21 ml, 1.31 mmol, 5 eq) was added to a suspension of 
hydroxymethylpolystyrene 361 (0.87 mmol/g, 300 mg, 0.26 mmol, 1 eq), pre-swollen in 
THF (5 ml) in a SPS cartridge. N,N’-dicyclohexylcarbodiimide (269 mg, 1.31 mmol, 5 
eq) and DMAP (96 mg, 0.78 mmol, 3 eq) were then added and the reaction mixture 
‘rotated’ at room temperature for 5 h. The resin was then drained and washed using a 
general washing procedure described below.
General washing and drying procedure
The resin was washed once with THF (20 ml), then THF:H20  (1:1) (3 x 20 ml), then 
THF:H20  (1:2) (3 x 20 ml), then THF:H20  (2:1) (3 x 20 ml), then H20  (20 ml), then 
DMF (2 x 20 ml). The resin was then washed with CH2C12 (3 x 20 ml) and MeOH (3 x 20 
ml), alternating between the two solvents. The resin was then left to dry for 10 min under 
water pump pressure before being dried for 6 h under high vacuum which gave resin 362; 
\)max KBr/cm' 1 1735s (C=C>).
Solid supported thioacetal 363
A solution of aldehyde 280 (44 mg, 0.22 mmol, 5 eq) in MeCN (1.5 ml) was added to a 
solution of resin 362 (<0.87 mmol/g, 50 mg, 0.04 mmol, 1 eq) in MeCN (1 ml). LiBr (38
’P(OEt);
362 363
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mg, 0.43 mmol, 10 eq) and triethylamine (45 pi, 0.43 mmol, 10 eq) were then added and 
the reaction mixture stirred slowly at room temperature for 3 d. The resin was then 
washed and dried according to the general washing procedure to give resin 363; Umax 
KBr/cmf1 1719s (C=0), 1651s (C=C).
Solid supported aldehyde 364
To a slowly stirred solution of resin 363 (<0.87 mmol/g, 41 mg, 0.04 mmol, 1 eq) in 
MeCN (1 ml) and H20  (0.25 ml) were added CaC03 (32 mg, 0.32 mmol, 9 eq) and Mel 
(0.13 ml, 2.14 mmol, 60 eq). The mixture was then heated at 60°C for 3 d before a further 
quantity of Mel (0.13 ml, 2.14 mmol, 60 eq) was added. After a further 24 h the reaction 
mixture was allowed to cool to room temperature before being drained, washed and dried 
according to the general washing procedure to give resin 364; u max KBr/cm' 1 1735s 
(C=Q), 1719s (C=C>), 1651s (C=C).
362 366
Solid supported alcohol 366
A solution of lactol (697 mg, 6.83 mmol, 5 eq) in MeCN (15 ml) was added to a solution 
of resin 362 (<0.87 mmol/g, 1.57 g, 1.37 mmol, 1 eq) in MeCN (10 ml). LiBr (1.19 g, 
13.7 mmol, 10 eq) and triethylamine (1.41 ml, 13.7 mmol, 10 eq) were then added and
184
the reaction mixture stirred slowly at room temperature for 4 d. The resin was then 
washed and dried according to the general washing procedure to give resin 366; 1) ^  
KBr/cm' 1 1735s (C=0), 1656s (C=C).
Solid supported aldehyde 367
DMSO (2.75 ml, 38.8 mmol, 30 eq) and triethylamine (2.65 ml, 25.6 mmol, 19.8 eq) 
were added to a suspension of resin 366 (<0.87 mmol/g, 1.49 g, 1.29 mmol, 1 eq), pre­
swollen in CH2C12 (30 ml) in a SPS cartridge. After 5 min, pyridine-sulfur trioxide 
complex (2.35 g, 14.7 mmol, 11.4 eq) was added and the reaction mixture ‘rotated’ at 
room temperature for 6 d. The resin was then washed and dried according to the general 
washing procedure to give resin 367; t)max KBr/cm' 1 1735s (C=0), 1703s (CHO), 1651s
366 367
(C=C).
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Appendix 1 
The Captodative Effect
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The captodative effect138
The captodative effect is the combined action of an electron withdrawing group and an 
electron-donating group to stabilise a radical. Below is a simplified molecular orbital 
explanation of the captodative effect. First the separate stabilising effect of both the 
acceptor group and the donor group will be discussed.
The stabilising effect of the acceptor group
An acceptor group has the effect of lowering the SOMO of the hybridised ACH2 orbital 
in comparison to the SOMO of the CH3 radical (figure 5.1). It therefore has a stabilising 
influence on the radical since the SOMO has a lower energy than the SOMO of the CH3 
radical.
’ c h 3 a ch2 a
')----- LUMO
SOMO - j - (
figure 5.1
The stabilising effect of the donor group
A donor group has the effect of stabilising the radical through a three electron interaction, 
whereby the radical is stabilised overall but the SOMO becomes higher in energy than the 
analogous CH3 radical (figure 5.2).
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figure 5 .2
The combined stabilising effect of the donor and acceptor groups
As the frontier orbitals of the radical and donor or acceptor become closer in energy the 
degree of stabilisation increases. Therefore, in a ACHD system, if the radical is stabilised 
by the donor group, the hybrid SOMO orbital, being of higher energy than the analogous 
CH3 radical group, becomes closer in energy to the LUMO of the acceptor. The resultant 
effect is a greater degree of stabilisation exerted by the acceptor group. Similarly, the 
ACHD radical being stabilised by the acceptor group means the hybrid SOMO orbital is 
lower in energy than the analogous CH3 radical, thus becoming closer in energy to the 
HOMO of the donor group. The resultant effect is a greater degree of stabilisation exerted 
by the donor group.
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Appendix 2
Crystal structure data for rel-(lR , 2S)-2,2-Dimethyl-4-[re/-(S)-methyIsulfanyl- 
(toluene-4-sulfonyl)-methyl]-cyclobutan-l-ol 304
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Table 1. Crystal data and structure refinement
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions
Volume
Z
Density (calculated)
Absorption coefficient 
F(000)
Crystal size
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 29.96°
Absorption correction 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
for km2600.
DJ3-22-1
C 1 5 H 2 2 O 3 S 2
314.45
100(2) K
0.71073 A
Triclinic
P-l
a = 7.4696(2) A a= 108.3780(12)
b = 9.8584(2) A J3= 99.2964(13)°.
c = 12.0585(3) A y = 107.2420(13)
772.30(3) A3 
2
1.352 Mg/m3 
0.349 mm"1 
336
0.40 x 0.30 x 0.18 mm3 
3.51 to 29.96°.
-7 < h < 10, -13 < k < 12, -15 < 1 < 16 
6088
4403 [R(int) = 0.0182]
98.0 %
None
Full-matrix least-squares on F2 
4403/0 /186
1.006
R1 = 0.0301, wR2 = 0.0862 
R1 = 0.0335, wR2 = 0.0890 
0.36 and -0.49 e.A"3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A ^  103) 
for km2600. U(eq) is defined as one third of the trace of the orthogonalized U'J tensor.
X y z U(eq)
S(l) -1245(1) -1605(1) 933(1) 13(1)
S(2) 2737(1) -1743(1) 1566(1) 13(1)
0 ( 1 ) 3676(1) -3002(1) -1449(1) 20(1)
0(2) 4539(1) -1394(1) 1218(1) 19(1)
0(3) 1919(1) -3227(1) 1637(1) 18(1)
C(l) 559(2) -3065(1) -2672(1) 13(1)
C(2) 2217(2) -2356(1) -1465(1) 13(1)
C(3) 661(2) -2730(1) -785(1) 12(1)
C(4) -845(2) -2802(1) -1870(1) 14(1)
C(5) 950(2) -1558(1) 473(1) 12(1)
C(6) 3091(2) -295(1) 2980(1) 13(1)
C(7) 4111(2) 1235(1) 3186(1) 16(1)
C(8) 4399(2) 2373(1) 4310(1) 17(1)
C(9) 3690(2) 1997(1) 5219(1) 17(1)
C(10) 2670(2) 454(1) 4986(1) 19(1)
C (ll) 2354(2) -700(1) 3870(1) 17(1)
C(12) 747(2) -2211(1) -3526(1) 17(1)
C(13) 106(2) -4781(1) -3351(1) 20(1)
C(14) -2557(2) -3627(1) 542(1) 20(1)
C(15) 4014(2) 3233(2) 6435(1) 25(1)
In the reference molecule C(2), C(3) and C(5) have respectively R, S and S absolute configurations.
Table 3. Bond lengths [A] and angles [°] for km2600.
S(l)-C(14)
S(l)-C(5)
S(2)-0(3)
S(2)-0(2)
S(2)-C(6)
S(2)-C(5)
0(1)-C(2)
C(l)-C(12)
C(l)-C(13)
C(l)-C(2)
C(l)-C(4)
1.8054(12)
1.8064(10)
1.4446(8)
1.4518(8)
1.7635(11)
1.8111(10)
1.4162(13)
1.5206(15)
1.5309(15)
1.5500(15)
1.5592(15)
C(2)-C(3)
C(3)-C(5)
C(3)-C(4)
C(6)-C(7)
C(6)-C(ll)
C(7)-C(8)
C(8)-C(9)
C(9)-C(10)
C(9)-C(15)
C(10)-C(ll)
1.5506(14)
1.5239(14)
1.5499(14)
1.3921(15)
1.3946(15)
1.3949(16)
1.3955(16)
1.3954(17)
1.5095(16)
1.3909(16)
C(14)-S(l)-C(5)
0(3)-S(2)-0(2)
0(3)-S(2)-C(6)
0(2)-S(2)-C(6)
0(3)-S(2)-C(5)
0(2)-S(2)-C(5)
C(6)-S(2)-C(5)
C(12)-C(l)-C(13)
C(12)-C(l)-C(2)
C(13)-C(l)-C(2)
C(12)-C(l)-C(4)
C(13)-C(l)-C(4)
C(2)-C(l)-C(4)
0(1)-C(2)-C(1)
0(1)-C(2)-C(3)
C(l)-C(2)-C(3)
C(5)-C(3)-C(4)
103.47(5)
117.84(5)
108.71(5)
108.55(5)
108.61(5)
106.66(5)
105.83(5)
111.21(9)
116.73(9)
112.37(9)
116.07(9)
111.60(9)
86.85(8)
116.15(9)
119.75(9)
89.30(8)
117.41(8)
C(5)-C(3)-C(2)
C(4)-C(3)-C(2)
C(3)-C(4)-C(l)
C(3)-C(5)-S(l)
C(3)-C(5)-S(2)
S(l)-C(5)-S(2)
C(7)-C(6)-C(ll)
C(7)-C(6)-S(2)
C(ll)-C(6)-S(2)
C(6)-C(7)-C(8)
C(7)-C(8)-C(9)
C(10)-C(9)-C(8)
C(10)-C(9)-C(15)
C(8)-C(9)-C(15)
C(ll)-C(10)-C(9)
C(10)-C(ll)-C(6)
118.33(9)
87.16(8)
88.99(8)
115.86(7)
108.25(7)
112.24(5)
121.26(10)
119.12(8)
119.62(8)
118.83(10)
121.03(11)
118.88(10)
120.31(11)
120.81(11)
121.13(10)
118.86(10)
Note: intramolecular hydrogen bond:
0(1)-H(1)...0(2) O-H = 0.84 A, O...H = 2.26 A, 0(1)...0 (2)=  2.9628(12) A, ZO-H...O = 140.77°.
Table 4. Anisotropic displacement parameters (A2x lO^for km2600. The anisotropic 
displacement factor exponent takes the form: -2t &[ h2a*2Un + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 u 12
S(l) 12(1) 14(1) 13(1) 4(1) 5(1) 5(1)
S(2) 12(1) 15(1) 12(1) 5(1) 4(1) 6(1)
0(1) 20(1) 32(1) 16(1) 11(1) 8(1) 17(1)
0(2) 13(1) 28(1) 17(1) 7(1) 6(1) 9(1)
0(3) 23(1) 16(1) 18(1) 8(1) 5(1) 9(1)
C(l) 16(1) 15(1) 11(1) 6(1) 5(1) 7(1)
C(2) 14(1) 17(1) 13(1) 7(1) 6(1) 8(1)
C(3) 14(1) 12(1) 10(1) 4(1) 5(1) 5(1)
C(4) 14(1) 17(1) 11(1) 5(1) 4(1) 5(1)
C(5) 12(1) 13(1) 11(1) 5(1) 4(1) 5(1)
C(6) 12(1) 16(1) 11(1) 5(1) 3(1) 5(1)
C(7) 13(1) 19(1) 15(1) 8(1) 4(1) 5(1)
C(8) 15(1) 18(1) 17(1) 6(1) 2(1) 5(1)
C(9) 16(1) 22(1) 13(1) 5(1) 2(1) 10(1)
C(10) 22(1) 24(1) 15(1) 10(1) 7(1) 9(1)
C (ll) 19(1) 19(1) 16(1) 9(1) 6(1) 6(1)
C(12) 21(1) 21(1) 14(1) 9(1) 7(1) 11(1)
C(13) 28(1) 16(1) 15(1) 5(1) 8(1) 9(1)
C(14) 17(1) 16(1) 24(1) 6(1) 9(1) 3(1)
C(15) 29(1) 27(1) 15(1) 3(1) 3(1) 13(1)
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A ^  103) 
for km2600.
X y z U(eq;
H(l) 4430 -2624 -741 30
H(2) 2833 -1217 -1220 16
H(3) 400 -3777 -767 14
H(4A) -1057 -1826 -1741 17
H(4B) -2102 -3682 -2146 17
H(5) 1551 -517 453 14
H(7) 4603 1499 2573 19
H(8) 5088 3421 4458 21
H(10) 2184 188 5600 23
H(ll) 1648 -1747 3716 21
H(12A) 1799 -2330 -3893 25
H(12B) 1050 -1117 -3066 25
H(12C) -486 -2637 -4169 25
H(13A) -1129 -5232 -3996 29
H(13B) -4 -5301 -2780 29
H(13C) 1160 -4908 -3712 29
H(14A) -2760 -4197 -325 30
H(14B) -3825 -3776 713 30
H(14C) -1797 -4007 1028 30
H(15A) 5234 3397 6997 37
H(15B) 2922 2912 6769 37
H(15C) 4097 4194 6330 37
All hydrogen atoms were observed in difference maps. All rode on their parent C-atoms. Orientation 
parameters were refined for the four methyl groups and for H(l).
Table 6. Torsion angles [°] for km2600.
C(12)-C(l)-C(2)-0(1) -98.39(11) 0(2)-S(2)-C(5)-C(3) 61.61(8)
C(13)-C(l)-C(2)-0(1) 31.79(13) C(6)-S(2)-C(5)-C(3) 177.07(7)
C(4)-C(l)-C(2)-0(1) 143.89(9) 0(3)-S(2)-C(5)-S(l) 62.77(7)
C(12)-C(l)-C(2)-C(3) 138.46(9) 0(2)-S(2)-C(5)-S(l) -169.27(5)
C(13)-C(l)-C(2)-C(3) -91.35(9) C(6)-S(2)-C(5)-S(l) -53.80(7)
C(4)-C(l)-C(2)-C(3) 20.74(8) 0(3)-S(2)-C(6)-C(7) 171.31(8)
0(1)-C(2)-C(3)-C(5) 99.29(11) 0(2)-S(2)-C(6)-C(7) 41.99(10)
C(l)-C(2)-C(3)-C(5) -140.66(9) C(5)-S(2)-C(6)-C(7) -72.18(9)
0(1)-C(2)-C(3)-C(4) -140.91(10) 0(3)-S(2)-C(6)-C(l 1) -8.45(11)
C(l)-C(2)-C(3)-C(4) -20.87(8) 0(2)-S(2)-C(6)-C(l 1) -137.78(9)
C(5)-C(3)-C(4)-C(l) 141.37(9) C(5)-S(2)-C(6)-C(ll) 108.05(9)
C(2)-C(3)-C(4)-C(l) 20.74(8) C(11)-C(6)-C(7)-C(8) 0.23(16)
C(12)-C(l)-C(4)-C(3) -139.09(9) S(2)-C(6)-C(7)-C(8) -179.53(8)
C(13)-C(l)-C(4)-C(3) 92.09(9) C(6)-C(7)-C(8)-C(9) 0.28(17)
C(2)-C(l)-C(4)-C(3) -20.75(8) C(7)-C(8)-C(9)-C(10) -0.34(17)
C(4)-C(3)-C(5)-S(l) 51.87(11) C(7)-C(8)-C(9)-C(15) 179.69(11)
C(2)-C(3)-C(5)-S(l) 154.36(8) C(8)-C(9)-C(10)-C(ll) -0.09(17)
C(4)-C(3)-C(5)-S(2) 178.94(7) C(15)-C(9)-C(10)-C(l 1) 179.88(11)
C(2)-C(3)-C(5)-S(2) -78.58(10) C(9)-C(10)-C(ll)-C(6) 0.58(17)
C(14)-S(l)-C(5)-C(3) 46.25(9) C(7)-C(6)-C(l 1)-C(10) -0.65(17)
C(14)-S(l)-C(5)-S(2) -78.79(7) S(2)-C(6)-C(l 1)-C(10) 179.11(9)
0(3)-S(2)-C(5)-C(3) -66.35(8)
Appendix 3
Crystal structure data for rel-(lR, 4R)-4-(2-Hydroxy-(IR)-l-deutero-methyl-ethyl)-
2,2-dimethyl cyclobutanol 311
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Table 1. Crystal data and structure refinement for km02 99.
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength
Crystal system, space group 
Unit cell dimensions
Volume
Z, Calculated density 
Absorption coefficient 
F ( 0 0 0 )
Crystal size
Theta range for data collection 
Index ranges
Reflections collected / unique
Absorption correction
Refinement method
Data / restraints / parameters
Goodness-of-fit on FA2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole 
Weight
where P = ( Max ( Fo a2, 0 ) + 2
km0299 
C9 H18 02 
158.23 
123(2) K 
0.71073 A
Orthorhombic, Pbna (No 60)
a = 8.2540(16) A
b = 11.2290(15) A 
c = 20.088(2) A
1861.8(5) A a3
8, 1.12 9 Mg/mA3
0.077 mm''-1
704
0.20 x 0.15 x 0.15 mm 
2.67 to 23.95 deg.
-l<=h<=9, -12<=k<=l, -22<=1<=2 
2044 / 1454 [R(int) = 0.0562]
None
Full-matrix least-squares on FA2
1454 / 0 / 111
1.026
R1 = 0.0505, wR2 = 0.1181 [933 data] 
R1 = 0.0977, wR2 = 0.1405 
0.19 and -0.27 e.AA-3 
1/[sigmaA2 (Fo a2) + (0.0760 * P)A2] 
FcA2 ) / 3
Note 1
Note 2
Table 2. Atomic coordinates ( x 10A4) and isotropic 
displacement parameters (Aa2 x  10a3) for km0299.
U(eq) is defined as one third of the trace of the orthogonalized 
Uij tensor for non-hydrogen atoms and is the isotropic 
displacement parameter for hydrogen atoms.
X y z U(eq)
0(1) 5184(2) 7239(2) 2956(1) 24(1)
0(2) 2086 (2) 3556(2) 2728 (1) 19 (1)
C(l) 2954 (3) 4686 (2) 3774(1) 17 (1)
C (2) 1636 (3) 4266 (2) 3286 (1) 16(1)
C (3) 668 (3) 3688 (2) 3865(1) 17 (1)
C (4) 1732 (3) 4435 (2) 4344(1) 21(1)
C (5) 4629 (3) 6050 (2) 3077(1) 18 (1)
C (6) 3617 (3) 5943 (2) 3705(1) 16(1)
C (7) 4580 (4) 6299 (2) 4323(1) 26(1)
C (8) -1146 (3) 3955 (2) 3878(1) 22 (1)
C (9) 981(3) 2361(2) 3920(1) 24(1)
H (1) 4400 (42) 7660 (28) 2743(16) 39(9)
H (2) 2870(44) 3070 (28) 2866 (16) 43 (10)
H (1A) 3863 4097 3788 20
H(2A) 1026 4978 3123 19
H(4A) 2198 3965 4715 25
H(4B) 1187 5159 4513 25
H(5A) 5579 5516 3114 22
H(5B) 3976 5781 2692 22
H(6) 2676 6499 3663 19
H(7A) 3882 6245 4716 38
H(7B) 4969 7119 4273 38
H(7C) 5508 5763 4376 38
H(8A) -1316 4818 3869 32
H(8B) -1621 3625 4286 32
H(8C) -16 66 3591 3490 32
H(9A) 521 2062 4337 36
H(9B) 2151 2213 3914 36
H(9C) 473 1950 3543 36
O-bonded H(l) and H(2) were freely refined. An orientation parameter 
was refined for each of the three methyl groups. Otherwise H atoms 
rode on their parent C atoms.
These coordinates define a molecule in which atoms C(l), C(2)
& C(6) each have absolute configuration R.
Table 3. Bond lengths [A] and angles [deg] for km0299.
0(1 -C (5 1.432 (3)
0(2 -C (2 1.425 (3)
C(1 -C (6 1.520 (3)
C(1 -C (2 1.538 (4)
C(1 -C (4 1.552 (4)
C (2 -C (3 1.552 (4)
C (3 -C (9 1.516(4)
C (3 -C (8 1.527(4)
C (3 -C (4 1.550 (4)
C (5 -C (6 1.517 (4)
C (6 -C (7 1.528(4)
C (6 -C(l -C (2) 118.8 (2)
C (6 -C(l -C (4) 118.0(2)
C (2 -C(l -C (4) 87.40 (19)
0(2 -C (2 -C(l) 119.2(2)
0(2 -C (2 -C (3) 119.3 (2)
C(1 -C (2 -C (3) 90.91(19)
C (9 -C (3 -C (8) 111.0(2)
C (9 -C (3 -C (4) 112.9(2)
C (8 -C (3 -C (4) 116.0(2)
C (9 -C (3 -C (2) 112.2 (2)
C (8 -C (3 -C (2) 115.9(2)
C (4 -C (3 -C (2) 86.98 (18)
C (3 -C (4 -C(l) 90.44(19)
0(1 -C (5 -C (6) 113.1(2)
C (5 -C (6 -C(l) 110.4 (2)
C (5 -C (6 -C (7) 111.6 (2)
C(1 -C (6 -C (7) 110.9 (2)
Table 4. Anisotropic displacement parameters (Aa2 x  10a3) for km02 99. 
The anisotropic displacement factor exponent takes the form:
-2 piA2 [ hA2 a*A2 Ull + ... + 2 h k a* b* U12 ]
Ull U22 U33 U23 U13 U12
0(1) 18(1) 24(1) 32(1) 11(1) -4(1) -5(1)
0(2) 17 (1) 22 (1) 18(1) -3 (1) -2(1) 3 (1)
C(l) 15 (i) 17 (1) 18(1) 0(1) -2(1) 1(1)
C (2) 15(1) 16(1) 16(1) -4(1) -1(1) 4(1)
C (3) 16(1) 19(1) 16(1) 0(1) 0(1) -2 (1)
C (4) 23(2) 23 (2) 17 (1) 2(1) -1(1) -4(1)
C(5) 16(1) 17(1) 22(1) 1(1) 0(1) -4(1)
C (6) 14(1) 16(1) 19(1) 0(1) -1(1) -1(1)
C (7) 28 (2) 25(2) 23 (2) -3(1) 1(1) -11(1)
C(8) 19(2) 22(1) 24(1) -1(1) 2 (1) -2 (1)
C (9) 20(1) 22 (1) 30(2) 4(1) -2 (1) -3 (1)
Table 5. Torsion angles [deg] for km0299.
C (6 -C(l -C (2 -0(2) 99.0 (3)
C (4 -C(l -C (2 -0(2) -140.3 (2)
C (6 -0(1 -C (2 -C (3) -136.3 (2)
C (4 -C(l -C (2 -C (3) -15.57(19)
0(2 -C (2 -C (3 -C (9) 26.7 (3)
C(1 -C (2 -C (3 -C (9) -98.0 (2)
0(2 -C (2 -C (3 -C (8) -102 .2 (3)
C(1 -C (2 -C (3 -C (8) 133.2 (2)
0(2 -C (2 -C (3 -C (4) 140.2 (2)
C(1 -C (2 -C (3 -C (4) 15.6 (2)
C (9 -C (3 -C (4 -C(l) 97.4(2)
C (8 -C (3 -C (4 -C(l) -132.9 (2)
C (2 -C (3 -C (4 -C(l) -15.45 (19)
C (6 -C(l -C (4 -c (3) 137.0 (2)
C (2 -C(l -C (4 -C (3) 15.59(19)
0(1 -C (5 -C (6 -C(l) 175.4 (2)
0(1 -C (5 -C (6 -C(7) -60.9 (3)
C (2 -C(l -C (6 -C (5) -69.9 (3)
C (4 -0(1 -C (6 -C (5) -173 .4 (2)
C (2 -C(l -C (6 -C(7) 165 .9 (2)
C (4 -C(l -C (6 -C (7) 62.4 (3)
Table 6. Hydrogen-bonds for km0299 [A and deg.].
D-H...A d(D-H) d(H...A) d(D...A) < (DHA)
0(1)-H(l)...0(2)#1 0.91(4) 1.84(4) 2.754(3) 176(3)
0(2)-H(2)...0(1)#2 0.89(4) 1.87(4) 2.734(3) 164(3)
Symmetry transformations used to generate equivalent atoms: 
#1 -x+1/2,y+l/2,-z+1/2 #2 -x+l,y-l/2,z
Appendix 4
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Table 1. Crystal data and structure refinement for
Identification code
Empiirical formula
Fornuula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Z
Density (calculated) 
Absorption coefficient 
Absorption correction 
F(OOO)
Crystal size
0 range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
R indices [2504 I>2o(I)]
R indices (all data)
Largest diff. peak and hole
km0500. 
km0500 
C18H21N 06 
347.36 
293(2)K 
0.71073 A 
Triclinic 
P - l
a = 6.5693(6) A 0=85.814(11)°
b = 7.6665(10) A p= 81.746(10)°.
c = 19.936(2) A y = 62.170(12)°.
878.70(18) A3 
2
1.313 Mg/m3 
0.099 mm'1 
None 
368
0.40x0.35x0.18 mm3
3.0 to 30.0°.
-9 < h < 8, -10 < k < 1, -27 < 1 < 27 
6176
5116 [R(int) = 0.0435]
Full-matrix least-squares on F2
5 1 16 /0 / 229
0,996
R1 =0.0506, wR2 = 0.1252 
R1 = 0.1339, wR2 = 0.1550 
0.19 and -0.23 e.A 3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103) 
for km<0500. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x y z U(eq)
0(1) 5080(2) 9549(2) 1202(1) 56(1)
0(2) 7678(2) 7916(2) 1908(1) 81(1)
0(3) 2562(2) 6949(2) 3542(1) 59(1)
0(4) -638(3) 7011(3) 4117(1) 85(1)
0(5) 6150(3) 8268(3) 6402(1) 90(1)
0(6) 3325(3) 8072(3) 7017(1) 86(1)
N(l) 4396(3) 8082(2) 6471(1) 60(1)
C(l) 1395(3) 12622(3) 1183(1) 53(1)
C(2) 2594(3) 10346(3) 1174(1) 46(1)
C(3) 1605(3) 10330(3) 1920(1) 46(1)
C(4) 1068(4). 12501(3) 1965(1) 62(1)
C(5) 5684(3) 8684(3) 1802(1)' 54(1)
C(6) 3602(3) 8813(3) 2271(1) 48(1)
C(7) 3652(3) 6796(3) 2355(1) 57(1)
C(8) 1856(3) • 6748(3) 2905(1) 58(1)
C(9) 1163(3) 7070(3) 4104(1) 51(1)
C(10) 2064(3) 7307(2) 4715(1) 46(1)
C(ll) 3947(3) 7670(3) 4663(1) 52(1)
C(12) 4705(3) 7921(3) 5240(1) 55(1)
C(13) 3566(3) 7808(2) 5859(1) 47(1)
C(14) 1714(3) 7420(3) 5927(1) 60(1)
C(15) 972(3) 7172(3) 5349(1) 59(1)
CO 6) 2777(4) 13650(4) 868(1) 87(1)
C(17) -933(4) 13491(4) 908(1) 87(1)
C(18) 2305(4) 9242(3) 632(1) 72(1)
Table 3. Bond lengths [Aj and angles [°] for km0500.
()(1)-C(.'5) 1.344(2) C(2)-C(3) 1.537(2)
()(1)-C(2) 1.4602(19) C(3)-C(6) 1.511(2)
()(2)-C(5) 1.203(2) C(3)-C(4) 1.538(3)
()(3)-C('9) 1.3232(19) C(5)-C(6) 1.508(2)
()(3)-C( 8) 1.455(2) C(6)-C(7) 1.528(2)
()(4)-C(9) 1.201(2) C(7)-C(8) 1.503(3)
0(5)-N( 1) 1.214(2) C(9)-C(10) 1.485(2)
()(6)-N(T) 1.2097(18) C(10)-C(ll) 1.378(2)
N(l)-C( 13) 1.472(2) C(10)-C(15) 1.383(2)
C(l)-C( 16) 1.507(3) C(ll)-C(12) 1.375(2)
C(l)-C(17) 1.523(3) C(12)-C(13) 1.369(2)
C(t)-C(2) 1.544(2) C(13)-C(14) 1.368(2)
C(l)-C(4) 1.544(2) C(14)-C(15) 1.372(3)
C(2)-CC 18) 1.505(2)
C(5)-O0)-C(2) 111.78(13) 0(2)-C(5)-0(l) 120.59(17)
C(9)-0((3)-C(8) 117.66(14) 0(2)-C(5)-C(6) 128.20(17)
()(6)-N<(l)-0(5) 123.38(17) 0(1)-C(5)-C(6) 111.21(14)
()(6)-N(l)-C(13) 118.54(17) C(5)-C(6)-C(3) 102.42(13)
0(5)-N( 1 )-C( 13) 118.06(15) C(5)-C(6)-C(7) 110.73(14)
C(I6)-C(1)-C(17) 110.28(18) C(3)-C(6)-C(7) 113.91(14)
C(16)-C(l)-C(2) 117.99(16) C(8)-C(7)-C(6) 113.26(15)
C(17)-C(l)-C(2) 111.31(16) 0(3)-C(8)-C(7) 106.26(14)
C( I6)-C(l )-C(4) 116.81(17) 0(4)-C(9)-C)(3) 123.70(17)
C( I7)-C(l)-C(4) 110.76(16) O(4)-C(9)-C(10) 124.08(16)
C(2)-C(l)-C(4) 88.01(12) O(3)-C(9)-C(10) 112.22(14)
C)(1 )-C (2)-C( 18) 107.32(14) C(ll)-C(10)-C(15) 119.48(16)
()(1)-C(2)-C(3) 103.37(12) C(ll)-C(10)-C(9) 121.52(14)
C( 18)-C(2)-C(3) 122.64(15) C(15)-C(10)-C(9) 119.00(15)
()(l)-C(2)-C(l) 110.57(13) • C(12)-C(ll)-C(10) 119.95(15)
C(I8)-C(2)-C(1) 121.33(15) C(13)-C(12)-C(ll) 119.17(16)
C(3)-C'(2)-C(l) 89.67(12) C(14)-C(13)-C(12) 122.23(17)
C(6)-C'(3)-C(2) 105.84(13) C(14)-C(13)-N(l) 119.20(15)
C(6)-C(3)-C(4) 117.33(15) C(12)-C(13)-N(l) 118.56(16)
C(2)-C(3)-C(4) 88.44(12) C(13)-C(14)-C(15) 118.09(16)
C(3)-C(4)-C(l). 89.64(13) C(14)-C(15)-C(10) 121.07(16)
Table 4. Anisotropic displacement parameters (A2x 103)for km0500. The anisotropic
displace ment factor exponent takes the form: -27t2[ h2a*2UH + .. . + 2 h k a *  b* UI2J
U 11 U22 u33 U23 u 13 u 12
0(1) 42(1) 69(1) 51(1) -2(1) 1(1) -22(1)
0(2) 48(1) 93(1) 98(1) -1(1) -25(1) -24(1)
0(3) 56(1) 81(1) 44(1) 3(1) -9(1) -36(1)
0(4) 78(1) 138(2) 70(1) -4(1) -4(1) -77(1)
0(5) 86(1) 148(2) 62(1) -9(1) -10(1) -72(1)
0(6) 93(1) 119(1) 46(1) -14(1) 7(1) -52(1)
N(l) 62(1) 67(1) 46(1) -5(1) -3(1) -26(1)
CO) 57(1) 54(1) 49(1) 3(1) -9(1) -26(1)
C(2) 45(1) 54(1) 41(1) -4(1) -7(1) -23(1)
C(3) 42(1) 53(1) 42(1) -1(1) -3(1) -21(1)
C(4) 66(1) 53(1) ■ 51(1) -9(1) -2(1) -15(1)
C(5) 47(1) 55(1) 58(1) -6(1) -12(1) -20(1)
C(6) 52(1) 51(1) 38(1) -5(1) -9(1) -20(1)
C(7) 68(1) 53(1) 46(1) -2(1) -11(1) -23(1)
C(8) 70(1) 64(1) 49(1) 6(1) -18(1) -36(1)
C(9) 52(1) 55(1) 51(1) 4(1) -4(1) -29(1)
C(IO) 42(1) 41(1) 50(1) 2(1) -3(1) -17(1)
C(l l ) 50(1) 66(1) 43(1) 6(1) -1(1) -31(1)
C(l 2) 50(1) 68(1) 53(1) 7(1) -4(1) -33(1)
CO 3) 46(1) 46(1) 43(1) 0(1) -2(1) -17(1)
CO 4) 54(1) 76(1) 47(1) ' 0(1) 7(1) -32(1)
C(15) 51(1) 79(1) 55(1) 2(1) 2(1) -39(1)
C(16) 99(2) 72(2) 95(2) 7(1) . -1(1) -47(1)
C( 17) 74(1) 76(2) 96(2) 10(1) -37(1) -16(1)
C(18) 92(2) 79(2) ' 51(1) -7(1) -19(1) -42(1)
Table 5. Torsion angles [°] for km0500.
C(5)-0(l)-C(2)-C(18) -116.48(16) C(2)-C(3)-C(6)-C(5) 21.81(17)
C(5)-()(l)-C(2)-C(3) 14.43(17) C(4)-C(3)-C(6)-C(5) -74.78(17)
C(5)-0(1)-C(2)-C(l) 109.18(16) C(2)-C(3)-C(6)-C(7) -97.79(16)
C( 16)-C(1)-C(2)-()(1) ' 30.8(2) C(4)-C(3)-C(6)-C(7) 165.62(14)
C( 17)-C( 1 )-C(2)-()( 1) 159.77(16) C(5)-C(6)-C(7)-C(8) 170.15(14)
C(4)-C( 1 )-C(2)-()(l) -88.69(14) C(3)-C(6)-C(7)-C(8) -75.06(18)
C(I6)-C(1)-C(2)-C(18) -96.1(2) C(9)-0(3)-C(8)-C(7) 175.93(14)
C( 17)-C( 1 )-C(2)-C(l 8) 32.8(2) C(6)-C(7)-C(8)-0(3) -68.68(19)
C(4)-C( 1)-C(2)-C(18) 144.38(17) C(8)-0(3)-C(9)-0(4) 0.4(3)
C( 16)-C( 1 )-C(2)-C(3) 134.98(18) C(8)-O(3)-C(9)-C(10) -178.97(14)
C( 17)-C( 1)-C(2)-C(3) -96.06(17) 0(4)-C(9)-C( 10)-C( 11) -169.81(18)
C(4)-C(l)-C(2)-C(3) 15.48(13) O(3)-C(9)-C(10)-C(l 1) 9.6(2)
()(1 )-C(2)-C(3)-C(6) -22.45(16) 0(4)-C(9)-C( 10)-C( 15) 9.7(3)
C(I8)-C(2)-C(3)-C(6) 98.59(19) O(3)-C(9)-C(10)-C(15) -170.87(15)
C( 1 )-C(2)-C(3)-C(6) -133.54(13) C(15)-C(10)-C(ll)-C(12) -0.9(3)
()(1 )-C(2)-C(3)-C(4) 95.56(14) C(9)-C(10)-C(ll)-C(12) 178.67(16)
C( 18)-C(2)-C(3)-C(4) -143.40(17) C(10)-C(ll)-C(12)-C(13) -0.1(3)
C(l)-C(2)-C(3)-C(4) -15.53(13) C(ll)-C(12)-C(13)-C(14) 1.1(3)
C(6)-C(3)-C(4)-C(l) 122.58(15) C(11)-C(12)-C(13)-N(1) -179.94(15)
C(2)-C(3)-C(4)-C(l) 15.53(13) 0(6)-N( 1 )-C( 13)-C( 14) . -4.3(3)
C( 16)-C( 1 )-C(4)-C(3) -136.03(18) 0(5)-N(l)-C(13)-C(14) 174.27(17)
C(I7)-C(1)-C(4)-C(3) 96.61(17) 0(6)-N(l)-C(13)-C(12) 176.63(16)
C(2)-C(D-C(4)-C(3) -15.46(13) 0(5)-N(l)-C(13)-C( 12) -4.7(3)
C(2)-0(l)-C(5)-()(2) 178.62(16) C(12)-C(13)-C(14)-C(15) -1.1(3)
C(2)-()(l)-C(5)-C(6) -0.51(19) N(l)-C(13)-C(14)-C(15) 179.97(17)
()(2)-C(5)-C(6)-C(3) 167.12(19) C(13)-C(14)-C(15)-C(10) 0.1(3)
()(1 )-C(5)-C(6)-C(3) -13.84(18) C(ll)-C(10)-C(15)-C(14) 0.9(3)
()(2)-C(5)-C(6)-C(7) -71.1(2) C(9)-C(10)-C(15)-C(14) -178.67(17)
()(1)-C(5)-C(6)-C(7) 107.96(16)
